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introduction
Heart failure (HF) remains one of the major public health problems in developed 
countries. In United States, nearly 6 million patients have HF symptoms and 500,000 
new patients are diagnosed yearly.1 Recently, important advances in HF therapy, such 
as cardiac resynchronization therapy (CRT), have improved the outcome of these 
patients.2 However, the prognosis remains poor with a 5-year mortality of 42.3% after 
hospitalization for HF.1
Selection of HF patients who are candidates for device therapies (such as CRT) 
is crucial to optimize the therapy results while minimizing the risk of potential 
complications (including lack of response to the device therapy). Advanced imag-
ing techniques have helped to better understand the pathologic substrate of heart 
failure patients and have provided novel insight into the determinants of response 
to therapy.
The study of cardiac mechanics and in particular, left ventricular (LV) strain and 
twist are important aspects of cardiac mechanics.3, 4 LV strain refers to the deforma-
tion of the LV, which occurs in the longitudinal, circumferential and radial directions. 
Furthermore, the spiral architecture of LV myofibers lead to a characteristic motion 
of rotation of the LV apex and base in opposite directions, counterclockwise and 
clockwise as viewed from the LV apex, respectively. The opposite rotation of LV apex 
and base leads to a LV systolic wringing motion during systole referred to as twist or 
torsion. In particular, LV twist is the net difference at isochronal time points between 
apex and base in the rotation angle along LV longitudinal axis, whereas LV torsion 
is LV twist indexed to the distance between LV apex and LV base.5 This characteristic 
motion of the LV contributes significantly to LV systolic and diastolic function. In 
the last decade, assessment of myocardial strain and twist has emerged as novel LV 
functional parameters for risk stratification of patients with structural heart disease.
Nowadays, echocardiography and magnetic resonance imaging allow the study 
of LV mechanics. However, echocardiography remains as the imaging technique of 
first choice due to its wide availability and less time-consuming analysis compared 
with magnetic resonance imaging. Two-dimensional (2D) speckle tracking, tissue 
Doppler imaging and, less frequently, calibrated integrated backscatter imaging, are 
the echocardiographic techniques to assess several aspects of LV mechanics. From 
2D speckle tracking echocardiography, the assessment of active myocardial defor-
mation in multiple directions (radial, circumferential and longitudinal) and LV twist 
can be obtained. From tissue Doppler imaging, velocities and indirect information 
on deformation may be derived. Integrated backscatter, finally, through the analysis 
of assessment of myocardial ultrasound reflectivity, may quantify the percentage of 
myocardial fibrosis.
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2d speckle tracking echocardiography
Based on 2D gray scale echocardiographic images, the myocardium exhibit natural 
acoustic markers or speckles that can be tracked frame-to-frame using speckle track-
ing software. Speckles are randomly distributed within the myocardium and the spe-
cific distribution of the speckles provides a distinguished pattern to each myocardial 
region, such as a fingerprint. The movement of the speckles along the cardiac cycle 
is tracked frame-to-frame independently from the ultrasound beam insonation angle 
permitting the evaluation of myocardial contraction/relaxation along the circumferen-
tial, longitudinal and radial direction.6, 7 The LV contraction in these 3 directions leads 
to rotation movement of the left ventricle. The speckle tracking software calculates LV 
rotation from the apical and basal short-axis images as the average angular displace-
ment of the 6 standard segments referring to the ventricular centroid, frame by frame. 
Counterclockwise rotation is marked as positive value and clockwise rotation as nega-
tive value when viewed from the LV apex. LV twist is defined as the net difference (in 
degrees) of apical and basal rotation at isochronal time points.8
figure 1. Examples of left ventricular (LV) twist in normal control (panel A) and in heart failure patient (panel 
B). In both panels, the upper parts represent apical and basal rotations and the lower parts represent LV twist 
calculation after exporting the data to a spreadsheet program (Excel 2003; Microsoft Corporation, Redmond, 
Washington). AVC: aortic valve closure. AVO: aortic valve opening.
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tissue doppler imaging
Tissue Doppler imaging (TDI) permits the assessment of low velocities of the myo-
cardium along the cardiac cycle. TDI can be applied with pulsed-wave Doppler or 
with color-coded TDI. While pulsed-wave TDI permits assessment of one myocardial 
region on-line, color-coded TDI permits assessment of several regions simultane-
ously off-line. In contrast to 2D speckle tracking echocardiography, the measurement 
of myocardial velocities with TDI is insonation angle dependent and therefore, the 
analysis is frequently limited to the basal and midventricular regions. From spatial 
derivation of myocardial velocities, regional strain rate can be obtained and from 
further temporal integration of strain rate, myocardial strain can be obtained.
The assessment of myocardial velocities and the time elapsed between electrical 
and mechanical (velocities) phenomena provide an estimate of the electromechani-
cal delay within the myocardium. It has been hypothesized that the time delay be-
tween the P-wave on the surface ECG and the A’ wave on TDI (total atrial conduction 
time) may reflect the amount of myocardial fibrosis. Total atrial conduction time may 
be estimated with color-coded tissue Doppler images by first placing the sample 
figure 2. The time-interval from the beginning of the electrocardiogram P wave and the peak of A’LATERAL wave 
(PA-TDI duration) was obtained with tissue Doppler images by placing the sample size on the LA lateral wall 
just above the mitral annulus; next the PA-TDI duration was measured.
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size on the LA lateral wall just above the mitral annulus. Next, the time-interval from 
the onset of the P-wave on lead II of the electrocardiogram (on echocardiographic 
images) to the peak of A’LATERAL wave (PA-TDI duration) is measured and an estima-
figure 3: Example of assessment of LV fibrosis in the antero-septal and posterior walls with calibrated IB. 
A fixed 9x9-pixel region of interest was positioned in the mid-myocardium of the antero-septal (ASW) and 
posterior wall (PW) and a fixed 2x3-pixel region of interest was positioned in the pericardium. Calibrated 
IB for the ASW is calculated by subtracting the pericardial IB intensity from the ASW IB intensity, and the 
calibrated IB for the PW is calculated by subtracting the pericardial IB intensity from the PW IB intensity.
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tion of atrial conduction time is obtained.9 In HF patients, this TA-TDI duration has 
been associated with increased risk of atrial fibrillation at follow-up.10
integrated backscatter
Calibrated integrated backscatter (IB) is a parameter based on gray-scale 2D images 
which evaluates myocardial ultrasound reflectivity. In the heart, the pericardium is the 
anatomic structure with the highest content of fibrosis and with the highest ultrasound 
reflectivity; whereas blood pool has the lowest ultrasound reflectivity since no fibrous 
tissue exists. The myocardium shows an intermediate ultrasound reflectivity and this 
reflectivity may increase together with the amount of fibrosis.11, 12 Gray-scale 2D images 
may be obtained at parasternal long-axis view, with frame rates between 80 and 120 
frames/s. A fixed region of interest is then positioned in the mid-myocardium of the 
antero-septal and posterior walls of the LV and a fixed region of interest is positioned 
in the pericardium. A measure of myocardial ultrasound reflectivity or tissue density 
is obtained with calibrated IB by subtracting pericardial IB intensity from myocardial 
IB intensity of the LV antero-septal and LV posterior walls.
objectives and outline of the thesis
The objectives of this thesis were to investigate the role of LV mechanics in the assess-
ment of HF patients who are candidates to CRT and to evaluate the prognostic value 
of parameters derived from the several imaging techniques to assess LV mechanics.
In Part i, the study of cardiac mechanics is applied to HF patients in order to: 1. 
distinguish LV mechanics between the different aetiologies of HF (chapter 3); 2. 
to investigate the beneficial effects of CRT on long-term outcome of HF patients 
(chapters 4-6); 3. how to optimize the response to CRT (chapter 7).
Finally, Part ii provides an overview of the several parameters, clinical and echo-
cardiographic, that influence the outcome of HF patients. Specifically, chapter 8 
demonstrates that echocardiographic response to CRT is an independent predictor 
of long-term outcome over other well-established prognostic indices of HF. chapter 
9 focuses on the assessment of risk of ventricular tachyarrhythmias in HF patients 
based on LV cardiac mechanics. chapter 10 shows that LV global longitudinal strain 
is strong prognostic determinant of patients with ischemic HF. Finally, chapter 11 
underscores the relevance of electromechanical delay within the atrial myocardium 
as a risk factor for atrial fibrillation in HF patients with an implantable cardioverter-
defibrillator.
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aBstract
 Technologic innovations in cardiac imaging have provided 
new tools and algorithms for accurate assessment of left ven-
tricular (LV) twist mechanics. This review provides a focused 
update on the incremental value of assessing LV twist mechan-
ics in patients with heart failure (HF) and its potential role in 
characterizing response to cardiac resynchronization therapy 
(CRT). First, the findings are summarized from recent experi-
mental and clinical studies that have specifically characterized 
the patterns of abnormal LV twist mechanics in HF. Next, the 
evolving application of LV twist is discussed in understand-
ing response to CRT, elucidating the independent relationship 
between LV twist mechanics and reversal of LV remodeling at 
6 months follow-up. Finally, the studies are addressed that un-
derscore a critical relationship between LV lead position and 
changes in LV twist after CRT. These data suggests that the 
reversal of LV remodeling seen in HF patients following CRT 
primarily results from restoration of the global sequence of LV 
twist mechanics.
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introduction
Heart failure (HF) remains one of the major public health problems in developed 
countries. In United States, nearly 6 million patients have HF symptoms and 500,000 
new patients are diagnosed yearly (1). Recently, important advances in HF therapy, 
such as cardiac resynchronization therapy (CRT), have improved the outcome of 
these patients (2). However, the prognosis still remains poor with a 5-year mortality of 
42.3% after hospitalization for HF (1).
LV rotation, twist and torsion are important aspects of the cardiac mechanics. The 
term rotation is referred to the rotation of LV short-axis sections. Due to the spiral 
architecture of LV myofibers, the rotation of LV apex and base are counterclockwise 
and clockwise, respectively, as viewed from the LV apex. The opposite rotation of LV 
apex and base leads to a LV systolic wringing motion during systole referred to as 
twist or torsion. In particular, LV twist is the net difference at isochronal time points 
between apex and base in the rotation angle along LV longitudinal axis, whereas LV 
torsion is LV twist indexed to the distance between LV apex and LV base (3). This 
peculiar characteristic of the LV contributes significantly to LV systolic function, in 
addition to myocardial shortening and thickening.
Following a brief overview of physiology of LV rotational mechanics, an in-depth 
discussion is provided on different LV twist patterns in systolic HF and the evolving 
role of LV twist as a marker of LV-dyssynchrony for understanding response to CRT.
norMaL LV twist MecHanics
In the normal heart, the myofiber geometry of the LV changes gradually from a right-
handed helix in the subendocardium to a left handed helix in the subepicardium. Taber 
et al. (4) explored the impact of this changing transmural myofiber orientation on LV 
rotational mechanics in a one-layer cylindrical model that consisted of obliquely aligned 
muscle fibers embedded in an isotropic matrix. The contraction of the epicardial fibers 
rotated the apical end of the model in the counterclockwise direction and the base in 
the clockwise direction. Conversely, shortening of the subendocardial fibers rotated 
the apex and base in clockwise and counterclockwise directions respectively. When 
both layers are coupled to contract simultaneously, a larger radius of rotation for the 
outer epicardial layer resulted in the epicardial fibers having a mechanical advantage 
in dominating the overall direction of rotation. The endocardial layer does provide 
some opposition to epicardial motion. This opposing action ensures that epicardial 
and endocardial sarcomere shortening in all directions are equilibrated during ejec-
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tion, resulting in an optimal distribution of LV stress and strain (5). Elimination of 
twist decreases epicardial shortening at the expense of an increase in endocardial 
shortening. This in turn increases endocardial stress and strain, which increases oxy-
gen demand and reduces the efficiency of LV systolic performance.
Taber’s model also provides explanation for the temporal changes in the sequence 
of LV twist during a cardiac cycle. The initial shortening of subendocardium causes 
a brief clockwise rotation of LV apex during the isovolumic contraction (3, 6). Subse-
quent transmural spread of electrical activation, results in simultaneous shortening 
of subendocardial and subepicardial fibers. Due to the subepicardial fibers having a 
larger moment arm, the direction of rotation is shifted towards a counterclockwise 
rotation for the LV apex and a clockwise rotation for the LV base (Figure 1).
In the subepicardium, this twist supports contraction in the principal fiber direc-
tion. In the midwall, the twist enhances shortening in the circumferential direction.
Twist deformation of the LV wall causes fiber rearrangement that maximizes the 
LV wall thickening. In particular, twisting and shearing of the subendocardial fibers 
also deforms the matrix and results in storage of potential energy by compression 
of cardiac proteins such as titin (6). The potential energy stored in the titin is subse-
quently unleashed during diastole, aiding myocardial relaxation and diastolic filling.
figure 1. Mechanism of left ventricular twist
Left ventricular (LV) fiber orientation changes from a right handed helix in the subendocardium to a left 
handed helix in the subepicardium (a). During isovolumic contraction (IVC), circumferential components 
of force (arrows) are generated by endocardial fiber shortening, which rotates the LV about the long axis 
clockwise as viewed from the apex (B). During ejection, shortening of subepicardial fibers wrapped in an 
opposite, left-handed helix, rotates the LV counterclockwise (c). Twisting force by epicardial shortening 
overcomes the forces of subendocardial shortening because the torque of the epicardial force is larger due to 
a greater radius of the epicardial fibers from the central LV long axis.
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Factors Affecting LV Twist
Alterations in preload, afterload and contractility have been shown to alter cardiac 
rotation (5). Loading mechanics influences twist through changes in LV end-diastolic 
and end-systolic volumes. The directly proportional relationship between torsion and 
LV end-diastolic volume and the inversely proportional relationship between torsion 
and end-systolic volume illustrate the volume dependency of LV torsion. Like changes 
in loading conditions, increasing contractility increases LV twist; for example, posi-
tive inotropic interventions such as dobutamine infusion and paired pacing, greatly 
increase LV twist, whereas negative inotropic interventions markedly reduce twist (5).
Moreover, the LV twist increases gradually from infancy to adulthood. Notomi et 
al. (7) assessed LV torsion and twisting velocities in individuals from 9 months to 
49 years and found that with advancing age there was an increase in LV torsion and 
untwisting velocity. Several other investigations examining older individuals have 
shown LV torsion to be maintained or increased compared with younger adults. 
It has been proposed that endocardial function is more likely to reduce with age 
due to the subendocardium’s greater susceptibility to fibrosis and/or subclinical 
reductions in perfusion. As per Taber’s model, the reduced endocardial function 
would result in less opposition to the dominant epicardial action causing increase 
in rotation. The finding of reduced subendocardial function and increased torsion in 
older individuals results in preservation of global LVEF, suggesting a compensatory 
mechanism that helps to preserve global LVEF despite the presence of subendocar-
dial dysfunction.
LV twist in tHe dyssyncHronous, faiLinG VentricLe
LV twist is emerging as an important parameter of LV systolic function. Several 
authors previously reported a significant correlation between LV twist and LVEF, the 
most commonly used index of LV systolic function in clinical practice (8). However, 
there is increasing evidence that LV twist is superior to LVEF in characterizing he-
modynamic aberrations in patients with HF. For example, Kim et al. (9), in a recent 
experimental study, reported a strong correlation between dP/dtmax (an invasive, 
relatively load-independent, measure of LV contractility) and LV twist (R2 = 0.747, p 
<0.001); however, the correlation between dP/dtmax and LVEF, despite significant, was 
weaker (R2 = 0.408, p <0.001). This observation is related to specific differences in LV 
twist and LVEF: LV twist is an index of systolic myocardial deformation, while LVEF 
simply reflects LV volume reduction during systole.
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In particular, the LV torsional deformation, related to the spiral architecture of LV 
myofibers, permits the generation of LVEF ≥60% from myofibers that can shorten 
by only 15%; otherwise, simple longitudinal or circumferential shortening would not 
allow LVEF higher than 30% (10, 11). Besides being a sensitive indicator of myocardial 
performance, the LV rotational mechanics appear strongly related to the sequence 
of LV depolarization as well; the propagation of the electrical cardiac activity is in-
deed significantly related to the spiral architecture and the anisotropic properties of 
cardiac myofibers (12). The assessment of LV twist, therefore, may provide more in-
depth understanding of the pathophysiology of HF, as compared to the traditional 
parameters of LV systolic function.
the ischemic versus the non-ischemic failing Ventricle
Significant alterations of LV rotational mechanics have been observed in patients with 
previous myocardial infarction (MI) and chronic ischemic and non-ischemic HF.
Myocardial infarction. Several studies showed an impairment of LV twist after MI 
(5, 8). The observed reduction of LV twist correlates with the reduction of LVEF (being 
more pronounced when LVEF is <45%) and the number of dysfunctional myocardial 
segments. In addition, Gjesdal et al. (13) recently observed a significant correlation 
between LV twist and the infarct mass (r = -0.59, p <0.001). The injury caused by the 
infarction to the LV myofiber architecture, may explain these findings. Indeed, Wu et 
al. (14), using diffusion tensor magnetic resonance imaging, observed an increase of 
left-handed myofibers and a decrease of right-handed myofibers in the infarct area; 
the extent of these changes was associated to the infarct size. Interestingly, opposite 
changes were observed in the remote zone, likely representing an adaptive response 
to increased wall stress.
Ischemic versus non-ischemic HF. As compared to MI patients, HF patients pres-
ent an even more pronounced impairment of LV rotational mechanics, irrespective 
of HF etiology as result of reduction of both LV basal and apical rotation (Figure 
2) (8, 15-17). In particular, the typical counterclockwise rotation of the LV apex may 
be completely abolished, or even reversed in a clockwise rotation. Recently, in a 
population of advanced HF patients with prolonged QRS duration, Bertini et al.(18) 
showed a modest but significant correlation between LV twist and LVEF (r = 0.53, p 
<0.001). This finding supports the hypothesis that LVEF and LV twist are not identi-
cal parameters, and LV twist may provide incremental information on LV systolic 
performance.
According to previous experimental studies, several mechanisms may explain the 
impairment of LV twist in HF patients. First, as demonstrated by Taber et al. (4), LV 
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dilatation and thinning, present in dilated cardiomyopathy, equalize the radii of the 
subepicardial and subendocardial layers; as a result, the mechanical advantage of 
the subepicardial myofibers (the major determinants of LV twist under physiologic 
conditions) is reduced. Consequently, LV twist decreases with increasing cavity 
volume. Second, the long lasting processes determining dilated cardiomyopathy 
and eccentric hypertrophy, cause myofibers disarray and alterations in myofibers 
angle (16). These phenomena eventually lead to the loss of the physiological spiral 
architecture of the LV and to the impairment of LV twist (19). Last but not least, 
slowed transmural fiber activation, related to fibrosis and remodeling of gap junc-
tions, may delay the activation of the epicardial myofibers, determining an initial 
clockwise twist (because of the unopposed rotation of the endocardial myofibers) 
and finally an impaired peak LV twist (20, 21).
According to these observations, it has been postulated that surgical techniques 
able to restore a more physiological shape of the LV would improve the LV torsional 
deformation (17). Indeed, in a preliminary study of 26 patients with ischemic dilated 
cardiomyopathy, LV reconstruction surgery improved LV twist in the patients with 
more severely impaired LV twist at baseline (17); these patients showed also signifi-
cantly greater improvement of LVEF after surgery as compared to the patients with 
figure 2. Left ventricular twist in acute myocardial infarction and ischemic versus non-ischemic heart 
failure.
Examples of left ventricular (LV) twist assessed with speckle tracking echocardiography in acute myocardial 
infarction (MI), and chronic ischemic versus non ischemic heart failure (HF). Of note, LV twist is markedly 
reduced in HF patients as compared to acute MI patient.
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relatively more preserved LV twist at baseline (∆LVEF 15 ± 8% vs. 6 ± 8%, p = 0.005) 
(17).
relation LV twist-LV dyssynchrony
An effective LV pumping function requires the combination of preserved LV archi-
tecture and a preserved electrical conduction system. The presence of an abnormal 
activation sequence of the ventricles (e.g. right ventricular apical pacing, right or left 
bundle branch block) results in a slower spread of the electrical breakthrough across 
the myocardium and in a dyssynchronous mechanical activation of the ventricles (22). 
In addition, the anisotropy of the LV myocardium determines the propagation of the 
electrical wavefront. As previously described, (12, 23) activation of the LV includes the 
development of a potential over the lateral-apical region which reflects endocardial-to-
epicardial propagation of the LV free-wall activation front. Subsequently this epicardial 
potential is seen to migrate from the lateral LV apex toward the posterolateral base. The 
propagation is faster in the longitudinal direction of the myofibers rather than across 
in the circumferential cross-fiber direction due to the higher density of gap junctions 
concentrated in the intercalated disks along the longitudinal axis, as compared to 
the cross-fiber densities (12). In the remodeled, failing LV this particular architectural 
pattern may be distorted, with loss of anisotropy and gap junctions, resulting in a 
slower conduction of the electrical excitation.
Several experimental studies have demonstrated the deleterious effects of asyn-
chronous ventricular activation on LV performance and the relation between the LV 
activation pattern and LV twist (24-28). Prinzen et al. (26) showed that ectopic activa-
tion induced asynchronous electrical activation and, subsequently, asynchronous 
cardiac motion (mechanical asynchrony). Interestingly, mechanical asynchrony was 
larger than electrical asynchrony because the time interval between the electrical 
activation and the onset of fiber shortening was more prolonged at the most delayed 
mechanical activated segments. Afterwards, changes in myofibers work within the 
LV wall were evaluated during right ventricular and LV pacing in normal hearts of 
dogs. Thus, both pacing modes determined a pronounced redistribution of midwall 
fiber shortening and work, with 50% decrease in myofiber work at the paced regions 
(hypofunctioning regions) and 150% increase at the remote areas (hyperfunctioning 
regions). These regional changes resulted in significant reductions in LV pump func-
tion, particularly when pacing from the right ventricle (27). Recently, Delgado et al. 
(29) compared the effects of right ventricular apical pacing on LV twist in 25 patients 
without structural heart disease. With the use of 2-dimensional speckle tracking 
imaging, the authors demonstrated that right ventricular apical pacing induced a 
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dyssynchronous mechanical activation of the LV, as measured by radial strain (from 
21 to 91 ms, p<0.001) and a subsequent significant decrease in LV global longitudi-
nal shortening (from -18.3 ± 3.5% to -11.8 ± 3.6%, p<0.001) and LV twist (from 12.4 
± 3.7° to 9.7 ± 2.6°, p=0.001; Figure 3).
Finally, two recent studies pointed out the relationship between LV-dyssynchrony 
and LV twist in advanced HF patients with prolonged QRS duration (18, 30). A first 
study showed that the extent of LV-dyssynchrony was inversely related to LV twist 
(30). Subsequently, these results were extended in another study demonstrating that 
LVEF and LV-dyssynchrony were both independently correlated to LV twist (18). This 
observation further underscores that LV twist is not only a parameter of LV function, 
but also reflects the extent of LV (dys)synchrony.
figure 3. Left ventricular twist during right ventricular pacing.
Example of left ventricular (LV) twist during sinus rhythm (baseline) and during right ventricular (RV) pacing 
in a patient without structural heart disease.
A standard diagnostic catheter was positioned in the RV apex as illustrated in the postero-anterior (PA) view 
at fluoroscopy (upper left panel) and the 4-chamber apical view at standard 2-dimensional echocardiography 
(upper right panel).
The curves of LV rotational parameters at baseline (lower left panel) and during RV pacing (lower right 
panel). RV pacing induced a severe impairment in LV twist by decreasing both LV apical and basal rotation.
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LV twist in crt
As previously indicated, LV mechanics and particularly LV twist are strictly dependent 
on electro-mechanical activation and are influenced by different pacing modalities 
(24, 25, 31). However, thus far, data on the effects of CRT on LV twist are limited (18, 30, 32).
Particularly, abnormal rotational mechanics in advanced HF patients with pro-
longed QRS duration may result from 2 different conditions that can also co-exist: 
1) absolute reduction of LV apical and basal rotation (and consequently of LV 
twist), due to an impaired myocardial contractility; 2) dyssynchronous contraction 
of LV apical and basal regions, due to an altered pattern of LV electro-mechanical 
figure 4. Left ventricular twist in the synchronous and dyssynchronous failing left ventricle.
Example of left ventricular (LV) twist in two patients with dilated cardiomyopathy and severe LV dysfunction 
(LV ejection fraction <30%).
Example of patients with synchronous (Panel A) and with dyssynchronous LV contraction LV (Panel B). 
In both the synchronous (Panel A) and the dyssynchronous LV (Panel B), the curves of the LV rotational 
parameters reveal reduced LV twist. Of note, the peaks of apical and basal rotation occur almost at the 
same time interval in the synchronous LV (Panel A), whereas they occur at different time intervals in the 
dyssynchronous LV (Panel B). In particular, in the dyssynchronous LV (panel B) apical rotation is markedly 
earlier as compared to the basal rotation, which may result in further worsening of LV twist.
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activation (Figure 4). Consequently, CRT, leading to a more physiologic electrical 
depolarization and mechanical contraction of the myofibers, has the potential to 
improve rotational mechanics in these patients.
Global changes in LV twist after crt
All the available studies are based on 2-dimensional speckle tracking echocardiogra-
phy that, unlike tagged magnetic resonance imaging, allows the analysis of rotational 
parameters also after device implantation.
Recently, Zhang et al. (32) studied 39 patients scheduled for CRT, measuring LV 
twist at baseline and 3 months after implantation. At baseline, peak LV twist was 
significantly reduced in the HF patients as compared to normal controls (6.8 ± 
4.2° vs.16.2 ± 5.5°, p <0.001). The authors also noted that in some patients, the 
presence of apical and/or basal segments showed a paradoxical rotation (clockwise 
for the apex and counterclockwise for the base), indicating a more compromised 
rotational mechanics. However, at short-term follow-up the authors could not detect 
any improvement of LV twist after CRT, although a significant increase of LVEF was 
observed (from 28.1 ± 6.7% to 35.0 ± 9.4%, p <0.001).
Different findings were reported by Sade et al. (30) that studied the acute effect of 
CRT on 33 patients. At baseline, LV twist was significantly reduced as compared to 
normal controls either for ischemic and non-ischemic HF patients and correlated 
well with LVEF and radial dyssynchrony. A significant improvement of LV rotational 
figure 5. Progressive improvement of LV twist induced by crt.
A significant and progressive improvement of LV twist was observed immediately after CRT and at 6 months 
follow-up.
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mechanics was observed immediately after CRT. These controversial results may be 
related to the potential role of the LV lead position in determining LV twist pattern. 
However, no data about LV lead position were reported in these studies.
A more recent study (18) reported the acute and long-term effects of CRT on LV 
twist exploring also the influence of LV lead position. Specifically, in a group of 80 HF 
patients candidates to CRT a significant and progressive improvement of LV twist 
was observed immediately after implantation and at 6 months follow-up (Figure 5).
responders versus non-responders
The effect of CRT on rotational mechanics is more evident if the evaluation is per-
formed according to the presence of LV reverse remodeling. Sade et al.(30) evaluated 
the changes in LV twist in 33 HF patients treated with CRT. Responder patients (with 
a reduction in LV end-systolic volume >10%) had an improved LV twist (from 1.5 ± 
2.8° to 6.3 ± 3.6°, p<0.0001). Conversely, in non-responders LV twist did not change 
or tended to worsen (from 5.3 ± 3.1° to 2.0 ± 3.4°). Similarly in a more recent study 
(18), a significant improvement in LV rotational mechanics was noted only in patients 
who showed LV reverse remodeling (responders), both at the acute and long-term 
follow-up. In particular, peak LV twist progressively improved in responders during 
follow-up, whereas in non-responders a gradual deterioration of peak LV twist was 
observed (Figure 6). Furthermore, at the multivariable logistic regression analysis, in 
which LV-dyssynchrony and function parameters were included, absolute difference in 
LV twist immediately after CRT was the strongest predictor of response to CRT at 6 
months follow-up (OR = 1.837, 95%CI = 1.378-2.449, p <0.001).
These findings suggest that CRT may (partially) restore LV twist, possibly by 
providing a more physiologic electrical depolarization and mechanical contraction 
of the myofibers.
LV twist and LV lead position
LV lead position is considered a potential tool to increase CRT response rate. In 
clinical scenarios, the optimal site for LV pacing in patients receiving CRT remains 
controversial. Previous studies indicated that patients with a (postero-)lateral LV 
lead position and patients with a LV lead located close to the region with the latest 
mechanical activation do not only derive more benefit in restoring systolic LV function, 
but also tend to have superior long-term survival after CRT (33-36). The different pat-
terns of LV depolarization induced by different LV lead positions may markedly change 




figure 6. Left ventricular twist changing in crt responders and non-responders .
Panel a: Example of responder to cardiac resynchronization therapy (CRT). Peak left ventricular (LV) twist 
increases progressively from baseline to 6-month follow-up. In this example, the improvement of LV twist 
is mainly due to the improvement of LV apical rotation over time. Immediately after CRT, LV twist increases 
secondary to an improved electro-mechanical activation of the LV. Further improvement is observed at 
6-month follow-up when LV reverse remodeling has also occurred. The lower panel shows the improvement 
in left ventricular ejection fraction (LVEF) and reduction in left ventricular end-systolic volume (LVESV) after 
6-month follow-up.
Panel B. Example of non-responder to CRT. Peak LV twist declines progressively from baseline to 6 months 
follow-up. In this example, the main determinant of the reduction in LV twist is the deterioration of LV apical 
rotation. Indeed, the direction of LV apical rotation is reversed (negative red dashed curve) immediately after 
CRT and at 6 months follow-up. Here, the apical and basal levels have the same direction of rotation which 
results in a worsening of LV twist. At 6 months follow-up a reduction in LV basal rotation is also observed, 
which contributes to a further deterioration of LV twist. The lower panel shows the parallel worsening in LVEF 
and LVESV after 6 months follow-up.
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the cardiac mechanics (12). Thus, in CRT patients, the magnitude of LV twist may be 
related to the LV pacing site. However, there is currently minimal data addressing 
this issue. Firstly, experimental studies showed that LV twist was influenced by the 
pacing mode (atrial, right and biventricular pacing) (24, 25, 31). For example, Sorger et 
a
B
figure 7. Left ventricular twist versus left ventricular lead position.
Panel a. Example of responder to cardiac resynchronization therapy (CRT) with the left ventricular (LV) 
lead placed in a (postero-)lateral vein with an apical position. Biplane fluoroscopy (left) displays the LV lead 
position. Particularly, the left anterior oblique (LAO) view shows the LV lead in the (postero-)lateral vein 
whereas the postero-anterior (PA) view shows the LV lead in an apical position. Peak LV twist increased from 
3.8° at baseline to 10.6° at 6-month follow-up. LV ejection fraction (LVEF) improved from 24% at baseline 
to 38% at 6-month follow-up. In this patient, pacing close to the LV apical region may produce a more 
physiological pattern of electro-mechanical activation, resulting in a significant improvement in LV twist.
Panel B. Example of non-responder with the LV lead placed in a lateral vein (LAO view) with a basal position 
(PA view). Peak LV twist decreased from 9.4° at baseline to 4.7° at 6-month follow-up. LVEF decreased from 
30% at baseline to 26% at 6-month follow-up. In this patient, pacing close to the LV basal region may induce 
a further worsening of the electro-mechanical activation with a significant worsening of LV twist.
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al.(25) evaluated the changes in LV twist during pacing from three different locations: 
right atrium, right ventricular apex and base of the LV free wall. Biventricular pacing 
with LV lead placed at the basal level of lateral wall, similarly to apical right ventricular 
pacing, worsened LV twist as compared to a more physiological electrical stimulation 
(i.e. right atrial pacing).
A recent study (18) explored the change in LV twist after CRT in relation to different 
LV lead positions in the (postero-)lateral veins. Interestingly, the authors observed 
that patients with LV leads positioned in mid-ventricular and apical regions exhib-
ited a larger increase in systolic function with a significant increase in LV twist as 
compared to patients with LV leads positioned in the basal regions of the LV free 
wall (Figure 7). Possibly, LV pacing sites that yield the largest improvement in LV 
twist may likely determine a more efficient cardiac contraction with subsequent 
improvement of LV energetic (37). Similar results were obtained in a experimental 
study in a canine HF model, reporting that the mid-apical part of the LV free wall was 
the optimal stimulation site (38). These findings could be explained by the direction 
of cardiac depolarization, traveling from the apex towards the base in the normal 
heart (12, 39). Therefore, pacing close to the LV apex may replicate a more physiologi-
cal pattern of LV depolarization and subsequent mechanical activation, leading to 
a significant improvement in LV twist (18, 25). Furthermore, as the myocardial wall is 
thinner in the LV apex compared to LV base (40, 41), pacing leads positioned near the 
apex are closer to the Purkinje network. This results in a faster electrical propagation 
of the cardiac pulse and subsequently a more synchronous LV contraction.
These are early data derived from small experimental and clinical studies, there-
fore larger multicenter studies are needed to confirm these findings.
future directions
Thus far, several indices of mechanical dyssynchrony have been proposed to select 
candidates for CRT. The analysis of LV twist may provide a more comprehensive evalu-
ation of LV mechanics and may help to understand the effects of CRT in HF patients. 
Moreover, at present, CRT response relies on changes in clinical status, LV reverse 
remodeling and improvement in LVEF. In this regard, LV twist analysis may be incre-
mental to changes in LV volumes and LVEF to characterize and define CRT response. 
Recently, Sade et al. (30) proposed to quantify the magnitude of LV twist at aortic valve 
closure timing as good index to predict CRT response, superior to LV-dyssynchrony. 
Furthermore, pioneer studies showed that an improvement of LV twist early after CRT 
predicts a reduction of LV volumes after 6 months (18). Future studies are warranted to 
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elucidate whether the magnitude and/or the specific pattern of baseline LV twist and 
immediate changes in LV twist after CRT may be used as a more sensitive index for the 
identification of CRT responders.
Currently, 2-dimensional speckle tracking echocardiography permits reliable 
assessment of LV twist mechanics (42). Furthermore, different authors reported a 
good reproducibility of the assessment of LV twist with 2-dimensional speckle track-
ing (18, 43, 44). However, 2-dimensional speckle tracking echocardiography has some 
limitations for the assessment of LV twist mainly related to the acquisition of LV 
apical short-axis images. This may be technically difficult and is highly dependent 
on the acoustic window and the through-plane motion, particularly at the basal 
level, that may affect accuracy of the measurement of LV rotational parameters. 
Recently developed 3-dimensional speckle tracking analysis may partially overcome 
these limitations and may provide even more global characterization of LV twist 
mechanics (45). Future technical advances will lead to improved accuracy and easier 
implementation of this technique in the clinical setting.
At present cardiac magnetic resonance remains the referral technique for the as-
sessment of LV twist mechanics although its use is limited by availability and the 
presence of devices (pacemakers, internal cardioverter-defibrillators).
suMMary and concLusion
LV twist mechanics is a promising tool for characterizing the pathophysiology of HF. 
In advanced systolic HF, the rotational parameters are severely deteriorated and may 
be improved by restoring electro-mechanical activation through CRT. An immediate 
improvement in LV twist after CRT may be a good surrogate of a more physiological 
LV depolarization, and is independently related to reversal of remodeling after CRT. 
Finally, LV lead position is important for modifying the extent of LV twist after CRT; 
in particular pacing sites which provide the greatest improvement of LV twist likely 
determine the largest reversal of LV remodeling after CRT.
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aBstract
 Left ventricular (LV) twist and untwisting rate are emerging 
as global and thorough parameters for the assessment of LV 
function. This study explored the differences of LV twist and 
untwisting rate among acute myocardial infarction (AMI) pa-
tients and ischemic and non-ischemic chronic heart failure 
(HF) patients. A total of 50 AMI patients, 49 ischemic HF and 
38 non-ischemic HF patients were studied. As a control group, 
28 normal subjects were included. Speckle tracking analysis 
was applied to LV short-axis images at basal and apical level. 
LV twist was defined as the net difference of apical and basal 
rotation at isochronal time points. The first time derivative of 
LV untwist was defined as LV untwisting rate. As compared to 
normal subjects, peak LV twist was reduced in AMI patients and 
extremely reduced in HF patients (ANOVA p value <0.001). A 
strong correlation (r=0.87, p<0.001) was found between peak 
LV twist and LV ejection fraction in the overall study popu-
lation. LV untwisting rate was progressively reduced in AMI 
and HF patients as compared to normal subjects (ANOVA p 
value <0.001). A moderate correlation (r=0.56, p<0.001) was 
noted between peak LV untwisting rate and the grade of dia-
stolic dysfunction in the overall study population. In conclu-
sions LV twist and untwisting rate are strongly related with LV 
systolic and diastolic function, respectively. The impairment 
of LV function observed in AMI and HF patients is associated 
with a reduction of LV twist and untwisting rate.
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introduction
Recently, novel speckle tracking analysis has become available as a simple echocar-
diographic modality to assess LV twist and the untwisting rate. This technique has 
been validated against sonomicrometry and tagged magnetic resonance imaging, 
which are currently considered the gold standards for the assessment of rotational 
parameters.1, 2 Initial studies evaluated LV twist and the untwisting rate in patients 
with myocardial infarction and heart failure (HF),3-5 but thus far, the impact of these 
different diseases on rotational mechanics has never been systematically evaluated. 
The present study assesses the differences of LV twist and the untwisting rate between 
patients with acute myocardial infarction (AMI) and chronic HF.
MetHods
A total of 137 consecutive patients were enrolled: 50 AMI patients, 49 patients with 
chronic ischemic HF and 38 with non-ischemic HF. The diagnosis of AMI was based 
on the presence of symptoms consistent with myocardial ischemia lasting ≥30 min-
utes and ≥2 mm ST-segment elevation in ≥2 contiguous electrocardiographic (ECG) 
leads.6 All AMI patients underwent urgent coronary angiography, followed by primary 
percutaneous coronary intervention, and the echocardiographic examination was 
performed within 48 hours after AMI. Etiology of HF was considered ischemic in the 
presence of significant coronary artery disease (>50% stenosis in ≥1 major epicardial 
coronary artery) on coronary angiography and/or the history of AMI or previous re-
vascularization.
In addition, 28 subjects without evidence of structural heart disease, matched for 
age and gender were included as a normal control group. The clinical echocardio-
graphic analysis included standard 2-dimensional echocardiography to assess LV 
systolic and diastolic function. Furthermore, speckle tracking analysis was applied 
to assess LV rotational parameters (the twist and untwisting rate).
All patients were imaged in the left lateral decubitus position with a commercially 
available system (Vingmed Vivid 7, General Electric-Medical Systems, Milwaukee, 
Wisconsin, USA) equipped with a 3.5-MHz transducer. Standard 2-dimensional im-
ages and Doppler and color-Doppler data acquired from the parasternal and apical 
views (2-, 3-, and 4-chamber) were digitally stored in cine-loop format; analyses 
were subsequently performed offline using EchoPAC version 7.0.0 (General Electric-
Medical Systems).
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Left ventricular (LV) end-diastolic (EDV) and end-systolic (ESV) volumes were 
measured according to the Simpson’s biplane method and LV ejection fraction (EF) 
was calculated as [(EDV-ESV)/EDV] x100.7
Transmitral and pulmonary vein pulsed-wave Doppler tracings, obtained in ac-
cordance to the recommendations of the American Society of Echocardiography,8 
were used to classify diastolic function as follows: 1) normal, when the E/A ratio 
= 0.9-1.5, deceleration time = 160-240 ms and pulmonary vein systolic velocity 
(PVs) ≥ pulmonary vein diastolic velocity (PVd); 2) diastolic dysfunction grade 1 
(mild), when the E/A ratio was <0.9, deceleration time >240 ms and PVs >> PVd; 3) 
diastolic dysfunction grade 2 (moderate), when the E/A ratio = 0.9-1.5, deceleration 
time = 160-240 ms and PVs < PVd; 4) diastolic dysfunction grade 3 (severe), when 
the E/A ratio >2.0, deceleration time <160 ms and PVs << PVd; 5) diastolic dysfunc-
tion grade 4 (severe), when the E/A ratio >2.5, deceleration time <130 ms and PVs 
<< PVd.9
Speckle tracking analysis is based on tracking of natural acoustic markers, or 
speckles, on standard gray scale images. This novel technique is angle independent 
and permits evaluation of myocardial contraction/relaxation along the circumferen-
tial, longitudinal and radial direction.10, 11
In the present evaluation, speckle tracking analysis was applied to determine the 
LV twist and LV untwisting rate. Parasternal short-axis images were acquired at 2 
distinct levels: 1) basal level, identified by the mitral valve; 2) apical level, defined as 
the smallest cavity achievable distally to the papillary muscles (moving the probe 
down and slightly laterally, if needed). The frame rate ranged from 45 to 100 frame/s 
and 3 cardiac cycles for each parasternal short-axis level were stored in cine-loop 
format for the offline analysis. The endocardial border was traced at an end-systolic 
frame and the region of interest (ROI) was chosen to fit the entire myocardium. The 
software allows the operator to check and validate the tracking quality and to adjust 
the endocardial border or modify the width of the ROI, if needed. Furthermore, 
each short-axis image was automatically divided into 6 standard segments: septal, 
anteroseptal, anterior, lateral, posterior, and inferior.
Subsequently, the speckle-tracking software calculates LV rotation from the apical 
and basal short-axis images as the average angular displacement of the 6 standard 
segments referring to the ventricular centroid, frame by frame. Counter-clockwise 
rotation was marked as positive value and clockwise rotation as negative value when 
viewed from the LV apex. The software automatically calculates LV twist, defined as 
the net difference (in degrees) of apical and basal rotation at isochronal time points. 
The opposite rotation following LV twist was defined as LV untwist and the time 
derivative of LV untwist was defined as LV untwisting rate (in °/s) (Figure 1).
The following measurements were obtained:
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1) peak apical and basal rotation,
2) peak LV twist and peak LV untwisting rate,
3) time to peak apical and basal rotation,
4) time to peak LV twist and untwisting rate.
A pulsed-wave Doppler tracing obtained from the LV outflow tract was used to identify 
the timing of aortic valve opening and closure. All the timings were expressed as 
percentage of systolic phase.
a B
c d
figure 1 Left ventricular twist and untwisting rate in a normal control (Panel A), AMI patient (Panel B), 
ischemic HF patient (Panel C) and non-ischemic HF patient (Panel D).
The green line represents apical rotation (upper) and apical rotation rate (lower); the purple line represents 
basal rotation (upper) and basal rotation rate (lower); the white line represents left ventricular twist/untwist 
(upper) and left ventricular twisting/untwisting rate (lower).
AMI: acute myocardial infarction, AVC: aortic valve closure. AVO: aortic valve opening, HF: heart failure.
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To assess the reproducibility of peak LV twist and peak LV untwisting rate measure-
ments, 20 patients were randomly selected. Bland-Altman analysis was performed to 
evaluate the intra- and inter-observer agreement repeating the analysis 1 week later 
by the same observer and by a second independent observer. Bland-Altman analysis 
demonstrated good intra-observer and inter-observer agreement, with small bias 
not significantly different from zero. Mean differences ± 2 standard deviation (SD) 
for peak LV twist and peak LV untwisting rate were 0.05±0.43° and -1.93±15.97°/s, 
for intra-observer agreement and 0.17±1.51° and -3.97±35.63°/s for inter-observer 
agreement.
Continuous variables are expressed as mean ±SD. Categorical data are presented 
as absolute numbers and percentages. One-way ANOVA test was used to assess 
differences in continuous variables between the different groups of patients; if the 
result of the analysis was significant, Bonferroni’s post-hoc test was applied. The 
differences in categorical variables were analyzed using Chi-square tests or Fischer’s 
exact tests, as appropriate. Linear regression analysis was used to determine the 
relations between peak LV twist and LVEF, between peak LV untwisting rate and the 
grade of diastolic dysfunction, and , between peak LV untwisting rate and LVESV. In 
order to identify independent determinants of peak LV untwisting rate, a multivari-
able linear regression analysis was performed including LVESV and the grade of 
diastolic dysfunction as covariates. All statistical tests were 2-sided, and a p value 
<0.05 was considered significant. Statistical analysis was performed using the SPSS 
software package (SPSS 14.0, Chicago, Illinois).
resuLts
Table 1 summarizes clinical and echocardiographic characteristics of the different 
patient groups and the normal controls.
As compared to normal controls, AMI patients had significantly lower values of 
LV apical rotation (9.8±3.0° vs. 7.6±3.8°, p = 0.007), LV basal rotation (-6.3±2.4° vs. 
-4.9±2.1°, p = 0.04), and LV twist (15.7±3.1° vs. 11.6±3.8°, p <0.001).
LV rotational parameters were not significantly different between ischemic HF 
and non-ischemic HF patients, but were significantly impaired as compared to AMI 
patients; peak apical rotation was 2.5±1.9° and 2.4±1.8°, respectively (p <0.001 as 
compared to AMI patients) and peak basal rotation was -3.4±2.0° and -2.8±2.2°, 
respectively (p = 0.003 and p <0.001, respectively, as compared to AMI patients). 
Consequently, the peak LV twist was 5.2±2.2° and 4.0±2.9°, respectively (p <0.001 as 
compared to AMI patients) (Table 1).
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Figure 2 shows the progressive reduction of peak LV twist and LVEF among the 4 
different groups. In particular, a strong correlation (r = 0.87, p <0.001) was found 
between peak LV twist and LVEF (Figure 3) and between peak LV apical rotation 
and LVEF (r = 0.79, p <0.001) in the overall study population; conversely, only a 
modest relation was found between peak LV basal rotation and LVEF (r = -0.48, p 
<0.001). Furthermore, time to peak LV twist occurred earlier in AMI, ischemic HF 
and non-ischemic HF patients as compared to normal controls (ANOVA p value 
<0.001, Table 1).
As compared to normal controls, AMI patients had significantly lower values of 
peak LV untwisting rate (-107±29°/s vs. -78±35°/s, p = 0.002).
table 1. Clinical, echocardiographic and rotational parameters of the different groups: normal controls, AMI 















age (years) 60±11 60±11 64±11 65±13 0.084
Men 21 (75%) 38 (76%) 43 (88%) 28 (74%) 0.16
LV end-diastolic volume (ml) 87±26* 103±28* 179±67¶ 214±74 <0.001
LV end-systolic volume (ml) 34±12* 55±21* 130±52¶ 164±61 <0.001
LV ejection fraction (%) 62±6† 47±10* 28±5¶ 24±6 <0.001
diastolic function † § <0.001
Grade 0 28 (100%) 7 (14%) 0 0
Grade 1 0 19 (38%) 12 (24%) 8 (21%)
Grade 2 0 14 (28%) 13 (26%) 6 (16%)
Grade 3-4 0 10 (20%) 24 (49%) 24 (63%)
Peak LV twist (°) 15.7±3.1† 11.6±3.8* 5.2±2.2 4.0±2.9 <0.001
Peak LV untwisting rate (°/s) -107±29*‡ -78±35║¶ -58±34 -59±32 <0.001
time peak LV twist (% systole) 98±8§‡ 83±14 83±19 75±27 <0.001
time peak LV untwisting (% systole) 114±9 118±17 116±17 116±23 0.75
*= p <0.001 vs. ischemic and non-ischemic heart failure
†= p <0.001 vs. acute myocardial infarction, ischemic and non-ischemic heart failure
¶= p <0.05 vs. non-ischemic heart failure
‡= p <0.01 vs. acute myocardial infarction
§= p <0.01 vs. , ischemic and non-ischemic heart failure
║= p <0.05 vs. , ischemic heart failure
AMI: acute myocardial infarction, HF: heart failure, LV: left ventricular.
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Peak LV untwisting rate was not significantly different between ischemic HF and 
non-ischemic HF patients with lower values as compared to AMI patients: -58±34°/s 
in ischemic HF patients (p = 0.018) and -59±32°/s in non-ischemic HF patients (p 
= 0.036) (Table1).
Peak LV untwisting rate and the grade of diastolic dysfunction among the 4 groups 
are shown in Figure 4. A moderate correlation (r = 0.56, p <0.001) was noted be-
tween peak LV untwisting rate and the grade of diastolic dysfunction in the overall 
study population (Figure 5). Furthermore, peak LV untwisting rate was significantly 
figure 2: Peak LV twist (left panel) and LVEF (right panel) in normal controls, AMI patients, ischemic HF and 
non-ischemic HF patients.
AMI: acute myocardial infarction, EF: ejection fraction, HF: heart failure failure, LV: left ventricular.
figure 3. Correlation between LVEF and peak LV twist in the entire study population including normal 
controls (white triangle), AMI patients (black triangle), ischemic HF patients (white circles) and non-
ischemic HF patients (black circles).
AMI: acute myocardial infarction, EF: ejection fraction, HF: heart failure, LV: left ventricular.
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figure 4: Left panel: A reduced peak LV untwisting rate is observed in AMI patients, IHF and NIHF patients 
as compared to normal controls. Right panel: The distribution of the different grades of diastolic dysfunction 
in normal controls, AMI patients, ischemic HF and non-ischemic HF patients is shown.
AMI: acute myocardial infarction, EF: ejection fraction, HF: heart failure, LV: left ventricular.
figure 5: Correlation between the grades of diastolic dysfunction (see definition in the text) and peak LV 
untwisting rate in the entire study population: normal controls (white triangle), AMI patients (black triangle), 
ischemic HF patients (white circles) and non-ischemic HF patients (black circles).
AMI: acute myocardial infarction, EF: ejection fraction, HF: heart failure, LV: left ventricular
48 ○ Chapter 3 
related to LVESV (r = 0.42, p <0.001). At multivariable linear regression analysis 
both LVESV (β = 0.16, p = 0.047) and the grade of diastolic dysfunction (β = 0.47, p 
<0.001) were independently related to peak LV untwisting rate.
No significant differences were found among the different groups for time to peak 
LV untwisting rate (Table 1).
discussion
The current study comprehensively evaluated the differences in LV twist and untwist-
ing rate among AMI, ischemic and non-ischemic HF patients, providing new insight in 
the relationship between LV rotational mechanics and LV function. The main findings 
can be summarized as follows: 1) LV twist is strongly related to LV systolic function 
and LV untwisting rate is modestly, but significantly related to diastolic function; 2) 
impairment of LV function is associated not only with a reduction of LV twist and 
untwisting rate, but also with an earlier peak of LV twist during systole.
As previously demonstrated in a mathematical model, LV twist distributes equally 
LV fiber stress and shortening across the LV wall.12 Accordingly, LV twist increases the 
efficiency of sarcomere shortening, and improves myocardial deformation during LV 
ejection.12 In the current study, a significant impairment of LV twist was observed in 
AMI and HF patients, compared to normal controls. Moreover, a strong relationship 
between the degree of impairment of LV twist and the observed impairment of LVEF 
was noted, confirming the previous findings demonstrating a relation between LV 
twist and LVEF.4, 5, 13 The strong correlation found between LV apical rotation and 
LVEF is not surprising, since LV apical rotation contributes more to LV twist than 
LV basal rotation.14 The different impact of acute myocardial infarction and chronic 
LV remodeling (in HF) on LV twist was also explored. LV twist was more reduced 
in chronic HF as compared to AMI patients. These findings may be explained by 
different mechanisms underlying a reduction in LV twist. In HF patients, LV twist 
impairment is probably the result of a long-lasting process, with a rearrangement 
of LV myofibers with a consequent loss of the specific LV architecture responsible 
for the wringing motion.4, 15, 16 Conversely, in AMI patients the reduction of LV twist 
may result from an acute impairment in rotation of the LV region involved in the 
infarction.3, 17 The severity of this impairment appears related to the transmurality of 
the infarction and to the extent of dysfunctional myocardial segments.13, 18
Intriguingly, the time to peak LV twist occurred earlier in both AMI and HF patients 
as compared to normal controls. The impaired LV rotational mechanics observed 
in AMI and HF most likely explains this finding; less time is needed to reach peak 
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LV twist because of the reduced contraction and rotation of the LV myofibers. In 
addition, the diseased LV myofibers are not able to fully counteract the systolic 
ventricular pressure, preventing further myocardial shortening and, consequently, 
leading to earlier peak LV twist.18
LV systolic twist comprehends a deformation of the interstitial matrix resulting in stor-
age of potential energy; the rapid release of the potential energy stored during systole 
in the isovolumic relaxation time leads to LV untwisting.19 In turn, LV untwisting gener-
ates an intraventricular pressure gradient facilitating diastolic LV filling.19 Indeed, the 
LV untwisting rate is emerging as an index of diastolic function.20-22 Particularly, LV 
untwisting rate was related to the time constant of LV pressure decay (Tau) and the 
intraventricular pressure gradient.21 In the present study, a good relation between the 
LV untwisting rate and global diastolic function was observed. The relation was not 
perfect, probably since the LV untwisting rate is a marker of diastolic suction rather 
than global diastolic function. LV untwisting rate was also independently related with 
LVESV; however, on multivariable linear regression analysis, the grade of diastolic 
dysfunction was the strongest determinant of LV untwisting rate.
A significant impairment of LV untwisting rate was observed in AMI and HF 
patients as compared to control subjects. In AMI patients, the impairment in LV 
untwisting rate may be related to the increased ventricular stiffness and consequent 
diastolic dysfunction due to recent acute ischemia and infarction.23 In HF patients, 
the LV untwisting rate was even more reduced as compared to AMI patients. This 
observation may be explained by the presence of extensive, diffuse LV fibrosis as 
encountered in HF patients, which is not (yet) present early after AMI.24
Finally, although groups of patients with different grades of diastolic dysfunction 
were studied, no significant differences in time to peak LV untwisting rate were 
noted. This finding is in line with previous experimental and clinical studies in which 
only the peak of untwisting rate but not the time to peak untwisting rate was affected 
by the grade of diastolic dysfunction.21, 25
As limitations, the acquisition of the LV apical short-axis images (highly dependent 
on the acoustic window) and through-plane motion, particularly at the basal level, 
could have affected the accuracy of the measurement of LV rotational parameters.
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aBstract
objectives. This study explored the effects of cardiac resynchronization 
therapy (CRT) on left ventricular (LV) twist, particularly in rela-
tion to LV lead position.
Background. LV twist is emerging as a comprehensive index of LV function.
Methods. Eighty heart failure (HF) patients were included. 2D-echo car di-
ography was performed at baseline, immediately after CRT, and 
at 6 months follow-up. Speckle-tracking analysis was applied to 
assess LV twist. LV lead was placed preferably in a (postero-)lat-
eral vein and at fluoroscopy, the position was classified as basal, 
mid-ventricular or apical. Response to CRT was defined as re-
duction of LV end-systolic volume ≥15% at 6 months follow-up. 
A control group comprised 30 normal subjects.
results. Peak LV twist in HF patients was 4.8±2.6° compared to 
15.0±3.6° of the controls (p<0.001). At 6 months follow-up, 
peak LV twist significantly improved only in responders (56%), 
from 4.3±2.4° to 8.5±3.2° (p<0.001). The strongest predictor 
of response to CRT was the improvement of peak LV twist im-
mediately after CRT (odds ratio 1.899, 95% confidence inter-
vals 1.334-2.703, p<0.001). Furthermore, LV twist significantly 
improved in patients with an apical (from 4.3±3.1° to 8.6±3.0°, 
p=0.001) and mid-ventricular (from 4.8±2.2° to 6.4±3.9°, 
p=0.038) but not with a basal (5.0±3.3 vs. 4.1±3.2, p=0.28) LV 
lead position. Similarly LVEF significantly increased in patients 
with an apical (from 26±7% to 37±7%, p<0.001) and mid-ven-
tricular (from 26±6% to 33±8%, p<0.001) but not with a basal 
(26±5% vs. 28±8%, p=0.30) LV lead position.
conclusions. An immediate improvement of LV twist after CRT predicts LV 
reverse remodeling at 6 months follow-up.
Effects of cardiac resynchronization therapy on left ventricular twist ○ 55
4
introduction
The human heart has a specific helical arrangement of the myofibers with a right-hand 
orientation from the base towards the apex in the endocardial layers and a left-hand 
orientation in the epicardial layers. This spiral architecture of the myofibers leads to a 
left ventricular (LV) systolic wringing motion as a result of an opposite rotation of LV 
apex and base (1, 2). The gradient between apex and base in the rotation angle along 
LV longitudinal axis is called twist and contributes significantly to LV systolic function, 
in addition to myocardial shortening and thickening (3-5).
In heart failure (HF) patients, LV twist is significantly reduced (6). Cardiac resyn-
chronization therapy (CRT) is considered a major therapeutic breakthrough for HF 
patients, and recent large randomized trials have shown that CRT has beneficial ef-
fects on HF symptoms, LV systolic function and survival (7, 8). At present, minimal 
data are available about the effect of CRT on LV twist (9, 10).
In the current study, the effect of CRT on LV twist was assessed using speckle-
tracking echocardiography. Furthermore, the relationship between the change in LV 
twist and LV reverse remodeling at 6 months follow-up was investigated. Finally, the 
influence of the LV lead position on the improvement in LV twist and response to 
CRT was explored.
MetHods
study population and protocol
A total of 87 consecutive HF patients scheduled for CRT were prospectively included. 
According to current guidelines, the inclusion criteria were: New York Heart Associa-
tion (NYHA) functional class III-IV, sinus rhythm, LV ejection fraction (LVEF) ≤35%, 
QRS duration ≥120 ms (11). Etiology of HF was considered ischemic in the presence 
of significant coronary artery disease (>50% stenosis in ≥1 major epicardial coronary 
artery) on coronary angiography and/or a history of myocardial infarction or revascu-
larization.
The clinical evaluation consists of: 1) assessment of clinical status: NYHA func-
tional class, quality of life (using the Minnesota Living with Heart Failure question-
naire) (12), and 6-minute walk distance (13) at baseline and 6 months follow-up; 
2) assessment of LV volumes, function, dyssynchrony and twist, using standard 
echocardiography and speckle-tracking analysis at baseline, within 48 hours (im-
mediately after CRT) and at 6 months follow-up.
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In addition, 30 subjects without evidence of structural heart disease, frequency-
matched for age, gender and body surface area, were included as a normal control 
group, selected from an echocardiographic data base. These subjects were referred 
for the echocardiographic evaluation because of atypical chest pain, palpitations or 
syncope without murmur.
standard echocardiography
All patients were imaged in left lateral decubitus position using a commercially 
available system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, 
USA). Standard 2-dimensional images were obtained using a 3.5-MHz transducer and 
digitally stored in cine-loop format; the analysis was performed offline using EchoPAC 
version 6.0.1 (General Electric-Vingmed).
From the standard apical views (4- and 2-chamber) LV volumes and LVEF were 
calculated according to the American Society of Echocardiography guidelines (14). 
At 6 months follow-up, patients were classified as echocardiographic responders 
based on a reduction ≥15% of LV end-systolic volume (LVESV) (15).
Segmental wall motion was assessed according to American Society of Echocar-
diography in order to evaluate the presence of scarred segments within ischemic 
HF patients (14). Akinetic and diskinetic segments (wall motion score 3 and 4) were 
classified as scarred segments (16).
speckle-tracking analysis
The speckle-tracking software tracks frame-to-frame the movement of natural myo-
cardial acoustic markers, or speckles, on standard gray scale images. Speckles are 
randomly distributed and each region of the myocardium has a distinguishing pat-
tern, a fingerprint. Furthermore, speckle-tracking analysis is angle independent and 
allows the evaluation of myocardial contraction/relaxation along the circumferential, 
longitudinal and radial direction (17, 18).
In the current study, speckle-tracking analysis was applied to evaluate LV dyssyn-
chrony (based on radial strain analysis) and LV twist. Parasternal short-axis images 
were acquired at 3 distinct levels: 1) basal level, identified by the mitral valve; 2) papil-
lary muscle level; 3) apical level (the smallest cavity achievable distally to the papillary 
muscles, moving the probe down and slightly laterally, if needed). Frame rate ranged 
from 45 to 100 frame/s and 3 cardiac cycles for each parasternal short-axis level were 
stored in cine-loop format for the offline analysis (EchoPAC). The endocardial border 
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was traced at an end-systolic frame and the region of interest (ROI) was chosen to 
fit the whole myocardium. The software allows the operator to check and validate 
the tracking quality and to adjust the endocardial border or modify the width of the 
ROI, if needed. Furthermore, each short-axis image was automatically divided into 
6 standard segments: septal, anteroseptal, anterior, lateral, posterior, and inferior.
Aortic valve opening and closure were identified on pulsed-wave Doppler tracings 
obtained from the LV outflow tract.
LV dyssynchrony analysis
LV dyssynchrony was derived from the radial strain curves obtained from the papillary 
muscle short-axis view. As previously described, LV dyssynchrony was defined as the 
time difference of peak radial strain between the anteroseptal and posterior segments 
(19).
LV twist analysis
The speckle-tracking software calculates LV rotation from the apical and basal short-
axis images as the average angular displacement of the 6 standard segments referring 
to the ventricular centroid, frame by frame. Counterclockwise rotation was marked 
as positive value and clockwise rotation as negative value when viewed from the LV 
apex. LV twist was defined as the net difference (in degrees) of apical and basal rota-
tion at isochronal time points. For the calculation of LV twist, averaged apical and 
basal rotation data were exported to a spreadsheet program (Excel 2003; Microsoft 
Corporation, Redmond, Washington) (Figure 1) (20, 21). The following measurements 
were derived: peak apical and basal rotation, peak LV twist.
reproducibility
Reproducibility of LV end-diastolic volume (LVEDV), LVESV, LVEF and peak LV twist 
was assessed on 20 randomly selected HF patients. Bland-Altman analysis was per-
formed to evaluate the intra- and inter-observer agreement repeating the analysis few 
days later by the same observer and by a second independent observer. The results 
were expressed as absolute mean difference ± 2 standard deviation (SD).
The intra-observer agreement for LVEDV, LVESV, LVEF and peak LV twist were 7.4 
± 11.2 ml, 7.0 ± 10.1 ml, 1.9 ± 4.4%, and 0.2 ± 0.3°, respectively.
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figure 1 (assessment of LV twist). Examples of left ventricular (LV) twist in normal control (panel A) and in 
heart failure patient (panel B). In both panels, the upper parts represent apical and basal rotations and the 
lower parts represent LV twist calculation after exporting the data to a spreadsheet program (Excel 2003; 
Microsoft Corporation, Redmond, Washington). AVC: aortic valve closure. AVO: aortic valve opening.
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The inter-observer agreement for LVEDV, LVESV, LVEF and peak LV twist were 12.9 
± 14.7 ml, 11.3 ± 13.9 ml, 2.5 ± 4.9%, and 0.7 ± 0.8°, respectively.
crt implantation
All patients received a biventricular pacemaker with cardioverter-defibrillator func-
tion (Contak Renewal 4RF, Boston Scientific St. Paul, Minnesota; or InSync Sentry, 
Medtronic Inc. Minneapolis, Minnesota; Lumax 340 HF-T, Biotronik, Berlin). The right 
atrial and ventricular leads were positioned conventionally. All LV leads were implanted 
transvenously, and positioned preferably in a (postero-)lateral vein. A coronary sinus 
venogram was obtained using a balloon catheter, followed by the insertion of the LV 
pacing lead. An 8-F guiding catheter was used to place the LV lead (Easytrak, Boston 
Scientific, or Attain-SD, Medtronic, or Corox OTW Biotronik) in the coronary sinus.
LV lead position
Target veins were lateral or postero-lateral veins. The LV lead position was determined 
using biplane fluoroscopy classification (22). In the right anterior oblique view and/
or in the postero-anterior view, the distance between the coronary sinus/mitral plane 
and the cardiac apex was divided in 3 parts and the LV lead position was classified in 
3 groups: basal, mid-ventricular and apical.
statistical analysis
All continuous variables had a normal distribution (as evaluated with Kolmogorov-
Smirnov tests). Summary statistics for these data are therefore presented as mean 
± SD. Categorical data are presented as numbers and percentages. Paired T test was 
used for the comparison between continuous variables at baseline and immediately 
after CRT and between baseline and at 6 months follow-up. Unpaired T test was per-
formed to compare continuous variables between normal controls and HF patients and 
between CRT responders and non-responders. Chi-square/Fischer’s exact tests were 
computed to test for differences in categorical variables. Linear regression analysis was 
performed to determine the relations between LV twist, LVEF and LV dyssynchrony. In 
order to identify independent determinants of LV twist, a multivariable linear regres-
sion analysis using the enter model was performed including as covariates LVEF and LV 
dyssynchrony. Linear regression analysis was used to assess the relation between the 
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∆ (difference between immediately after CRT and baseline) peak LV twist and ∆ LVEF. 
The differences in peak LV twist during follow-up in responders and non-responders 
were assessed using ANOVA for repeated measurements. In order to identify variables 
related to a positive response to CRT, univariable and multivariable logistic regres-
sion analysis were performed including clinical (age, gender, etiology, QRS duration 
at baseline and 6-minute walk distance at baseline) and echocardiographic (LVESV at 
baseline, ∆ LVESV, LV dyssynchrony at baseline, ∆ LV dyssynchrony, peak LV twist at 
baseline, ∆ peak LV twist) characteristics of the patients. Only, significant (p <0.05) 
univariable predictors were entered as covariates in the multivariable logistic regres-
sion analysis which was performed using the enter model. Odds ratio (OR) and 95% 
confidence intervals (CI) were calculated. Model discrimination was assessed using 
c-statistic and model calibration was assessed using Hosmer-Lemeshow statistic. The 
differences in peak LV twist and LVEF between the groups of patients with different LV 
lead position were assessed by one-way ANOVA. All statistical tests were 2-sided, and 
a p value <0.05 was considered significant. A statistical software program SPSS 14.0 
(SPSS Inc, Chicago, IL, USA) was used for statistical analysis.
resuLts
study population
Reliable speckle-tracking for rotation analysis was obtained in all normal controls 
and in 80 (92%) HF patients. Consequently, 7 (8%) patients were excluded from the 
study. Of the 80 HF patients enrolled, 9 did not complete the 6 months follow-up; 3 
patients died of worsening HF, 1 had LV pacing switched off due to intolerable phrenic 
stimulation, 1 had CRT device explantation secondary to infection, and 4 were lost to 
follow-up. Therefore, data at baseline and immediately after CRT were collected for 80 
patients and data at 6 month follow-up were collected for 71 patients.
Baseline characteristics of normal controls and the HF patients are listed in Table 1.
LV twist baseline
As shown in Table 1, peak apical rotation, peak basal rotation and peak LV twist were 
severely reduced in HF patients compared to normal controls: 2.4 ± 1.8° vs. 9.4 ± 
3.2° (p <0.001), -3.3 ± 2.0° vs. -6.1 ± 2.4° (p <0.001) and 4.8 ± 2.6° vs. 15.0 ± 3.6° (p 
<0.001), respectively.
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A significant relation (r = 0.53, p <0.001) was observed between peak LV twist 
and LVEF in HF patients. This relation was stronger in non-ischemic (r = 0.60, p 
<0.001) than in ischemic HF patients (r = 0.34, p = 0.020) (Figure 2A). Moreover, 
a modest relation (r = -0.33, p = 0.003) was observed between peak LV twist and LV 
dyssynchrony in HF patients.
At multivariable linear regression analysis, LVEF (β = 0.47, p <0.001) and LV dys-
synchrony (β = -0.21, p = 0.032) were independent determinants of LV twist.
table 1. Baseline characteristics of normal controls and heart failure (HF) patients.





age (years) 61 ± 11 64 ± 11 0.091
Gender (male/female) 22/8 61/19 0.46
nyHa class - 3.0 ± 0.4 -
QoL - 34 ± 20 -
6-minute walk distance (m) - 321 ± 109 -
Qrs duration (ms) 91 ± 9 148 ± 30 <0.001
etiology, n (%)
ischemic - 45 (56) -
non-ischemic - 35 (44) -
Medication, n (%)
ace inhibitors - 74 (92) -
β-blockers - 69 (86) -
diuretics and/or spironolactone - 67 (84) -
LVedV (ml) 86 ± 26 196 ± 74 <0.001
LVesV (ml) 34 ± 11 146 ± 60 <0.001
LVef (%) 62 ± 7 26 ± 6 <0.001
LV dyssynchrony (ms) 14 ± 9 146 ± 81 <0.001
Peak apical rotation (°) 9.4 ± 3.2 2.4 ± 1.8 <0.001
Peak basal rotation (°) -6.1 ± 2.4 -3.3 ± 2.0 <0.001
Peak LV twist (°) 15.0 ± 3.6 4.8 ± 2.6 <0.001
LVEDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction; LVESV: left ventricular 
end-systolic volume, NYHA: New York Heart Association, QoL: Score on the Minnesota Living with Heart 
Failure Questionnaire
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LV twist after crt
Immediately after CRT
Immediately after CRT, peak LV twist increased from 4.8 ± 2.6° to 5.9 ± 3.2° (p = 0.007). 
In particular, ∆ peak LV twist was strongly related to ∆ LVEF (r = 0.83, p <0.001) and 
this relation was good in both non-ischemic (r = 0.85, p <0.001) and ischemic HF 
patients (r = 0.82, p <0.001) (Figure 2B). Furthermore, the relations between ∆ peak 
LV twist and ∆ LV dyssynchrony (r = -0.57, p <0.001) and between ∆ LV dyssynchrony 
and ∆ LVEF (r = -0.63, p <0.001) were good but less strong than the previous relation 
between ∆ peak LV twist and ∆ LVEF.
a
B
figure 2 (LV twist and LV systolic function). Panel a: Correlation between baseline peak LV twist and LVEF in 
heart failure patients (ischemic, white circles, and non-ischemic, black circles). Panel B: Correlation between 
∆ peak LV twist and ∆ LVEF immediately after CRT in heart failure patients (ischemic, white circles, and non-
ischemic, black circles).
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Six months follow-up
At 6 months follow-up, 40 of 71 (56%) patients were classified as echocardiographic 
responders to CRT (defined as a decrease in LVESV ≥15%).
No significant differences in the baseline clinical characteristics were found be-
tween responders and non-responders (Table 2). At 6 months follow-up, significant 
improvement in NYHA class (from 3.0 ± 0.5 to 2.0 ± 0.7, p <0.001), quality of life 






age (years) 66 ± 10 66 ± 11 0.88
Gender (male/female) 32/8 20/11 0.18
Medication, n (%)
ace inhibitors 37 (92) 29 (93) 0.77
β-blockers 35 (87) 27 (86) 0.82
diuretics and/or
spironolactone 34 (84) 26 (84) 0.82
etiology, n (%)
ischemic 20 (50) 18 (58)
non-ischemic 20 (50) 13 (42) 0.63
Qrs duration (ms) 149 ± 32 149 ± 30 0.97
nyHa class
Baseline 3.0 ± 0.5 3.0 ± 0.5 0.92
6 months follow-up 2.0 ± 0.7* 2.7 ± 0.6† <0.001
QoL
Baseline 35 ± 23 32 ± 15 0.51
6 months follow-up 20 ± 20* 29 ± 19 0.065
6-minute walk distance (m)
Baseline 306 ± 106 330 ± 107 0.34
6 months follow-up 363 ± 109* 327 ± 110 0.17
* = p <0.001 baseline vs. 6 month follow-up; † = p<0.05 baseline vs. 6 month follow-up.
Abbreviations see Table 1.
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(from 35 ± 23 to 20 ± 20, p <0.001), and 6-minute walk distance (from 306 ± 106 m 
to 363 ± 109 m, p <0.001) were observed in CRT responders only (Table 2).
Baseline echocardiographic characteristics were also similar between the 2 groups, 
except for LV dyssynchrony (Table 3) that was larger in responders compared to non-
responders (182 ± 71 ms vs. 116 ± 83 ms, p = 0.003). A trend towards lower values of 
peak LV twist were noted in responders as compared to non-responders (4.3 ± 2.4° 
vs. 5.4 ± 2.9°, p = 0.072). At 6 months follow-up, LV dyssynchrony improved in CRT 
responders (from 182 ± 71 ms to 60 ± 45 ms, p <0.001), whereas in non-responders 
LV dyssynchrony did not change (116 ± 83 ms vs. 136 ± 89 ms, p = 0.30) (Table 3). 
Importantly, within ischemic HF patients, CRT responders presented significantly 
lower number of scarred segments at 2D-echocardiography as compared to non-
responders (2.7 ± 0.9 vs. 4.2 ± 2.2, p = 0.016).
Concerning the rotational parameters, in responders peak LV twist progressively 
improved during follow-up (ANOVA p value <0.001), whereas in non-responders 
a progressive deterioration of peak LV twist was noted (ANOVA p value <0.001) 
(Figure 3). Particularly, both apical and basal rotation significantly improved in 
responders (from 2.3 ± 1.7° to 5.0 ± 3.0°, p <0.001 and from -3.2 ± 2.2° to -4.3 ± 1.9°, 
p = 0.006), whereas only basal rotation significantly deteriorated in non-responders 
(from -3.5 ± 1.7 to -2.1 ± 2.2, p = 0.001) (Table 3).
figure 3 (LV twist in responders and non-responders). Peak LV twist in responders and non-responders at 
baseline, immediately after CRT and at 6 months follow-up.
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Prediction of LV reverse remodeling
At univariable logistic regression, LV dyssynchrony at baseline, ∆ LV dyssynchrony, 
∆ LVESV and ∆ peak LV twist were significantly related to LV reverse remodeling at 6 
months follow-up (Table 4). At multivariable logistic regression analysis, ∆ peak LV 
twist was the strongest predictor of response to CRT at 6 months follow-up (OR = 
1.899, 95%CI = 1.334-2.703, p <0.001) (Table 4).
table 3. Standard echocardiographic variables and rotational parameters in responders vs. non-responders at 









Baseline 144 ± 58 153 ± 67 0.56
6 months follow-up 110 ± 43* 164 ± 72‡ 0.001
LVef (%)
Baseline 26 ± 6 26 ± 6 0.91
6 months follow-up 37 ± 7* 26 ± 6 <0.001
LV dyssynchrony (ms)
Baseline 182 ± 71 116 ± 83 0.003
6 months follow-up 60 ± 45* 136 ± 89 <0.001
Peak apical rotation (°)
Baseline 2.3 ± 1.7 2.8 ± 2.1 0.32
6 months follow-up 5.0 ± 3.0* 2.1 ± 2.3 <0.001
Peak basal rotation (°)
Baseline -3.2 ± 2.2 -3.5 ± 1.7 0.51
6 months follow-up -4.3 ± 1.9† -2.1 ± 2.2† <0.001
Peak LV twist (°)
Baseline 4.3 ± 2.4 5.4 ± 2.9 0.072
6 months follow-up 8.5 ± 3.2* 3.3 ± 2.2* <0.001
* = p <0.001 baseline vs. 6 month follow-up; † = p <0.01 baseline vs. 6 month follow-up; ‡ = p<0.05 baseline 
vs. 6 month follow-up.
Abbreviations see Table 1.
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LV twist in relation to LV lead position
Considering the 71 patients with 6 months follow-up, 68 patients had the LV lead 
placed in a (postero-)lateral vein and 3 in an anterior vein. The 3 patients with the LV 
lead positioned in an anterior vein were non-responders at 6 months follow-up. Of 
the remaining 68 patients, the LV lead position was classified (from the right anterior 
oblique/postero-anterior view on fluoroscopy) as basal in 17 (25%), mid-ventricular 
in 34 (50%), and apical in 17 (25%) patients. At baseline, peak LV twist was not sig-
nificantly different between patients with apical, mid-ventricular and basal LV lead 
position, (ANOVA p value = 0.68). However, at 6 months follow-up, peak LV twist 
showed a significant improvement in patients with apical (from 4.3 ± 3.1° to 8.6 ± 
3.0°, p = 0.001) and mid-ventricular (from 4.8 ± 2.2° to 6.4 ± 3.9°, p = 0.038) LV lead 
position, whereas in patients with a basal LV lead position, peak LV twist did not 
change significantly (5.0 ± 3.3° vs. 4.1 ± 3.2°, p = 0.28) (Figure 4A). Similarly, LVEF 
table 4. Univariable and multivariable logistic regression analysis for prediction of response to CRT (defined 
as reduction in LVESV ≥15%)
dependent variable:
Response to CRT at 6 months follow-
up
univariable analysis Multivariable analysis
or (95% ci) p value or (95% ci) p value
independent variables
Age 1.003 (0.958-1.050) 0.90
Female gender 2.198 (0.756-6.404) 0.15
Ischemic etiology 0.722 (0.281-1.858) 0.50
QRS width at baseline 1.000 (0.985-1.016) 0.97
6 minutes walking test at baseline 0.998 (0.993-1.002) 0.34
LVESV at baseline 0.998 (0.990-1.005) 0.56
∆ LVESV immediately after CRT 0.949 (0.915-0.984) 0.005 0.998 (0.950-1.049) 0.94
LV dyssynchrony at baseline 1.013 (1.005-1.021) 0.002 1.011 (1.001-1.022) 0.037
∆ LV dyssynchrony immediately after 
CRT
0.992 (0.986-0.998) 0.010 1.007 (0.996-1.017) 0.21
Peak LV twist at baseline 0.844 (0.698-1.019) 0.078
∆ peak LV twist immediately after CRT 1.837 (1.378-2.449) <0.001 1.899 (1.334-2.703) <0.001
c-statistic: 0.885
CI: confidence intervals; CRT: cardiac resynchronization therapy; LV: left ventricular; LVEF: left ventricular 
ejection fraction; LVESV: left ventricular end-systolic volume; OR: odds ratio.
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increased significantly in patients with an apical (from 26 ± 7% to 37 ± 7%, p <0.001) 
and mid-ventricular (from 26 ± 6% to 33 ± 8%, p <0.001) but not with a basal (26 ± 
5% vs. 28 ± 8%, p = 0.30) LV lead position (Figure 4B).
Figure 5 shows an example of responder with the LV lead placed in an apical posi-
tion of a postero-lateral vein and significant improvement in peak LV twist and LVEF 
after CRT (both immediately after CRT implantation and at 6 months follow-up).
discussion
The current study evaluated the effects of CRT on LV twist and provides new insights on 
the relationship between LV rotational mechanics, CRT response and LV lead position. 
The main findings can be summarized as follows: 1) LV twist was significantly reduced 
in HF patients; 2) LV twist improved in responders and worsened in non-responders 
to CRT; 3) the strongest predictor of LV reverse remodeling at 6 months follow-up was 
∆ peak LV twist (immediate change in LV twist after CRT); 4) an LV lead placed in a 
(postero-)lateral vein with apical or mid-ventricular position was associated with the 
greatest improvement of LV twist after CRT and with the highest response rate to CRT.
a B
figure 4 (LV twist and LVef in relation to LV lead position). Panel a. Peak LV twist at baseline and 6 months 
follow-up in patients with basal, mid-ventricular and apical LV lead position. Significant improvement was 
observed in patients with an apical or mid-ventricular LV lead position but not in patients with basal LV lead 
position. Panel B. LVEF at baseline and 6 months follow-up in patients with basal, mid-ventricular and apical 
LV lead position. Significant improvement was observed in patients with an apical or mid-ventricular LV lead 
position but not in patients with basal LV lead position.
LV: left ventricular; LVEF: left ventricular ejection fraction
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relationship between LV twist and LV function
Several techniques have been applied for the assessment and quantification of LV 
twist. For this purpose, tagged cardiac magnetic resonance imaging and sonomi-
crometry are considered the gold standard, but the most recent speckle-tracking echo-
cardiographic technique, used in the present study, demonstrated a good agreement 
with these imaging modalities (20, 21). Previous studies, using both tagged cardiac 
magnetic resonance imaging and speckle-tracking analysis, suggested an important 
relation between LV twist and LVEF (4, 9). Similarly, in the current study the relation 
between LV twist and LV systolic function was good (r = 0.53, p <0.001), illustrating 
the potential role of LV twist as comprehensive index of LV systolic function. Further-
more, the results of the present study highlight that the relation between LV systolic 
function and LV twist was stronger in non-ischemic patients as compared to ischemic 
patients. A possible reason may be the presence of regional myocardial damage in 
ischemic patients, involving specifically the apex or the base with a different effect on 
LV twist (23).
Finally, LV twist was modestly related to LV dyssynchrony (r = -0.33, p <0.001), but 
at multivariable linear regression analysis, LV dyssynchrony was still independently 
figure 5. Example of a CRT responder with LV lead in an apical position. Panel a. Peak LV twist improved 
from 3.9° at baseline to 9.7° immediately after CRT implantation. Peak LV twist further improved at 6 months 
follow-up (peak LV twist 10.9°). AVC: aortic valve closure. Panel B. Biplane fluoroscopy: the left anterior 
oblique (LAO) view shows the LV lead in a posterolateral cardiac vein; in the postero-anterior (PA) view the 
distance between the coronary sinus/mitral plane and the cardiac apex was divided (dotted lines) in 3 parts 
(basal, mid-ventricular and apical).
Effects of cardiac resynchronization therapy on left ventricular twist ○ 69
4
related to LV twist. This finding points out that LV twist not only is a sensitive and 
thorough parameter of LV function, but also it may reflect the extent of LV (dys)
synchrony.
relationship between LV twist and crt response
The effects of CRT on torsional mechanics were different in responders and non-
responders. A trend towards more reduced LV twist at baseline in responders as 
compared to non-responders was observed. In the present study, a significant im-
provement of LV twist was observed in CRT responders and a significant worsening 
in non-responders. In contrast, a previous study of Zhang et al. did not show any 
significant increase of LV twist in responders to CRT (10). The different results may be 
related to sample size and population characteristics.
In the multivariable model, baseline LV dyssynchrony and an immediate improve-
ment in LV twist after CRT were the only predictors of LV reverse remodeling at 
6 months follow-up. The predictive value of LV dyssynchrony has been shown 
already in previous studies (19, 24). The novelty of the present study is that CRT 
may (partially) restore LV twist, possibly by providing a more physiologic electri-
cal depolarization and mechanical contraction of the myofibers. Specifically, CRT 
partially restored LV torsional behavior in responders, by not only improving apical 
rotation but also basal rotation. In non-responders, the deterioration of LV twist 
was mainly due to worsening of the basal rotation underscoring the influence of the 
basal level on LV twist (25).
relationship between LV twist and LV lead position
Previous studies showed that HF patients treated with CRT showed the best hemo-
dynamic improvement when the LV pacing lead was positioned in (postero-)lateral 
veins (26). In the current study, 3 patients had the LV lead placed in an anterior vein, 
and none of them responded to CRT. The remaining 68 patients had the LV lead posi-
tioned in the (postero-)lateral vein. In these patients, the optimal position of LV lead 
inside the target vein was explored. Patients with a mid-ventricular or apical position 
had the largest systolic improvement, and showed a significant increase in LV twist, 
whereas patients with a basal LV lead position did not improve systolic function and 
decreased in LV twist, confirming that pacing site may influence torsional behavior 
of the LV (27). Similarly, a recent study by Helm et al.(28) reported that the optimal 
site of stimulation (although in a canine model of HF) was the LV free wall centered 
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over the mid-apical part. This finding may be related to the fact that normal cardiac 
depolarization is directed from the apex towards the base (29), and an earlier activa-
tion of the LV basal region, altering the normal contraction pattern of the myofibers, 
may lead to a significant deterioration of LV twist. Another explanation for the findings 
may be related to the fact that the myocardial wall is thinner towards the apex (30, 
31); therefore, the epicardial LV lead in this position is closer to the Purkinje network. 
Consequently, pacing from this position may generate a cardiac pulse which spreads 
faster to the entire myocardium with a more physiological activation (32-34).
conclusion
LV twist is reduced in HF patients and improves in patients who respond to CRT. 
Particularly, the change in LV twist immediately after CRT predicts LV reverse remodel-
ing at 6 months follow-up.
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aBstract
 The analysis of left ventricular (LV) mechanics provides novel 
insights into the effects of cardiac resynchronization therapy 
(CRT) on LV performance. Currently, advances in speckle-
tracking echocardiography analysis have permitted to char-
acterize subendo- and subepicardial LV twist. This study 
investigated the role of the acute changes in subendo- and 
subepicardial LV twist for the prediction of mid-term benefi-
cial effects of CRT.
 A total of 84 heart failure patients scheduled for CRT were re-
cruited. All patients underwent echocardiography prior to, with-
in 48 hours after CRT implantation, and at 6 months follow-up. 
The assessment of LV volumes, ejection fraction (EF) and me-
chanical dyssynchrony (SDI) was performed with real-time 3D 
echocardiography. The assessment of subendo- and subepicar-
dial LV twist was performed with 2D speckle-tracking echocar-
diography. Favorable outcome was defined by the occurrence 
of reduction ≥15% in LV end-systolic volume associated to im-
provement ≥1 in NYHA functional class at 6 months follow-up. 
At 6 months follow-up, 53% of the patients showed a favorable 
outcome. Ischemic etiology for heart failure, baseline SDI, im-
mediate improvement in LVEF, immediate improvement in SDI, 
and immediate improvement in subendo- and subepicardial LV 
twist were significantly related to favorable outcome. However, 
at multivariable logistic regression analysis, only the immedi-
ate improvement of subepicardial LV twist was independently 
related to favorable outcome (odds ratio=2.31, 95%CI=1.29-
4.15, p=0.005). Furthermore, the immediate improvement of 
subepicardial LV twist had incremental value over established 
parameters. In conclusion, the immediate improvement in 
subepicardial LV twist (but not subendocardial LV twist) is in-
dependently related to favorable outcome after CRT.
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introduction
Recent advances in speckle-tracking echocardiography analysis have permitted to 
characterize subendo- and subepicardial left ventricular (LV) twist.1-6 The aim of the 
present study was to investigate the changes induced by cardiac resynchronization 
therapy (CRT)7-9 on the rotational mechanics detected with speckle-tracking echocar-
diography. Specifically, the role of the acute changes in subendo- and subepicardial LV 
twist for the prediction of mid-term beneficial effects of CRT (LV reverse remodeling 
associated with clinical improvement at 6 months follow-up), was explored over the 
classical parameters including mechanical LV dyssynchrony and LV ejection fraction 
(EF).
MetHods
A total of 106 consecutive heart failure patients scheduled for CRT were included. 
According to current guidelines, the inclusion criteria were: New York Heart Associa-
tion (NYHA) functional class III-IV, sinus rhythm, LVEF ≤35% and QRS duration ≥120 
ms. Etiology of heart failure was considered ischemic in the presence of significant 
coronary artery disease (>50% stenosis in ≥1 major epicardial coronary artery) on 
coronary angiography and/or a history of myocardial infarction or revascularization.
All patients underwent complete baseline clinical evaluation, 12-lead surface 
electrocardiogram and transthoracic echocardiography prior to and within 48 hours 
after CRT device implantation. Global measures of LV performance were evalu-
ated with real-time 3-dimensional (3D) echocardiography and 2-dimensional (2D) 
speckle tracking. The assessment of LV volumes, ejection fraction and mechanical 
dyssynchrony was performed with real-time 3D echocardiography. The assessment 
of subendo- and subepicardial LV twist was performed with 2D speckle-tracking. In 
addition, the clinical and echocardiographic evaluation was repeated 6 months after 
CRT implantation. Favorable outcome was defined by the occurrence of LV reverse 
remodeling (reduction ≥15% in LV end-systolic volume) associated with clinical im-
provement (≥1 NYHA functional class) at 6 months follow-up. Finally, the variables 
related to favorable outcome were investigated and the role of the newest rotational 
parameters over the established parameters was explored.
All patients were imaged in left lateral decubitus position using a commercially 
available system (iE33, Philips Medical Systems, Bothell, Washington) equipped with 
an X3, fully sampled matrix transducer. Apical full-volume data sets were obtained 
at a frame rate of 20-35 frames/sec and quantitative analysis was performed off-
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line using a semiautomated contour tracing algorithm (Q-Lab, version 6.0, Philips 
Medical Systems), as previously described.10-12 LV volumes and ejection fraction 
were measured. In addition, the systolic dyssynchrony index (SDI) was obtained as 
marker of global LV dyssynchrony, as previously reported.10-12
Two-dimensional gray-scale harmonic images were obtained in the left lateral 
decubitus position using a commercially available ultrasound system (iE33, Philips 
Medical Systems, Bothell, Washington) equipped with a broadband S5-1 transducer. 
Parasternal short-axis images were acquired at 2 different levels: 1) basal level, 
identified by the mitral valve; 2) apical level, defined as the smallest cavity achiev-
able distally to the papillary muscles (just proximal to the level with end-systolic 
luminal obliteration), moving the probe down and slightly laterally. Patients without 
appropriate apical level were excluded from the study. Frame rate ranged from 55 
to 90 frame/s and 3 cardiac cycles for each parasternal short-axis level were stored 
in cine-loop format for the off-line analysis (Q-Lab, version 6.0, Philips Medical 
Systems).
In the current study, 2D speckle-tracking analysis (Q-Lab, version 6.0, Philips 
Medical Systems) was performed by placing manually several small kernel regions 
in the subendo- and subepicardial border on an end-diastolic frame. Then, the 
software tracked the 2 borders frame by frame and the tracking could be adjusted 
manually, if needed.4
The 2D speckle-tracking software calculates LV rotation from the apical and basal 
short-axis images as the average angular displacement of the 6 standard segments 
referring to the ventricular centroid, frame by frame. Counterclockwise rotation was 
marked as positive value and clockwise rotation as negative value when viewed from 
the LV apex. LV twist was defined as the net difference (in degrees) of apical and 
basal rotation at isochronal time points. For the calculation of LV twist, averaged 
apical and basal rotation data were exported to a spreadsheet program (Excel 2003; 
Microsoft Corporation, Redmond, Washington). The following measurements were 
derived both for subendo- and subepicardial layers: peak apical and basal rotation, 
peak LV twist.
All patients received a biventricular pacemaker with cardioverter-defibrillator func-
tion (Contak Renewal 4RF, Boston Scientific St. Paul, Minnesota; or InSync Sentry, 
Medtronic Inc. Minneapolis, Minnesota; Lumax 340 HF-T, Biotronik, Berlin). The 
right atrial and ventricular leads were positioned conventionally. All LV leads were 
implanted transvenously, and positioned preferably in a (postero-)lateral vein. A 
coronary sinus venogram was obtained using a balloon catheter, followed by the 
insertion of the LV pacing lead. An 8-F guiding catheter was used to place the LV 
lead (Easytrak, Boston Scientific, or Attain-SD, Medtronic, or Corox OTW Biotronik) 
in the coronary sinus.
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All continuous variables are presented as mean ± SD. Categorical data are pre-
sented as numbers and percentages. Unpaired T-test was used to compare baseline, 
immediately after CRT and 6 months follow-up parameters between patients with 
vs. without favorable outcome. Chi-squared test was used to compare categorical 
variables between patients with and without favorable outcome. Paired T-test was 
used to compare baseline and 6 months follow-up data in each group of patients. 
In order to identify variables related to favorable outcome at 6 months follow-up, 
uni- and multivariable logistic regression analysis were performed including clinical 
and echocardiographic characteristics of the patients at baseline and immediately 
after CRT. Only significant (p <0.05) univariable factors were entered as covariates 
in the multivariable analysis using backward selection model. Finally, the incre-
mental value of the newest rotational parameters (subendo- and subepicardial LV 
twist) over other variables was assessed by calculating the global chi-square test for 
each model. All statistical tests were 2-sided, and a p value <0.05 was considered 
significant. A statistical software program SPSS 16.0 (SPSS Inc, Chicago, IL, USA) 
was used for statistical analysis.
resuLts
A total of 22 of 106 (21%) patients were excluded because the image quality did 
not allow reliable analysis. Therefore, the overall patient population consisted of 84 
patients. Of the 84 heart failure patients enrolled, 4 did not complete the 6 months 
follow-up; 1 patients died of worsening heart failure, 1 had LV pacing switched off due 
to intolerable phrenic stimulation, and 2 were lost to follow-up.
Baseline characteristics of the overall patient population are listed in Table 1. The 
mean age was 65 ± 9 years, and all the patients had dilated LV with poor LV func-
tion (mean LVEF 26 ± 5%). In addition, the LV rotational parameters were severely 
reduced in the subendo- and subepicardial layers (peak subendo- and subepicardial 
LV twist were 4.2 ± 2.9° and 2.3 ± 1.8°, respectively).
At 6 months follow-up, 42 of 80 (53%) patients showed a favorable outcome (LV 
reverse remodeling associated to clinical improvement at 6 months follow-up).
The baseline parameters of the patients with and without favorable outcome (LV 
reverse remodeling associated with clinical improvement at 6 months follow-up) 
are reported in Table 2. The patients with favorable outcome had less frequently 
ischemic etiology of heart failure (p = 0.025). Both groups of patients showed 
comparable LV volumes and ejection fraction. However, the baseline SDI was sig-
nificantly larger in the group of patients with favorable outcome (8.1 ± 2.3% vs. 6.4 
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± 1.4%, p <0.001). In addition, no differences in baseline subendocardial LV twist 
(4.0 ± 3.1° vs. 4.5 ± 2.7°, p = 0.45) or subepicardial LV twist (1.9 ± 1.8° vs. 2.6 ± 1.8°, 
p = 0.10) were observed.
Immediately after CRT, the group of patients with favorable outcome showed a 
significantly larger improvement in LVEF and SDI than patients without favorable 
table 1. Baseline characteristics of the overall patient population
Variable Heart failure patients
(n = 84)
age (years) 65 ± 9
Male/female 55/29
Medication
ace inhibitors 76 (91%)
β-blockers 71 (85%)
diuretics and/or spironolactone 71 (85%)
etiology of the heart failure
ischemic 44 (52%)
non-ischemic 40 (48%)
nyHa functional class iii/iV, n 81/3
Qrs duration (ms) 151 ± 29
LV end-diastolic volume (ml) 200 ± 61
LV lead positioned in postero-lateral vein 80 (95%)
LV end-systolic volume (ml) 147 ± 50
LV ejection fraction (%) 26 ± 5
systolic dyssynchrony index (%) 7.3 ± 2.1
Peak subendocardial apical rotation (°) 2.5 ± 2.1
Peak subendocardial basal rotation (°) -2.5 ± 2.1
Peak subendocardial LV twist (°) 4.2 ± 2.9
Peak subepicardial apical (°) 1.5 ± 1.4
Peak subepicardial basal rotation (°) -1.7 ± 1.4
Peak subepicardial LV twist (°) 2.3 ± 1.8
ACE: angiotensin-converting enzyme; LV: left ventricular; NYHA: New York Heart Association
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outcome (delta [Δ] LVEF was 8 ± 6% vs. 3 ± 4%, p <0.001 and Δ SDI was -2.6 ± 2.8% 
vs. -0.3 ± 2.1%, p <0.001; Figure 1 A, B). Similarly, the improvement in subendo- and 
subepicardial LV twist immediately after CRT was more pronounced in patients with 
favorable outcome (Δ subendocardial LV twist was 1.9 ± 2.8° vs. 0.3 ± 2.9°, p = 0.012 
and 2.1 ± 2.1° vs. -0.2 ± 1.7°, p <0.001; Figure 1 C, D).
table 2. Patients with vs. without favorable outcome (left ventricular reverse remodeling associated to clinical 








ischemic etiology, n (%) 16 (38) 24 (63) 0.025
Qrs duration (ms) 152 ± 27 151 ± 31 0.87
nyHa functional class i/ii/iii/iV, n
Baseline 0/0/41/1 0/0/36/2 0.50
6 months follow-up 10/31/1/0* 2/8/26/2* <0.001
LV end systolic-volume (ml)
Baseline 150 ± 47 143 ± 54 0.50
6 months follow-up 107 ± 39* 149 ± 54 <0.001
LV ejection fraction (%)
Baseline 26 ± 6 26 ± 5 0.97
6 months follow-up 38 ± 7* 27 ± 7 <0.001
systolic dyssynchrony index (%)
Baseline 8.1 ± 2.3 6.4 ± 1.4 <0.001
6 months follow-up 5.1 ± 1.8* 8.0 ± 3.8 <0.001
Peak subendocardial LV twist (°)
Baseline 4.0 ± 3.1 4.5 ± 2.7 0.45
6 months follow-up 5.7 ± 2.9* 3.8 ± 2.8 0.004
Peak subepicardial LV twist (°)
Baseline 1.9 ± 1.8 2.6 ± 1.8 0.10
6 months follow-up 4.0 ± 2.1* 1.9 ± 1.8† <0.001
*: p <0.01 vs. baseline; †: p <0.05 vs. baseline
LV: left ventricular; NYHA: New York Heart Association
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figure 1. Changes immediately after cardiac resynchronization therapy (CRT) in left ventricular ejection 
fraction (LVEF; Panel A), systolic dyssynchrony index (SDI; Panel B), subendocardial left ventricular (LV) twist 
(Panel C) and subepicardial LV twist (Panel D) in patients with favorable outcome (LV reverse remodeling 
associated to clinical improvement at 6 months follow-up, white bars) and without favorable outcome (no LV 
reverse remodeling and clinical improvement at 6 months follow-up, black bars).
figure 2. Example of patient with LV reverse remodeling associated to clinical improvement at 6 months 
follow-up. Subendo- and subepicardial left ventricular (LV) twist were both significantly increased at 6 
months follow-up and a parallel reduction of systolic dyssynchrony index (SDI) was observed between 
baseline and 6 months follow-up.
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Finally, at 6 months follow-up, a further improvement in subendo- and subepicar-
dial LV twist was observed in patients showing favorable outcome (from 4.0 ± 3.1° 
to 5.7 ± 2.9°, p = 0.002 for subendocardial LV twist and from 1.9 ± 1.8° to 4.0 ± 2.1°, 
p <0.001 for subepicardial LV twist; Table 2). In Figure 2 an example of a patient 
with favorable outcome (LV reverse remodeling associated to clinical improvement 
at 6 months follow-up) is shown. In contrast, patients without favorable outcome 
showed a trend towards a deterioration of subendocardial LV twist (from 4.5 ± 2.7° 
to 3.8 ± 2.8°, p = 0.11; Table 2), and a significant worsening of subepicardial LV twist, 
(from 2.6 ± 1.8° to 1.9 ± 1.8°, p = 0.037; Table 2).
At univariable logistic regression, ischemic etiology for heart failure, baseline SDI, 
immediate improvement in LVEF, immediate improvement in SDI, and immediate 
improvement in subendo- and subepicardial LV twist were significantly related to 
favorable outcome. At multivariable logistic regression analysis, only the immedi-
ate improvement of subepicardial LV twist was independently related to favorable 
outcome at 6 months (odds ratio = 2.31, 95%CI = 1.29-4.15, p = 0.005; Table 3). In 
table 3. Variables related to favorable outcome (left ventricular reverse remodeling associated to clinical 
improvement at 6 months follow-up)
dependent variable: favorable outcome
univariable analysis Multivariable analysis
or (95% ci) p value or (95% ci) p value
Baseline independent variables:
Age (years) 0.98 (0.93-1.03) 0.36 … …
Male gender 0.52 (0.20-1.36) 0.18 … …
Ischemic etiology 0.36 (0.14-0.89) 0.027 0.50 (0.16-1.55) 0.23
LV ejection fraction (%) 1.00 (0.92-1.01) 0.97 … …
Systolic Dyssynchrony Index (%) 1.75 (1.26-2.43) 0.001 1.42 (0.96-2.01) 0.078
Peak subendocardial LV twist (°) 0.94 (0.81-1.02) 0.45 … …
PeaK subepicardial LV twist (°) 0.81 (0.62-1.05) 0.11 … …
immediately after crt independent variables:
Δ LV ejection fraction (%) 1.25 (1.11-1.40) <0.001 1.02 (0.87-1.21) 0.77
Δ Systolic Dyssynchrony Index (%) 0.68 (0.55-0.85) 0.001 … …
Δ Subendocardial LV twist (°) 1.23 (1.04-1.47) 0.017 0.82 (0.63-1.08) 0.16
Δ Subepicardial LV twist (°) 2.21 (1.50-3.27) <0.001 2.31 (1.29-4.15) 0.005
CI: confidence intervals; CRT: cardiac resynchronization therapy; LV: left ventricular; OR: odds ratio; Δ: 
immediate change (immediately after CRT value – baseline value)
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particular, the immediate improvement of subepicardial LV twist had incremental 
prognostic value over baseline SDI and the immediate improvement of LVEF. In 
contrast, the immediate improvement of subendocardial LV twist did not provide 
any significant incremental prognostic value over baseline SDI and the immediate 
changes of LVEF (Figure 3).
discussion
The current study provides novel insights in the effects of CRT on LV mechanics by 
demonstrating that the immediate improvement of subepicardial LV twist after CRT 
was independently related to favorable outcome at 6 months follow-up. Particularly, 
the immediate improvement of subepicardial LV twist provided incremental prognos-
figure 3. incremental value of the variables detected immediately after crt over the baseline variables.
Bar graph illustrating the incremental value (depicted by chi-square value on the Y-axis) of the immediate 
improvement in left ventricular (LV) ejection fraction (LVEF) after cardiac resynchronization therapy (CRT) 
and of the immediate improvement in subendo- and subepicardial LV twist after CRT for the prediction of 
favorable outcome (LV reverse remodeling associated to clinical improvement at 6 months follow-up). The 
addition of the immediate improvement in LVEF provides incremental prognostic information to baseline 
variables (Model 2). Conversely, the addition of the immediate improvement of subendocardial LV twist does 
not add further incremental prognostic value (Model 3). Finally, the addition of the immediate improvement 
of subepicardial LV twist provides significant incremental prognostic information over baseline variables and 
the immediate improvement in LVEF (Model 4).
Model 1: baseline variables (ischemic etiology and systolic dyssynchrony index).
Model 2: model 1 + immediate improvement in LVEF.
Model 3: model 2 + immediate improvement in subendocardial LV twist.
Model 4: model 3 + immediate improvement in subepicardial LV twist.
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tic value over immediate improvement of LVEF, whereas the immediate improvement 
of subendocardial LV twist did not.
The contraction of the subepicardial fibers rotates the LV apex in the counterclock-
wise direction and the LV base in the clockwise direction.13 Conversely, shortening of 
the subendocardial fibers rotates the LV apex and LV base in clockwise and counter-
clockwise directions, respectively. The larger radius of rotation for the subepicardial 
layer results in the subepicardial fibers having a mechanical advantage in dominat-
ing the overall direction of rotation.13
Advanced systolic heart failure patients have extensive LV remodeling with 
severely deteriorated subendo- and subepicardial LV twist, partially related to the 
LV dilatation and distortion of the spiral architecture of the myofibers and to the 
altered LV electromechanical activation.2, 14-17 Recently, novel speckle-tracking echo-
cardiography analysis has been introduced that permits exploration of subendo- and 
subepicardial LV twist,3, 4 and this approach was applied in the current study. A 
typical patient population was included, characterized by end-stage systolic heart 
failure, dilated LV and prolonged QRS duration. The patients showed pronounced 
impairment of rotational parameters, and particularly subendo- and subepicardial 
LV twist were severely reduced (4.2 ± 2.9° and 2.3 ± 1.8°, respectively) underscoring 
transmural myocardial dysfunction.
It has recently been shown that CRT can increase global LV twist by restoring 
a more physiological LV electromechanical activation in advanced heart failure 
patients.1, 17 The current findings extend these results by exploring the LV twist in the 
subendo- and subepicardial layers. In patients with favorable 6 months outcome 
after CRT (defined as improved symptoms and reverse remodeling), an acute im-
provement of LV twist was observed in both layers, possibly related to a (partially) 
restored LV electromechanical activation. These patients showed a further improve-
ment of LV twist in both layers at 6 months follow-up, probably related to LV reverse 
remodeling with subsequent partial restoration of the spiral architecture of the LV 
myofibers. It was particularly interesting to note that the immediate improvement 
in subepicardial LV twist was an independent predictor of favorable outcome at 6 
months follow-up, whereas the immediate improvement of subendocardial LV twist 
was not. Moreover, the immediate improvement in subepicardial LV twist added 
incremental value over the classical parameters including mechanical LV dyssyn-
chrony and LVEF. This observation underscores that the beneficial effects of CRT 
at 6 months follow-up may mostly rely on the acute improvement in subepicardial 
LV twist. Several reasons may explain this important finding. First, subepicardial 
LV twist may reflect the positive effects of CRT better than subendocardial LV twist, 
because the subepicardial layer is the major determinant of LV twist.13 Second, LV 
pacing in CRT is applied from the epicardial surface which may be more closely 
84 ○ Chapter 5 
related to mechanical changes in the subepicardial than the subendocardial LV layer. 
Finally, the immediate changes in subepicardial LV twist is more strongly related to 
LV energetics and LV dP/dt max than LVEF;18 therefore, immediate improvement in 
subepicardial LV twist may identify patients who have better LV energetics after CRT 
and most likely these patients will improve clinical status and reduce LV volumes.19
Accordingly, immediate assessment of changes in rotational mechanics of the 
subepicardial layer after CRT implantation may be useful to predict a favorable 
mid-term outcome, although the long-term prognostic value remains to be dem-
onstrated.
Speckle-tracking echocardiography provides reliable values of LV apical rotation, 
but only when acquisition of the short axis view close to the real LV apex is possible4; 
for this reason, patients without adequate apical acoustic window were excluded in 
the current study. Moreover, motion throughout the planes of the myocardial re-
gions during the cardiac cycle may reduce the accuracy of speckle tracking analysis 
in particular at the basal level where this motion is more pronounced.
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aBstract
Background. Left ventricular (LV) fibrosis is important for the response to 
cardiac resynchronization therapy (CRT). Calibrated integrat-
ed backscatter (IB) derived by 2D-echocardiography quantifies 
myocardial ultrasound reflectivity which may provide a surro-
gate of LV fibrosis. The aim of the study was first to investigate 
the relation of myocardial ultrasound reflectivity assessed with 
calibrated IB on CRT-response; second to explore the “myo-
cardial ultrasound reflectivity-CRT-response” relation in isch-
emic and non-ischemic heart failure (HF) patients.
Methods and results. 159 HF patients referred for CRT underwent an exten-
sive echocardiographic evaluation at baseline and at 6-month 
follow-up. LV dyssynchrony was derived from speckle-tracking 
analysis. Calibrated IB was obtained from the parasternal long-
axis view. The mean value of calibrated IB of the antero-septal 
and posterior wall was used to estimate myocardial ultrasound 
reflectivity. CRT-response was defined as reduction ≥15% of 
LV end-systolic volume. At baseline LV dyssynchrony was sig-
nificantly larger in responders as compared to non-respond-
ers (188±96ms vs. 115±68ms, p<0.001) and CRT-responders 
showed less myocardial ultrasound reflectivity as compared 
to non-responders (-20.8±3.0dB vs. -17.0±3.0dB, p<0.001). In 
multivariable logistic regression analysis independent predic-
tors for CRT-response were LV dyssynchrony, renal function 
and myocardial ultrasound reflectivity. Importantly, myocar-
dial ultrasound reflectivity provided an incremental value to 
CRT-response (Chi-square change=40, p<0.001). Considering 
ischemic HF patients, the only independent predictor of CRT-
response was myocardial ultrasound reflectivity whereas in 
non-ischemic HF patients independent predictors of LV re-
verse remodeling were myocardial ultrasound reflectivity, LV 
dyssynchrony and renal function.
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conclusions. Assessment of myocardial ultrasound reflectivity is important 
in the prediction of CRT-response in ischemic and non-isch-
emic patients.
introduction
Landmark randomized clinical trials have shown the benefits of cardiac resynchroniza-
tion therapy (CRT) on heart failure (HF) symptoms, left ventricular (LV) function and 
survival.1, 2 Thus far, despite current selection criteria,3 up to 30% of the patients does 
not show clinical response to CRT. Furthermore, considering LV reverse remodeling as 
end-point of the treatment, non-response rate is even higher (40-45%).4
Among different reasons proposed to explain the lack of response to CRT, the 
etiology of HF remains still controversial. In the CARE-HF trial, ischemic HF pa-
tients showed a reduction in LV volumes or improvement in LV function to a lesser 
degree than non-ischemic HF patients.5, 6 Previous data suggest that the extent and 
location of LV fibrosis, strongly influence response to CRT in patients with ischemic 
etiology of HF.7-12 The presence of LV fibrosis has been also demonstrated in mixed 
population of ischemic and non-ischemic HF patients.13 However, particularly in 
non-ischemic HF patients, little is known about the influence of the LV fibrosis on 
CRT response. At present, contrast-enhanced cardiac magnetic resonance (CMR) 
is considered the gold standard to detect LV fibrosis,14 but its use is limited by 
low availability.15 Two-dimensional (2D) echocardiography imaging is more widely 
available than contrast-enhanced CMR and, ultrasonic integrated backscatter (IB) 
derived by 2D echocardiography provides information on myocardial ultrasound 
reflectivity which may be a surrogate for fibrosis of the insonified tissue.16, 17 Recent 
studies demonstrated the use of this technique in different groups of patients to 
characterize myocardial ultrasound reflectivity.18-20 The echocardiographic assess-
ment of myocardial ultrasound reflectivity along with the evaluation of LV mechani-
cal dyssynchrony may provide more comprehensive and valuable information to 
select candidates to CRT. In the current study calibrated IB was used to quantify 
myocardial ultrasound reflectivity in HF candidates for CRT. The aim of the study 
was twofold: first to investigate the influence of myocardial ultrasound reflectivity on 
CRT-response in general; second to explore the “myocardial ultrasound reflectivity 
-CRT response” relation specifically in ischemic and non-ischemic HF patients.
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MetHods
Patient population and protocol
A total of 184 consecutive HF patients scheduled for CRT were prospectively included. 
According to current guidelines, the inclusion criteria were: New York Heart Associa-
tion (NYHA) functional class III-IV, sinus rhythm, LV ejection fraction (LVEF)≤35% and 
QRS duration≥120 ms.3 Etiology of HF was considered ischemic in the presence of sig-
nificant coronary artery disease (>50% stenosis in ≥1 major epicardial coronary artery) 
on coronary angiography and/or a history of myocardial infarction or revascularization.
All patients underwent a clinical and echocardiographic evaluation at baseline 
and 6 months after CRT assessing NYHA functional class, hemoglobin and renal 
function,21 LV volumes and LVEF. Finally, the extent of myocardial ultrasound 
reflectivity was estimated as the mean of calibrated IB of the antero-septal and 
posterior walls in order to: 1. determine the role of myocardial ultrasound reflectivity 
on CRT-response; 2. study the relation between myocardial ultrasound reflectivity 
and CRT-response in ischemic and non-ischemic HF patients.
standard echocardiography
All patients were imaged in the left lateral decubitus position using a commercially 
available system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, 
USA). Standard 2D images were obtained using a 3.5-MHz transducer and, digitally 
stored in cine-loop format; the analysis was performed offline using EchoPAC version 
7.0.0 (General Electric-Vingmed).
From the standard apical views (4- and 2-chamber) LV volumes and LVEF were 
calculated according to the American Society of Echocardiography guidelines.22 At 6 
months follow-up, patients were classified as echocardiographic responders based 
on a reduction ≥15% of LV end-systolic volume (LVESV).4
Mechanical dyssynchrony
In the current study 2 types of mechanical dyssycnhrony were assessed: the inter-
ventricular mechanical dyssynchrony and the intra-LV mechanical dyssynchrony (LV 
dyssynchrony). Interventricular mechanical dyssynchrony was quantified using the 
interventricular mechanical dyssynchrony index.2 LV dyssynchrony was assessed us-
ing speckle-tracking echocardiography.23 LV dyssynchrony was derived from the radial 
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strain curves obtained at the 2D gray scale images of the mid-ventricular short-axis 
(frame rate ranged from 45 to 100 frame/s). As previously described, LV dyssynchrony 
was defined as the time to peak radial strain difference between the antero-septal and 
posterior segments.24
calibrated integrated backscatter
Calibrated IB is a parameter based on gray-scale 2D images which evaluates myocar-
dial ultrasound reflectivity. In the heart, the pericardium is the anatomic structure with 
the highest content of fibrosis and with the highest ultrasound reflectivity; whereas 
blood pool has the lowest ultrasound reflectivity since no fibrous tissue exists. The 
myocardium shows an intermediate ultrasound reflectivity and this reflectivity may 
increase together with the amount of fibrosis.16, 18-20 Gray-scale 2D images were ob-
tained at parasternal long-axis view, with frame rates between 80 and 120 frames/s, 
depending on the sector width, and 3 cardiac cycles were stored in cine-loop format 
for the offline analysis (EchoPAC version 7.0.0, General Electric-Vingmed). A fixed 
9x9-mm region of interest was positioned in the mid-myocardium of the antero-septal 
and posterior walls of the LV and a fixed 2x3-mm region of interest was positioned in 
the pericardium. A measure of myocardial ultrasound reflectivity or tissue density was 
obtained with calibrated IB by subtracting pericardial IB intensity from myocardial 
IB intensity of the LV antero-septal and LV posterior walls. The measurements of 
calibrated IB were performed at a fixed point in the cardiac cycle (peak of the QRS 
complex) and expressed in decibel (dB).16, 18-20 The mean value of calibrated IB of the 
LV antero-septal and posterior walls was calculated to indicate the myocardial ultra-
sound reflectivity (Figure 1).16
crt implantation
All patients received a biventricular pacemaker with cardioverter-defibrillator function 
(Contak Renewal, Cognis, Boston Scientific St. Paul, Minnesota; or InSync Sentry, 
Consulta, Medtronic Inc. Minneapolis, Minnesota; Lumax 340 HF-T, Biotronik, 
Berlin). The right atrial and ventricular leads were positioned conventionally. All LV 
leads were implanted transvenously, and placed preferably in a (postero-)lateral vein. 
A coronary sinus venogram was obtained using a balloon catheter, followed by the 
insertion of the LV pacing lead. An 8-F guiding catheter was used to place the LV lead 
(Easytrak, Boston Scientific, or Attain-SD, Medtronic, or Corox OTW Biotronik) in the 
coronary sinus.
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statistical analysis
Continuous variables are presented as mean ± standard deviation. Categorical data 
are presented as numbers and percentages. Unpaired T test was used to compare 
continuous variables between HF patients with vs. without 6 months follow-up, re-
sponders vs. non-responders, and ischemic vs. non-ischemic HF patients. Paired T 
test was used to compare baseline and 6 months follow-up data either in responders 
and non-responders. Chi-square test was used to compare categorical variables. To 
determine the reproducibility of calibrated IB, 20 HF patients were randomly selected. 
For each of the selected patients, the measurements of calibrated IB were repeated 
by the same observer in a blinded-fashion and at a separate time (1 week later). To 
evaluate interobserver variability, a second independent observer re-analyzed the 
same dataset.
Intra- and inter-observer variability were assessed using intraclass correlation 
co-efficients.
figure 1: Example of assessment of LV fibrosis in the antero-septal and posterior walls with calibrated IB. 
A fixed 9x9-pixel region of interest was positioned in the mid-myocardium of the antero-septal (ASW) and 
posterior wall (PW) and a fixed 2x3-pixel region of interest was positioned in the pericardium. In this patient 
example, calibrated IB for the ASW is calculated by subtracting the pericardial IB intensity (-1.1dB) from 
the ASW IB intensity (-17.6dB), and the calibrated IB for the PW is calculated by subtracting the pericardial 
IB intensity (-1.1dB) from the PW IB intensity (-21.4dB). This results in calibrated IB of the ASW and PW of 
-16.5dB and -20.3dB, respectively. Accordingly, the mean calibrated IB was -18.4dB.
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Linear regression analysis was performed to assess the correlation between the 
relative change of LVESV and calibrated IB in the overall population, in ischemic and 
non-ischemic HF patients.
In order to identify variables related to a positive response to CRT, uni- and mul-
tivariable logistic regression analyses were performed including baseline clinical 
(age, gender, etiology, NYHA functional class, QRS duration, renal function and 
hemoglobin) and baseline echocardiographic (LVESV, LVEF, LV dyssynchrony, cali-
brated IB) characteristics of the patients. Only variables with p<0.10 in univariable 
analysis were entered as covariates in the multivariable model. The multivariable 
logistic regression analysis was performed using a forward selection method with 
entry p value <0.05. Model discrimination was assessed using c-statistic and model 
calibration using Hosmer-Lemeshow statistic. Odds ratio (OR) and 95% confidence 
intervals (CI) were calculated. To increase clinical utility, OR and 95%CI of continu-
ous variables were reported as per 1 year increase in age, per 10ms increase in QRS 
width at baseline, per 30ml/min increase in estimated glomerular filtration rate, 
per 1mmol/ l increase in hemoglobin, per 50ml increase in LVESV, per 5% increase 
in LVEF, per 50ms increase in LV dyssynchrony, and per 5dB increase in calibrated 
IB. The incremental value of myocardial ultrasound reflectivity over other variables 
was assessed by calculating the global chi-square test for each model. In order to 
identify variables related to a positive response to CRT in the subgroups of patients 
with ischemic and non-ischemic etiology of heart failure, uni- and multivariable 
logistic regression analyses were performed including the same baseline variables 
as indicated above, using the same inclusion criteria for the multivariable logistic 
regression analysis.
All statistical tests were 2-sided, and a p value<0.05 was considered significant. 
The statistical software program SPSS 16.0 (SPSS Inc, Chicago, IL, USA) was used 
for statistical analysis.
The authors had full access to the data and take responsibility for its integrity. All 
authors have read and agree to the manuscript as written.
resuLts
In 13(7%) of 184 patients, calibrated IB analysis was not feasible due to suboptimal 
gray-scale 2D images with poor differentiation between myocardium and pericardium, 
and these patients were excluded from the analysis. Furthermore, of the 171 patients 
included, 12(7%) did not complete the 6 months follow-up; 4 patients died, 2 patients 
had LV pacing switched off due to intolerable phrenic stimulation and 6 patients were 
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lost to follow-up. Therefore, baseline and 6 months follow-up data were available for 
159 patients.
Patient population
The general characteristics of the overall patient population are summarized in Table 
1.
The mean age was 66±10 years and 132 patients were male. Importantly, 58% 
of the patients had ischemic etiology of HF; the mean LV end-diastolic volume 
(LVEDV) was 218±81ml and the mean LVEF was 25±7%. No significant differences 
were observed between HF patients with and without 6 months follow-up data.
calibrated integrated backscatter
The mean myocardial ultrasound reflectivity of the LV at baseline quantified with 
calibrated IB was -19.2±3.7dB. The intra- and inter-observer agreements for calibrated 
IB were 0.91 and 0.92, respectively.
In addition, myocardial ultrasound reflectivity was not related to QRS duration 
(r=0.09, p=0.24), whereas a weak but significant inverse relation between myocar-
dial ultrasound reflectivity and renal function (r=-0.17, p=0.039) was observed.
responders vs. non-responders
Table 2 shows the baseline clinical characteristics of CRT responders and non-
responders. There were no differences in clinical characteristics, although non-
responders showed a trend to higher prevalence of ischemic etiology (p=0.10). 
Conversely, QRS duration, estimated glomerular filtration rate and hemoglobin were 
higher in responders as compared to non-responders. There were no differences 
in baseline LV volumes and LVEF for responders and non-responders (Table 3). LV 
dyssynchrony was significantly larger in responders as compared to non-responders 
(188±96ms vs. 115±68ms, p<0.001), whereas only a trend towards a larger interven-
tricular dyssynchrony in responders as compared to non-responders was observed 
(41±23 ms vs. 35±33ms, p=0.17). Finally, CRT responders showed lower myocardial 
ultrasound reflectivity as compared to non-responders (-20.8±3.0dB in responders vs. 
-17.0±3.0dB in non-responders, p<0.001; Table 3).
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At 6 months follow-up, only responders showed a significant decrease in LVEDV 
and LVESV (by definition), with a significant increase in LVEF (Table 3). In addition, 














Hf patients with 
vs. without 6 
months follow-up
p value
age (years) 66±10 66±10 66±10 0.99
Gender (male/female) 132/39 123/36 9/3 0.85 (df=1)
nyHa class (iii/iV) 157/14 147/12 10/2 0.27 (df=1)
Qrs duration (ms) 154±32 154±32 150±20 0.63
estimated glomerular filtration rate 
(ml/min)
70.9±33.2 70.9±33.2 70.8±33.0 0.99
Hemoglobin (mmol/l) 8.2±0.9 8.2±0.9 8.3±0.8 0.64
etiology, n(%)
ischemic 99(58) 93(58) 6(50) 0.57 (df=1)
non-ischemic 72(42) 66(42) 6(50)
Medication, n(%)
ace inhibitors 154(90) 144(91) 10(83) 0.69 (df=1)
β-blockers 149(87) 137(86) 12(100) 0.35 (df=1)
diuretics and/or
spironolactone 145(85) 134(84) 11(92) 0.74 (df=1)
(Postero-)lateral LV lead, n(%) 161(94) 151(95) 10(83) 0.28
LVedV (ml) 218±81 218±81 240±86 0.35
LVesV (ml) 167±71 167±71 190±70 0.28
LVef (%) 25±7 25±7 22±6 0.12
interventricular dyssynchrony (ms) 39±28 33±29 33±17 0.96
LV dyssynchrony (ms) 157±92 157±92 155±81 0.96
calibrated iB (dB) -19.2± 3.7 -19.2± 3.7 -18.8± 3.0 0.70
dB: decibels, df: degree of freedom; IB: integrated backscatter LVEDV: left ventricular end-diastolic volume, 
LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume, NYHA: New York Heart 
Association.
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responders revealed a more synchronous LV contraction after 6 months of CRT 
whereas in non-responders the LV dyssynchrony remained unchanged (Table 3).
Of note, the relative change in LVESV (delta LVESV %) at 6 months follow-up was 
significantly related to calibrated IB (r=0.50, p<0.001; Figure 2A).
Prediction of LV reverse remodeling
At univariable logistic regression, ischemic etiology, QRS duration, estimated glo-
merular filtration rate, hemoglobin, LV dyssynchrony, calibrated IB were significantly 
related to LV reverse remodeling at 6 months follow-up (Table 4). At multivariable 
logistic regression analysis, the independent predictors of response to CRT were 
estimated glomerular filtration rate, LV dyssynchrony and calibrated IB (Table 4). 
Furthermore, calibrated IB had incremental value over LV dyssynchrony and estimated 
glomerular filtration rate for prediction of response to CRT (chi-square change=40, 
p<0.001, degree of freedom=1).






age (years) 65±9 67±11 0.43
Gender (male/female) 71/20 52/16 0.85 (df=1)
Medication, n(%)
ace inhibitors 83(91) 61(90) 0.95 (df=1)
β-blockers 78(86) 59(87) 0.96 (df = 1)
diuretics and/or
spironolactone 77(85) 57(84) 0.96 (df = 1)
etiology, n(%)
ischemic 48(53) 45(66)
non-ischemic 43(47) 23(44) 0.10 (df=1)
Qrs duration (ms) 159±32 148±32 0.028
estimated glomerular filtration rate (ml/min) 76±31 64±35 0.023
Hemoglobin (mmol/l) 8.4±0.9 8.0±0.9 0.040
nyHa class (iii/iV) 85/6 62/6 0.60 (df=1)
Abbreviations see Table 1.
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ischemic vs. non-ischemic etiology of heart failure
Of the 159 patients with 6 months follow-up data, 93 patients had ischemic etiology 
of HF, whereas 66 had a non-ischemic HF. The baseline clinical characteristics were 
not different between patients with ischemic and non-ischemic cardiomyopathy. Con-
versely, patients with ischemic cardiomyopathy had significantly higher LVEF (26±7% 
vs. 23±7%, p<0.001) and less LV dyssynchrony (144±92ms vs. 175±90ms, p=0.036) 
as compared to patients with non-ischemic cardiomyopathy. In addition, myocardial 
ultrasound reflectivity estimated with calibrated IB was higher in patients with isch-
emic as compared to non-ischemic cardiomyopathy (-18.5±3.8dB vs. -20.2± 3.0dB, 
table 3. Standard echocardiographic variables and calibrated IB in responders vs. non-responders at baseline 









Baseline 223± 81 211±80 0.34
6 months follow-up 186±71* 212±84 0.045
LVesV (ml)
Baseline 173±72 159±69 0.22
6 months follow-up 123±57* 161±73† 0.001
LVef (%)
Baseline 24±7 26±7 0.058
6 months follow-up 36±8* 26±7 <0.001
LV dyssynchrony (ms)
Baseline 188±96 115 ± 68 <0.001
6 months follow-up 80±132* 125 ± 121 0.032
calibrated iB (dB)
Baseline -20.8±3.0 -17.0±3.0 <0.001
6 months follow-up -21.9±3.2† -15.6±3.5† <0.001
*=p<0.001 baseline vs. 6 month follow-up; † =p<0.05 baseline vs. 6 month follow-up.
Abbreviations see Table 1.
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p=0.002). Finally, the relationship between the relative change of LVESV at 6 months 
follow-up and calibrated IB was stronger in patients with ischemic cardiomyopathy 
(r=0.56, p<0.001; Figure 2B) as compared to patients with non-ischemic HF (r=0.35, 
p=0.005; Figure 2C).
Prediction of LV reverse remodeling in ischemic etiology
In the subgroup of patients with ischemic HF, in univariable logistic regression, LVEF, 
LV dyssynchrony, calibrated IB were significantly related to LV reverse remodeling at 
6 months follow-up (Table 5). In multivariable logistic regression analysis, the only 
independent predictor of response to CRT was calibrated IB (Table 5).
a B
c
figure 2a. Panel a: Relation between the relative change of LVESV at 6 months follow-up (delta LVESV) and 
calibrated integrated backscatter (IB) in the overall population. Panel B: Relation between the delta LVESV 
in ischemic HF patients and calibrated IB. Panel c: Relation between the delta LVESV in non-ischemic HF 
patients and calibrated IB.
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Prediction of LV reverse remodeling in non-ischemic etiology
In the subgroup of patients with non-ischemic etiology of HF, in univariable logistic 
regression, estimated glomerular filtration rate, LV dyssynchrony and calibrated IB 
were significantly related to LV reverse remodeling at 6 months follow-up (Table 6). In 
multivariable logistic regression analysis, these variables were all independent predic-
tors of response to CRT (Table 6).
table 4. Multivariable logistic regression analysis for prediction of response to CRT (defined as reduction in 
LVESV≥15%)
dependent variable:
Response to CRT at 6 months follow-up
univariable analysis Multivariable analysis
or (95%ci) p value or (95%ci) p value
independent variables
Age (per 1 years) 0.98(0.96-1.02) 0.42
Female gender 1.09(0.52-2.31) 0.82
Ischemic etiology 0.58(0.30-1.09) 0.09 … …
NYHA class IV 0.73(0.22-2.37) 0.60
QRS width at baseline (per 10ms) 1.12(1.01-1.24) 0.029 … …
Estimated glomerular filtration rate (per 
30ml/min)
1.43(1.04-1.96) 0.026 1.93(1.26-2.95) 0.003
Hemoglobin (per 1mmol/l) 1.46(1.01-2.12) 0.043 … …
LVESV at baseline (per 50ml) 1.15(0.92-1.45) 0.22
LVEF at baseline (per 5%) 0.80(0.63-1.01) 0.060 … …
LV dyssynchrony at baseline (per 50ms) 1.77(1.38-2.28) <0.001 1.90(1.39-2.59) <0.001
Calibrated IB (per 5dB) 0.11(0.05-0.24) <0.001 0.10(0.04-0.25) <0.001
c-statistic: 0.89
Hosmer and Lemeshow Test: chi-square=9.5, p=0.30 (df=8)
CI: confidence intervals; CRT: cardiac resynchronization therapy; df: degree of freedom; IB: integrated 
backscatter; LV: left ventricular; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic 
volume; OR: odds ratio.
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discussion
The current study investigated the role of LV fibrosis in the prediction of CRT response 
and demonstrated that: 1) myocardial ultrasound reflectivity assessed with calibrated 
IB together with LV mechanical dyssynchrony and renal function were the major de-
terminants of LV reverse remodeling after CRT; 2) myocardial ultrasound reflectivity 
assessed with calibrated IB provided incremental value over LV mechanical dyssyn-
chrony and renal function for prediction of CRT response; 3) myocardial ultrasound 
reflectivity was the only independent predictor of CRT response in patients with isch-
emic HF; 4) myocardial ultrasound reflectivity was also an independent determinant 
of CRT response in non-ischemic HF.
Myocardial ultrasound reflectivity with calibrated iB
Currently, contrast-enhanced CMR provides accurate assessment of the extent of LV 
fibrosis with high spatial resolution, but CMR remains limited for daily practice.14 Two-
table 5. Univariable and multivariable logistic regression analysis for prediction of response to CRT (defined 
as reduction in LVESV≥15%) in ischemic heart failure
dependent variable:
Response to CRT at 6 months follow-up
univariable analysis Multivariable analysis
or (95%ci) p value or (95%ci) p value
independent variables
Age (per 1 years) 0.98(0.94-1.03) 0.45
Female gender 0.68(0.23-2.02) 0.49
QRS width at baseline (per 10ms) 1.13(1.00-1.27) 0.053 … …
Estimated glomerular filtration rate (per 
30ml/min)
1.30(0.90-1.89) 0.16
Hemoglobin (per 1mmol/l) 1.51(0.91-2.48) 0.11
LVESV at baseline (per 50ml) 1.21(0.89-1.66) 0.23
LVEF at baseline (per 5%) 0.71(0.51-0.99) 0.041 … …
LV dyssynchrony at baseline (per 50ms) 1.37(1.06-1.78) 0.017 … …
Calibrated IB (per 5dB) 0.07(0.02-0.23) <0.001 0.07(0.02-0.23) <0.001
c-statistic: 0.87
Hosmer and Lemeshow Test: chi-square=12.6, p=0.13 (df=8)
Abbreviations as in Table 4
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dimensional echocardiography permits assessment of myocardial ultrasound reflectiv-
ity or tissue density using calibrated IB analysis. The analysis of myocardial reflectivity 
with IB relies on the quantification of ultrasonic energy returned to the transducer after 
interactions with individual scattering elements within the myocardium.16-20, 25 Picano 
et al.16 showed a modest but significant relation (r=0.55, p<0.05) between the percent 
connective tissue area determined in histologic sections of myocardial biopsies ob-
tained from the LV septum and the ultrasonic reflectivity of the same region of myocar-
dium assessed with 2D echocardiography. Moreover, experimental and clinical studies 
demonstrated the usefulness of this technique for the detection of subtle alterations 
of myocardial function and structure.17-20, 25 In an animal model, Perez et al.17 found that 
myocardial areas with increased IB corresponded histologically to discrete fibrocalcific 
lesions whereas areas with normal IB corresponded to normal myocardium.
The present study explored the value of calibrated IB to estimate myocardial ultra-
sound reflectivity as a surrogate of LV fibrosis in HF patients who are candidates for 
CRT. No significant relation was found between myocardial ultrasound reflectivity 
and QRS duration. Furthermore, although QRS duration was larger in non-ischemic 
as compared to ischemic HF patients (162±25 ms vs. 149±35ms, p=0.006), myocar-
table 6. Univariable and multivariable logistic regression analysis for prediction of response to CRT (defined 
as reduction in LVESV≥15%) in non-ischemic heart failure
dependent variable:
Response to CRT at 6 months follow-up
univariable analysis Multivariable analysis
or (95%ci) p value or (95%ci) p value
independent variables
Age (per 1 years) 0.99(0.94-1.05) 0.86
Female gender 0.99(0.33-2.95) 0.99
QRS width at baseline (per 10ms) 1.04(0.85-1.28) 0.67
Estimated glomerular filtration rate (per 
30ml/min)
1.93(1.04-3.56) 0.036 5.76(1.55-21.4) 0.009
Hemoglobin (per 1mmol/l) 1.29(0.72-2.29) 0.39
LVESV at baseline (per 50ml) 1.03(0.73-1.45) 0.86
LVEF at baseline (per 5%) 1.02(0.70-1.49) 0.87
LV dyssynchrony at baseline (per 50ms) 4.03(1.90-8.58) <0.001 6.94(2.14-
22.48)
0.001
Calibrated IB (per 5dB) 0.20(0.06-0.60) 0.004 0.06(0.01-0.60) 0.017
c-statistic: 0.94
Hosmer and Lemeshow Test: chi-square=2.5, p=0.96 (df=8)
Abbreviations as in Table 4
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dial ultrasound reflectivity was higher in ischemic as compared to non-ischemic HF 
patients (-18.5±3.8dB vs. -20.2±3.0dB, p=0.002). These results extend the findings 
of previous studies indicating the lack of relation between the QRS duration and 
fibrosis in dilated cardiomyopathy.26 Therefore, the extent of fibrosis or a surrogate 
such as myocardial ultrasound reflectivity can not be estimated by the QRS duration 
on the surface ECG. In addition, renal function was weakly but significantly related 
to myocardial ultrasound reflectivity underscoring that worse renal function was as-
sociated with higher IB reflectivity (possibly indicating more extensive LV fibrosis).27
Myocardial ultrasound reflectivity and crt response
Previous studies showed that beyond mechanical dyssynchrony, the quantification of 
myocardial fibrosis is an important pathophysiological determinant of CRT response. 
In particular, studies performed with nuclear imaging and contrast-enhanced CMR 
underscored the importance of the assessment of LV fibrosis for clinical and echo-
cardiographic response to CRT.7, 10-12, 28, 29 For example, White et al.29 studied 23 HF 
patients with previous myocardial infarction and demonstrated that the extent of scar 
tissue in the LV, assessed with contrast-enhanced CMR, was significantly less in CRT 
responders as compared to non-responders (1.0% vs. 24.7%, p=0.002). Furthermore, 
a recent study from Bilchick and colleagues13 used CMR to assess both mechanical 
dyssynchrony and LV fibrosis in a small group of 20 HF patients with ischemic and 
non-ischemic etiology referred for CRT. The authors showed that the combined ap-
proach (assessment of mechanical dyssynchrony and quantification of LV fibrosis) 
significantly improved predictive accuracy for clinical CRT response.
In the current study, mechanical dyssynchrony and myocardial ultrasound 
reflectivity (a potential surrogate of LV fibrosis) were comprehensively evaluated 
with 2D echocardiography techniques (speckle-tracking imaging and calibrated IB). 
Myocardial ultrasound reflectivity was larger in non-responders as compared to 
responders (-17.0±3.0dB vs. -20.8±3.0dB, respectively, p<0.001). Moreover, myo-
cardial ultrasound reflectivity was directly related to the extent of reverse remodeling 
after CRT and provided incremental value over LV dyssynchrony and renal function 
for prediction of CRT response, in line with previous studies.24, 30, 31
Myocardial ultrasound reflectivity in ischemic and non-ischemic Hf patients
Various studies have focused on the relation between LV fibrosis and CRT response 
in ischemic HF patients.7, 10-12, 28, 29 In particular, Ypenburg et al.11 demonstrated in 34 
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ischemic HF patients the close relation between the total scar burden assessed with 
contrast-enhanced CMR and LV reverse remodeling after CRT (r=0.91, p<0.05). In the 
present study, in ischemic HF patients, the amount of myocardial ultrasound reflectivity 
was not only significantly related to LV reverse remodeling, but also the strongest inde-
pendent predictor of LV reverse remodeling. These findings underscore the relevance 
of this indirect parameter of LV fibrosis for CRT response in the setting of ischemic HF.
Few studies have reported on the presence of LV fibrosis in patients with non-
ischemic dilated cardiomyopathy,14, 32 but none have explored the relation between 
LV fibrosis and CRT response in patients with non-ischemic HF. The current results 
demonstrated a significant direct relation between the extent of myocardial ultra-
sound reflectivity, as a potential surrogate of LV fibrosis, and LV reverse remodeling 
after CRT. Moreover, in non-ischemic HF patients myocardial ultrasound reflectivity 
was an important and independent predictor of CRT response. Accordingly, the 
current findings underscore the role of the assessment of myocardial ultrasound 
reflectivity to improve CRT response rate in non-ischemic HF patients.
study limitations
As previously described,16, 18-20 calibrated IB assessed in the antero-septal and posterior 
wall was used to detect myocardial ultrasound reflectivity. The measurement of calibrated 
IB in the antero-septal and posterior wall is dependent on ultrasound machine settings 
(focus, depth, gain and insonation angle). These settings were adjusted in all patients 
in order to optimize the image quality for offline analysis. In addition, by correcting cali-
brated IB of the antero-septal and posterior walls for the calibrated IB of the pericardium, 
the effect of these technical issues on the accuracy of this analysis may be minimized. In 
addition, no independent technique as CMR was used to prove the association between 
myocardial ultrasound reflectivity and fibrosis. However, previous studies showed a 
potential relation between myocardial ultrasound reflectivity and fibrosis.16, 17
concLusions
In the current study, myocardial ultrasound reflectivity assessed with calibrated IB 
was related to CRT-response. In particular, myocardial ultrasound reflectivity provided 
incremental value to CRT response over mechanical LV dyssynchrony and renal func-
tion. Furthermore, myocardial ultrasound reflectivity was a strong determinant of LV 
reverse remodeling after CRT, both in ischemic and non-ischemic HF patients.
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1. introduction
At present, up to 40% of patients do not show improvement in left ventricular (LV) 
performance or clinical symptoms after cardiac resynchronization therapy (CRT).1 This 
suboptimal response may be secondary to several pre-implantation and implantation 
issues such as lack of LV mechanical dyssynchrony, the presence of substantial scar 
tissue or non-optimal LV lead position.2 Furthermore, the presence of suboptimal LV 
filling time (atrioventricular [AV] dyssynchrony) or remaining LV dyssynchrony after 
CRT may reduce benefit of this therapy.3 Current CRT devices allow manipulation of 
the AV and interventricular (VV) timings in order to maximize LV filling and stroke 
volume. However, multiple single center and few multicenter trials have provided con-
troversial data on the beneficial effects of AV and VV intervals optimization on cardiac 
performance and clinical status.4-7 In addition, multiple methodologies have been 
proposed to optimize AV and VV intervals but no consensus has been reached on 
which methodology should preferably be used.4-7 Finally, whether AV and VV intervals 
may be evaluated and adjusted periodically remains also controversial.8-10 The present 
article reviews the clinical evidence on AV and VV interval optimization by addressing 
why, how and when we need to optimize AV and VV intervals.
2. wHy do we need to oPtiMize crt settinG?
Management of heart failure patients after CRT implantation should include the 
evaluation of the effects of CRT on LV hemodynamics and mechanics. A suboptimal 
programming of the AV and/or VV interval may partially contribute to the presence 
of AV or LV dyssynchrony and, consequently, may curtail the beneficial effects of CRT. 
The hemodynamic importance of AV interval optimization was first demonstrated in 
studies with dual chamber pacemakers; next, these benefits were confirmed also in 
CRT recipients.3, 11 Auricchio et al. demonstrated in 39 heart failure patients treated 
with CRT that the maximum rate of increase of LV pressure (dP/dtmax) and pulse pres-
sure were measured at different AV and VV intervals. The maximum hemodynamic 
benefit occurred at the AV interval that provided the optimal LV diastolic filling and did 
not decrease the LV end-diastolic pressure.3 In addition, several prospective studies 
have demonstrated the benefits of tailored optimized sequential biventricular pacing 
strategies.12, 13 In 41 heart failure patients receiving CRT, Bordachar et al. evaluated the 
effect of several sequential VV intervals on LV dyssynchrony, as assessed with pulsed-
wave tissue Doppler imaging (TDI) and hemodynamics (cardiac output and mitral 
regurgitation).12 Changes in LV dyssynchrony were strongly correlated with changes in 
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cardiac output and mitral regurgitation. An optimized VV interval provided the most 
LV synchronous contraction, the largest cardiac output, and significantly reduced the 
severity of mitral regurgitation.12
3. How to oPtiMize tHe aV and VV interVaLs?
3.1 aV interval optimization
About 20-30% of the resting stroke volume in heart failure patients is due to atrial 
contraction. A too short AV interval results in early LV contraction and mitral valve 
closure, thereby reducing left atrial contribution to LV filling (resulting in truncation 
of the A wave on pulsed-wave Doppler transmitral inflow). In contrast a too long AV 
interval is characterized by early left atrial contraction, with fusion of E and A wave, 
with reduction of LV filling time and possible induction of diastolic mitral regurgita-
tion. Both these conditions result in impaired LV filling with a reduction in LV perfor-
figure 1. effect of aV interval programming on echocardiographic pulsed-wave doppler transmitral 
inflow. An optimal AV interval (upper panel) permits completion of the left atrial contraction and the mitral 
valve closes at the end of the A wave. When the AV interval is too long (middle panel), left atrial contraction 
occurs prematurely, and the A wave is superimposed to the E wave (fusion of E and A wave). The LV diastolic 
filling time is shortened and diastolic mitral regurgitation can occur. In contrast, when the AV interval is 
too short (lower panel), LV contraction occurs earlier and the mitral valve closes before completion of left 
atrial contraction. On pulsed-wave Doppler recordings of the transmitral inflow truncation of the A wave is 
observed
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mance.6 The optimal AV interval is the shortest AV delay that does not compromise 
left atrial contribution to the LV diastolic filling (Figure 1). Several echocardiographic 
and non-echocardiographic methods have been proposed to optimize the AV interval 
(Table 1). Using echocardiography, the AV interval can be optimized by maximizing 
LV diastolic filling or LV hemodynamics.7 The iterative method evaluates the effects of 
the AV interval on LV diastolic filling. A long AV interval is first programmed and the 
LV diastolic filling pattern is evaluated on the pulsed-wave Doppler transmitral inflow. 
Thereafter the AV interval is shortened by increments of 20 ms until truncation of the 
A wave occurs. The optimal AV interval is then identified by increasing the AV delay in 
10 ms increment until the A wave is not longer truncated (Figure 2). The multicenter, 
randomized CARE-HF trial optimized the AV interval with this method.14 However, 
the effects of performing routinely AV interval optimization on clinical outcome or 
LV systolic function and remodeling have not been reported. The ritter’s method is 
also based on pulsed-wave Doppler recordings of the transmitral inflow.7 With this 
method, two extreme AV intervals are programmed: a long AV interval with A wave 
attenuation (AVlong) and a short AV interval with A wave truncation (AVshort). For each 
table 1. AV interval optimization methods
Echocardiography Non-echocardiography













Abbreviations = LV = left ventricular; VTI = velocity time integral.
figure 2. aV interval optimization with the iterative method. From a long AV interval (left panel), the AV 
interval is shortened by 20 ms steps until the A wave is truncated (middle panel, yellow arrow). Thereafter, 
the AV interval is increased to obtain the optimal AV interval (the shortest AV interval without truncation of 
the A wave) (right panel).
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AV interval, the time between the QRS complex onset to the completion of the A-wave 
is measured. The optimal AV interval is calculated with the formula: AVshort + [(AVlong + 
QAlong) – (AVshort + QAshort)] (Figure 3). This method has been used in several multicenter 
trials (MUSTIC, MIRACLE, InSyncIII).15-17 However, the clinical use of this method may 
be limited in patients with high heart rate or with an intrinsic AV interval <150 ms. In 
addition, measurement of LV filling volume may be a useful method to optimize the AV 
interval. On pulsed-wave Doppler recordings of the transmitral inflow, the measure-
ment of the velocity time integral (VTI) is a surrogate for LV filling volume (Figure 4). 
The optimal AV interval is defined by the largest VTI. Another method to optimize AV 
interval is the method described by Meluzin.18 The AV interval is optimized by aligning 
the end of LV filling and the onset of ventricular contraction. On pulsed-wave Doppler 
recordings of the transmitral inflow, a long AV interval is defined as the maximum 
AV delay that allows full ventricular capture (lowered by 5-10 s). Thereafter, the time 
between the end of the A wave and the onset of the mitral regurgitation spectral signal 
is measured (t1). The difference between the long AV interval and the t1 yields the 
optimal AV interval. The use of this method in clinical practice may be limited by the 
need for detectable mitral regurgitation signal. Echocardiographic methods that opti-
mize AV interval based on LV hemodynamics include measurement of stroke volume 
on pulsed- or continuous-wave Doppler recordings of the LV outflow tract (LVOT) or 
the non-invasive measurement of LV dP/dtmax on continuous-wave Doppler spectral 
figure 3. aV interval optimization with the ritter’s method. Two extreme AV intervals are programmed, a 
long AV interval (AVlong) and a short AV interval (AVshort). The time difference between the QRS onset to the 
completion of the A wave is measured at each AV interval. The optimal AV interval is calculated according to 
the formula.
Why, how and when do we need to optimize the setting of cardiac resynchronization therapy? ○ 113
7
signal of mitral regurgitation (Figure 5).7 The product of the LVOT cross-sectional area 
and VTI measured on the pulsed- or continuous-wave Doppler recordings of the LVOT 
or aortic valve yields the stroke volume.19, 20 The optimal AV interval is defined by the 
largest stroke volume. The measurement of the LV dP/dtmax provides information on 
LV contractility. Non-invasive measurement of this parameter is performed on the 
continuous-wave Doppler spectral signal of the mitral regurgitation. First, the time 
figure 4. Mitral inflow velocity time integral to optimize the aV interval. The mitral inflow velocity time 
integral (VTI) is a surrogate for LV filling volume, assuming a constant mitral valve area. The optimal AV 
interval yields the largest mitral VTI.
figure 5. echocardiographic methods to optimize the aV interval based on LV systolic function. 
Measurement of LV dP/dtmax as indicator of LV performance that permit AV interval optimization.
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difference between two points of the spectral signal is measured (usually between 
1 m/s and 3 m/s time points). Then, the pressure gradient between these two points 
is calculated according to Bernoulli equation. The optimal AV interval corresponds 
to the highest value of LV dP/dtmax. Finally, the measurement of the myocardial per-
formance index may be a useful method to optimize the AV interval.5 The myocardial 
performance index is a comprehensive measurement of LV function. This index is 
calculated as the sum of isovolumic contraction and relaxation times divided by the 
ejection time (Figure 6). The optimal AV interval is defined by the lowest myocardial 
performance index.
Several non-echocardiographic methods have been proposed to optimize AV 
interval. The aforementioned measurement of the LV dP/dtmax can be performed 
invasively. During CRT device implantation, this parameter can be measured and 
the AV interval can be set. However, this invasive approach limits its usability in rou-
tine clinical follow-up. acoustic cardiography was proposed as fast and reproducible 
method to optimize CRT setting.21 Moreover, impedance cardiography optimizes 
the AV interval by measuring changes in the impedance of an alternating current 
applied across the thorax of the patient. These changes indicate the cardiac output. 
With the use of intracardiac electrograms the optimal AV interval can be defined 
by measuring electrical conduction delays (i.e., AV interval and QRS duration) that 
maximize LV hemodynamics.22
figure 6. aV interval optimization based on myocardial performance index evaluation. The myocardial 
performance index is calculated by dividing the sum of the isovolumic relaxation and contraction times by 
the LV ejection time. The sum of the isovolumic contraction and relaxation times is calculated by measuring 
the A-E time on pulsed-wave Doppler transmitral inflow recordings (panel A) and the LV ejection time on 
pulsed-wave Doppler recordings of the LV outflow tract (panel B). Sum of the isovolumic contraction and 
relaxation times = A-E time – LV ejection time.
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3.2 VV interval optmization
VV interval is the time delay between the contraction of the right and LV. In normal 
subjects, the right and left ventricle are not simultaneously activated.23 In heart fail-
ure patients (particularly in the presence of left bundle branch block) the electrical 
activation delay between both ventricles is more pronounced with a prolongation of 
LV pre-ejection time and a shortening of LV ejection time. CRT partially reduces this 
electrical activation delay, by pacing both the right and left ventricle. However, the first 
generation of CRT devices could not differentiate the pacing channels and both ven-
tricles were always paced simultaneously. The recent generation of CRT devices allows 
tailoring the activation delays between right and left ventricle (VV interval), aiming a 
more physiological activation.24 The most common methods used to optimize VV 
interval are based on the assessment of surrogates of stroke volume or cardiac output 
(LVOT VTI) or on the assessment of mechanical dyssynchrony (Table 2).
The echocardiographic method based on the assessment of LV systolic perfor-
mance (LVOT VTI) has been discussed in the AV interval optimization section. 
Similarly, the largest LVOT VTI defines the optimal VV interval (Figure 7).
In contrast to AV interval optimization, measurement of mechanical dyssynchrony 
at different levels (interventricular and intra-LV dyssynchrony) may constitute a 
further helpful tool to select the optimal VV interval setting. Interventricular dys-
synchrony is assessed by the difference between the left and right pre-ejection time 
measured with pulsed-wave Doppler echocardiography at LVOT and right ventricular 
outflow tract, respectively. Intra-LV dyssynchrony mainly measured with TDI is also 
table 2. VV interval optimization methods
Echocardiography Non-echocardiography
Optimization of LV 
systolic function
Optimization of LV mechanical 
dyssynchrony
•	 LV	outflow	tract	VTI •	 	Interventricular	dyssynchrony	
(difference between aortic and 
pulmonary pre-ejection times)
•	 	Time	to	peak	systolic	velocity	at	
TDI (time difference between 2 or 4 
opposing walls, standard deviation 
of 12 LV segments)
•	 	Speckle-tracking	echocardiography	












Abbreviations = LV = left ventricular; TDI = tissue Doppler imaging; VTI = velocity time integral.
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used as effective means of guiding VV interval optimization.13, 25 The time difference 
between peak systolic velocity of 2 or 4 opposing walls or the standard deviation 
of time to peak systolic velocity of 12 LV segments are the most common meth-
ods to measure intra-LV dyssynchrony (Figure 8A). In addition, speckle tracking 
echocardiography and real time 3-dimensional echocardiography are valuable novel 
techniques for intra-LV dyssynchrony assessment but so far no studies investigated 
the role of these techniques for VV interval optimization (Figure 8 B,C).26
Several non-echocardiographic methods have been also proposed to optimize VV 
interval (Table 2). However, the majority of these methods are not routinely used in 
clinical practice because they require invasive measurements (i.e. invasive LV dP/
dtmax) or are time-consuming or not widely available (i.e radionuclide ventriculogra-
phy, acoustic cardiography or finger photo-pletismography).24,21, 27, 28
Among the non-echocardiographic methods, surface ecG derived methods are 
the simplest and widely available. Different parameters have been proposed, with 
measurement of QRS duration at surface ECG in different VV intervals as the easiest 
method.29, 30 A substantial agreement was shown between the selection of the opti-
mal VV interval based on the narrowest QRS duration and on LVOT VTI measured 
with echocardiography among 5 tested VV intervals (LV pre-excitation of 80 and 
40 ms, simultaneous pacing, and right ventricle pre-excitation of 40 and 80 ms; 
Figure 9).29 This study proposed a combined approach for VV interval optimization 
figure 7. Example of VV interval optimization by measuring stroke volume and cardiac output. Velocity-
time integral (VTI) at left ventricular outflow tract (LVOT) is measured with pulsed-wave Doppler 
echocardiography. Stroke volume can be derived by multiplying the cross sectional area (CSA) with VTI. 
Cardiac output can be derived by multiplying stroke volume with heart rate (HR). CSA = π/4 X LVOT 
diameter; Stroke volume = CSA X VTI; Cardiac output = stroke volume X HR.
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figure 8. Examples of VV interval optimizations by measuring LV mechanical dyssynchrony. Panel a. Tissue 
Doppler imaging (left) permits the assessment the time difference between peak systolic velocities of 2 
opposing walls (septal and lateral wall). Panel B. Speckle-tracking echocardiography (middle) permits the 
assessment of radial dyssynchrony from the parasternal short axis view at papillary muscle level. Radial 
dyssynchrony is defined as the time difference between the peak systolic radial strain of the antero-septal 
and posterior wall. Panel c. Real time 3D echocardiography (right) permits the assessment of systolic 
dyssynchrony index (SDI). The LV 3D model is automatically subdivided in 17 standard wedge-shaped (apart 
from the apex) subvolumes. For each volumetric segment, the time interval to reach the minimum systolic 
volume is automatically calculated. The standard deviation of these timings for 16 segments (excluding the 
true apex) is expressed as a percentage of the cardiac cycle, obtaining the SDI.
figure 9. Example of VV interval optimization by measuring QRS duration at surface ECG. The Figure shows 
QRS complex in D1 and V1 leads for 5 VV intervals. Among these 5 QRS duration measurements, the value 
corresponding to the narrowest QRS duration was considered as the ECG-optimized VV interval. In this 
example the ECG-optimized VV interval was simultaneous (LV and RV VV interval = 0 ms). LV: left ventricle; 
RV: right ventricle
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with ECG and echocardiography in 2 steps: first VV interval may be selected by the 
ECG recording at the 5 VV intervals (LV pre-excitation of 80 and 40 ms, simultane-
ous pacing, and right ventricle pre-excitation of 40 and 80 ms); next the interval with 
the greatest QRS duration shortening could be scanned in depth with pulsed-wave 
Doppler echocardiography (20 ms steps) to determine the optimal VV interval. Such 
an approach may save time reducing the number of VV intervals that should be 
tested with echocardiography.29
Finally, several methods based on automated algorithms typical of different manu-
facturers have been proposed for VV interval optimization, the majority of them are 
based on the intracardiac electrograms.22, 31-33
3.3 which method?
At present there are no gold standard methods for AV and VV optimization. Recently, 
Thomas et al. compared different echocardiographic measurements used for VV inter-
val optimization.34 The authors showed that among different measurements used for 
VV interval optimization, LVOT VTI and interventricular dyssynchrony were the most 
feasible (100% and 93% of feasibility, respectively). Furthermore, LVOT VTI resulted 
the most reproducible with a coefficient of variation of only 3.0%.34 Conversely, Zuber 
et al. found a poor performance of LVOT VTI as method to optimize CRT settings as 
compared to acoustic cardiography.21 These controversial results and the absence of 
a well recognized gold standard method to optimize the setting of the CRT devices 
claim warrant further larger studies to address this issue.
3.4 under which conditions?
Preliminary data suggested that AV and VV optimization may improve LV filling and 
hemodynamic performance. However different physiologic conditions like rest and 
exercise may markedly change the heart rate and loading conditions of the heart, and 
therefore some authors hypothesized that in CRT recipients an optimal setting deter-
mined at rest may be different during exercise.35, 36 Particularly, the optimal AV interval 
was shown to be different between rest and during semisupine bicycle exercise in a 
considerable proportion of patients and the same group also demonstrated a similar 
behaviour of optimal VV interval that differed in 57% of the patients between rest 
and during exercise.35, 36 These preliminary observations may have important clinical 
implications since one of the major benefits of CRT is the improvement of exercise 
capacity. However, no studies investigated the potential long-term clinical benefit of 
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this strategy. Furthermore, an important field of research may be the development of 
CRT devices that, similarly to particular dual chamber pacemakers, are able to find the 
optimal setting automatically (for both AV and also VV interval), and reset it regularly 
at rest and during exercise.
3.5 which interval first?
A recurrent question that was never completely addressed in the various studies, is 
whether AV optimization should be followed by VV optimization or vice versa (or even 
simultaneously). Indeed, performing this procedure in different order not necessarily 
produces the same results.21 The common clinical practice is to optimize the AV interval 
first, followed by VV optimization; in all studies, AV and VV intervals were optimized 
separately. It could be possible however that a method that permits simultaneous 
optimization of the AV and VV intervals may provide additional hemodynamic benefit.
4. wHen do we need to oPtiMize tHe crt settinGs?
Preliminary evidence showed that the optimal settings obtained immediately after 
CRT implantation may change during follow-up.9, 10, 37 Valzania et al. demonstrated in 
14 patients who underwent CRT and were followed for 12 months, that optimal AV and 
VV intervals changed over time. In particular a difference ≥ 40 ms in the optimal VV 
interval was observed in 57% of the patients at 12 months follow-up.10 More recently, 
Zhang et al. underscored the importance of periodic reassessment of the optimal AV 
delay in CRT recipients; indeed the optimal AV delay had changed (as compared to 
acutely after CRT implantation) in 56% of the patients at long-term follow-up.37
Therefore, the optimal setting of the CRT devices changes during follow up, as 
loading LV conditions change over time due to LV (reverse) remodeling. Periodic 
tailoring of CRT devices seems important in order to maintain or improve a posi-
tive hemodynamic effect over the long term, and to enhance benefit from CRT. In 
the daily practice however, systematic optimization and periodic reassessment of 
AV and VV intervals may not be feasible, but could be restricted to non-responder 
patients, to potentially improve the effect of CRT. A practical algorithm to decide 
when this procedure should be performed is proposed in Figure 10.
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5. cLinicaL eVidence and triaLs on aV and VV interVaL oPtiMization
Several data form single center studies showed that the optimal AV settings further 
improved hemodynamic benefits of CRT. At present, only one single blind randomized 
trial investigated the impact of AV delay optimization based on aortic VTI on clinical 
status 3 months after CRT.38 The authors showed that 75% of the patients in the arm 
with optimized AV delay had an improvement by at least 1 New York Heart Association 
functional class whereas only 40% of the patients in the arm with empiric AV delay had 
an improvement by at least 1 New York Heart Association functional class (p <0.03).38
figure 10: Algorithm to decide when to optimize AV and VV interval during follow-up
LVESV: left ventricular end-systolic volume; NYHA: New York Heart Association
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Similar to AV interval optimization, several data from small single center studies 
demonstrated that sequential CRT after VV interval optimization, rather than simul-
taneous CRT, may acutely further improve LV systolic performance (stroke volume, 
dP/dtmax) and LV dyssynchrony.
4, 6, 7 Sogaard et al.13 showed for the first time the 
additional benefits on the LV systolic function of the sequential biventricular pacing 
after VV optimization performed using tissue tracking echocardiography. However, 
Vidal et al.25 in single center, nonrandomized clinical study did not show differences 
in the numbers of CRT non-responders between patients with and without AV and 
VV intervals optimized.
Finally, 3 multicenter trials investigated the benefits of VV interval optimization on 
long-term outcomes (InSyncIII, RHYTHM II ICD and DECREASE-HF).17, 39, 40
The InSyncIII clinical study17 evaluated the clinical effect of optimized sequential 
CRT as compared to the control group (optimal pharmacological medical therapy 
alone) and to the treatment group (simultaneous biventricular pacing) of the 
MIRACLE trial. They demonstrated that: 1. optimized sequential CRT significantly 
improved functional status as compared to the control group; 2. the optimal VV 
interval showed a relative narrow range between right ventricular pre-excitation of 
40 ms and LV pre-excitation of 40 ms, with a higher prevalence of LV pre-excitation; 
3. controversial results about the clinical benefits of optimized sequential CRT as 
compared to simultaneous biventricular pacing (optimized sequential CRT signifi-
cantly improved only the 6 minute walking distance but not NYHA functional class 
or quality of life).
In the RHYTHM II ICD study39 121 CRT recipients were included randomly assigned 
in a 1:3 ratio to receive simultaneous biventricular pacing or optimized sequential 
CRT. After AV interval optimization based on LV filling pattern, optimal VV interval 
was set at the maximum stroke volume derived by LVOT VTI. The authors evaluated 
the improvement in clinical end-points, such as NYHA class and 6 minute walking 
test, after 3 and 6 months follow-up. Similar to InSync III, no additional clinical 
benefit was demonstrated by the optimized sequential CRT over the simultaneous 
biventricular pacing.
The DECREASE-HF trial40 evaluated 306 patients with advanced heart failure and 
QRS duration ≥150 ms comparing simultaneous biventricular pacing, optimized se-
quential CRT, and LV pacing alone. Although all 3 pacing modalities led to reduced LV 
size and improved LV systolic function, there was a trend toward a greater benefit in 
patients with sequential and simultaneous pacing as compared to LV pacing alone. 
Furthermore, despite the trial was not designed to specifically compare simultane-
ous biventricular pacing vs. optimized sequential CRT, no significant differences 
between these 2 pacing modalities were observed in terms of improvement of LV 
size and function after 6 months of CRT. Of interest in this trial, the VV interval was 
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programmed based on intracardiac electrocardiograms at the time of the implanta-
tion and was not individually optimized according to the hemodynamic response.
In light of this evidence, AV and VV interval optimization may be beneficial in 
some groups of heart failure patients treated with CRT, improving the clinical status 
and LV performance. Non-responder patients and ischemic heart failure patients 
with extensive myocardial scar tissue may benefit most likely from VV interval 
optimization. Particularly, in ischemic heart failure patients, the inter- and intra-
ventricular conduction of the electrical pulse is very slow and may require larger LV 
pre-excitation.41
Finally, whether AV and VV interval optimization may result in better long-term 
outcome awaits further studies.
6. future PersPectiVes and concLusions
Single center studies pointed out the additional hemodynamic benefits provided by 
the optimized CRT setting. Several echocardiographic and non-echocardiographic 
techniques have been used to perform this operation but so far there is no accepted 
gold standard method. In addition, what are the best physiologic conditions (rest or 
during exercise) to perform the AV and VV optimization and which interval should be 
optimized first, are issues that still need further study. Furthermore, it has been dem-
onstrated that optimal CRT settings may change during follow-up, but when repeat 
optimization should be performed is unclear. Thus far, the available multicenter trials 
did show modest clinical benefits of AV and VV interval optimization at mid- or long-
term follow-up. It remains to investigate whether AV and VV interval optimization may 
improve the long-term survival.
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aBstract
Background. Clinical or echocardiographic mid-term responses to cardiac 
resynchronization therapy (CRT) may have a different influ-
ence on long-term prognosis of heart failure patients treated 
with CRT. The aim of the study was to establish which defini-
tion of response to CRT, clinical or echocardiographic, best 
predicts long-term prognosis.
Methods and results. A total of 679 heart failure patients treated with CRT 
were included. All patients underwent a complete history and 
physical examination and transthoracic echocardiogram prior 
to CRT implantation and at 6 months follow-up. The clinical 
and echocardiographic responses to CRT were defined based 
on clinical improvement (≥1 NYHA class) and LV reverse 
remodeling (reduction of LV end-systolic volume≥15%) at 6 
months follow-up, respectively. All patients were prospectively 
followed-up for the occurrence of death. The mean age was 
65±11 years and 79% of the patients were male. At 6 months 
follow-up, 510 (77%) patients showed clinical response to CRT 
and 412 (62%) patients showed echocardiographic response 
to CRT. During a mean follow-up of 37±22 months, 140 (21%) 
patients died. Clinical and echocardiographic responses to 
CRT were both significantly related to all-cause mortality on 
univariable analysis. However, on multivariable Cox regres-
sion analysis only echocardiographic response to CRT was 
independently associated with a superior survival (hazard ra-
tio:0.38; 95% CI,0.27-0.50; p<0.001).
conclusions. In a large population of heart failure patients treated with CRT, 
the reduction of LV end-systolic volume at mid-term follow-up 
demonstrated to be a better predictor of long-term survival 
than improvement in clinical status.
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introduction
The long-term survival benefits of cardiac resynchronization therapy (CRT) dem-
onstrated in various trials have changed the clinical management of heart failure 
patients.1-3 CRT improves left ventricular (LV) performance by partially restoring more 
physiological and synchronous contraction. As a consequence, significant improve-
ments in clinical status and reduction in LV volumes and mitral regurgitation have 
been reported. Ultimately, these favorable changes result in improved long-term 
morbidity and mortality rates.4, 5 Most of the landmark trials have evaluated the ef-
ficacy of CRT by means of improvement in clinical status and/or a reduction of LV 
end-systolic volume (LVESV) at mid-term follow-up.6, 7 The value of these surrogate 
end points relies on their ability to predict long-term survival.8, 9 Thus far, only few 
studies have attempted to evaluate the long-term survival implications of mid-term 
clinical and echocardiographic responses to CRT (commonly assessed at 3-6 months 
follow-up).4, 5, 10 In a series of 141 heart failure patients treated with CRT, mid-term LV 
reverse remodeling had superior accuracy to predict long-term survival than improve-
ment in clinical parameters.5 A recent subanalysis of the CARE-HF trial showed that 
LV volumes measured 3 months after CRT implantation predicted long-term survival 
on univariable analysis with a hazard ratio higher than LV volumes at baseline; how-
ever, LV volumes (baseline and after 3 months) were not independent determinants 
of long-term survival.10 In view of these results, it remains unclear whether clinical 
or echocardiographic mid-term responses to CRT have an influence on long-term 
prognosis of heart failure patients treated with CRT. Accordingly, the present study 
aimed to establish which definition of CRT response at mid-term follow-up (clinical 
improvement or LV reverse remodeling) best predicts long-term prognosis.
MetHods
Patient population and protocol
A total of 679 heart failure patients undergoing CRT implantation were included. Ac-
cording to current guidelines, the inclusion criteria were: New York Heart Association 
(NYHA) functional class III-IV, sinus rhythm, LV ejection fraction ≤35%, and QRS 
duration ≥120 ms. Etiology of heart failure was considered ischemic in the presence 
of significant coronary artery disease (>50% stenosis in ≥1 major epicardial coronary 
artery) on coronary angiography and/or a history of myocardial infarction or revascu-
larization.
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All patients underwent a complete history and physical examination, 12-lead 
surface ECG and transthoracic echocardiogram prior to CRT implantation and at 6 
months follow-up. Clinical and ECG variables recorded included NYHA functional 
class, medication, hemoglobin level, renal dysfunction (estimated glomerular filtra-
tion rate ≤60 ml/min/1.73m2),11, 12 and QRS duration.
In addition, the number of hospitalizations for heart failure within 6 months 
follow-up was recorded. All clinical data were prospectively entered into the depart-
mental Cardiology Information System (EPD-Vision®, Leiden University Medical 
Center, Leiden, the Netherlands) and retrospectively analyzed.
The echocardiographic examination consisted of comprehensive evaluation of LV 
volumes and function, and severity of mitral regurgitation, if present.
Finally, the clinical and echocardiographic responses to CRT were defined based 
on clinical improvement and LV reverse remodeling at 6 months follow-up, respec-
tively, as previously described.6
All patients were prospectively followed-up for the occurrence of death. To test 
whether the clinical and echocardiographic mid-term responses to CRT could inde-
pendently predict mortality, the long-term follow-up started at 6 months after CRT 
implantation.
echocardiography
Transthoracic echocardiography was performed with the patients in the left lateral 
decubitus position using a commercially available ultrasound transducer and equip-
ment (M4S probe, Vivid 7, GE-Vingmed, Horten, Norway). All transthoracic echocar-
diographic examinations were performed prior to CRT implantation and at 6 months 
follow-up. All images were digitally stored on hard disks for offline analysis (EchoPAC 
version 7.0.0 and 108.1.5 GE-Vingmed, Horten, Norway).
A complete 2-dimensional and color Doppler echocardiographic examination was 
performed. LV end-diastolic (LVEDV) and LVESV were calculated using Simpson’s 
biplane method of discs. LV ejection fraction was calculated and expressed as a 
percentage.13 Intra- and inter-observer variability for the assessment of LV volumes 
and LVEF were previously reported.14 Severity of mitral regurgitation was graded 
semi-quantitatively from color-flow Doppler data using the 4-chamber apical views 
according to the ACC/AHA guidelines. Mitral regurgitation was classified as mild 
(jet area/left atrial area <20%), moderate (jet area/left atrial area 20-40%) and 
severe (jet area/left atrial area >40%).15
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crt implantation
All patients received a biventricular pacemaker with cardioverter-defibrillator func-
tion (Contak Renewal 4RF, Boston Scientific St. Paul, Minnesota; or InSync Sentry, 
Medtronic Inc. Minneapolis, Minnesota; Lumax 340 HF-T, Biotronik, Berlin). The right 
atrial and ventricular leads were positioned conventionally. All LV leads were implanted 
transvenously, and positioned preferably in a (postero-)lateral vein. A coronary sinus 
venogram was obtained using a balloon catheter, followed by the insertion of the LV 
pacing lead. An 8-F guiding catheter was used to place the LV lead (Easytrak, Boston 
Scientific, or Attain-SD, Medtronic, or Corox OTW Biotronik) in the coronary sinus.
definition of crt response
As previously reported, clinical response to CRT was defined as improvement ≥1 in 
NYHA functional class at 6 months follow-up and echocardiographic response to CRT 
was defined by the occurrence of LV reverse remodeling (reduction ≥15% in LVESV at 
6 months follow-up).6
All clinical and echocardiographic analyses were performed by independent 
blinded physicians.
study end points
All patients were followed-up regularly (every 3-6 monthly intervals) and all deaths 
occurring after 6 months follow-up were recorded as events. All-cause mortality was 
adjudicated by physicians blinded to the clinical and echocardiographic data.
statistical analysis
All continuous variables are presented as mean and standard deviation. Categorical 
variables are presented as frequencies and percentages, and were compared using 
Chi-square test. Student T test was used to compare unpaired continuous variables. 
First, the cumulative event rates 6 months after CRT implantation were calculated 
using the Kaplan-Meier method and dichotomizing the population according to the 
clinical and echocardiographic response to CRT. The log-rank tests for time-to-event 
data with respect to all-cause mortality were used for statistical comparison between 2 
patient groups. In order to identify independent predictors of all-cause mortality, mul-
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tivariable Cox proportional-hazards models were constructed with backward selection 
(Correct) model. All significant univariable clinical and echocardiographic predictors 
at baseline, clinical and echocardiographic response to CRT at 6 months follow-up, 
and hospitalizations for heart failure within 6 months follow-up were entered in the 
multivariable model as covariates. The Cox proportional-hazards models were then 
used to estimate hazard ratios and 95% confidence intervals (CI) for those indepen-
dent variables. To avoid multicollinearity between the univariable predictors, a correla-
tion coefficient of <0.7 (corresponding to a tolerance level of >0.5) was set. Second, 
the cumulative event rates 6 months after CRT implantation were calculated using the 
Kaplan-Meier method after dividing the populations in 4 different subgroups based 
on combined clinical and/or echocardiographic response: patients with both clinical 
and echocardiographic response, patients with clinical but not echocardiographic 
response, patients with echocardiographic but not clinical response and patients with 
neither clinical or echocardiographic response. The log-rank tests for time-to-event 
data with respect to all-cause mortality were used for statistical comparison between 
4 patient subgroups All statistical tests were 2-sided, and a p value <0.05 was con-
sidered significant. A statistical software program SPSS 16.0 (SPSS Inc, Chicago, IL, 
USA) was used for all statistical analyses.
resuLts
overall patient population
Of the 679 patients enrolled in the study, 16 (2.4%) patients died before 6 months 
follow-up and these patients were excluded from further analysis. Therefore, the 
patient population consisted of 663 heart failure patients.
Baseline clinical, ECG and echocardiographic characteristics are reported in 
Table 1. The mean age was 65±11 years and 79% of the patients were male. All 
patients had dilated with depressed LV systolic function.
At 6 months follow-up, 510 (77%) patients showed an improvement ≥1 in NYHA func-
tional class (clinical response to CRT) and 412 (62%) patients showed ≥15% reduction of 
LVESV (echocardiographic response to CRT). Furthermore, the patient population (n = 
663) was divided in 4 subgroups based on combined clinical and/or echocardiographic 
response to CRT at 6 months follow-up: 348 (52.4%) patients showed both clinical and 
echocardiographic response, 159 (24%) patients showed clinical but not echocardio-
graphic response, 64 (9.7%) were echocardiographic but not clinical responders, and 
92 (13.9%) patients did not show either clinical or echocardiographic response.
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Age (yrs) 65±11 65±11 68±10 0.003
Male [n, (%)] 523(79) 405(77) 118(84) 0.078
Body surface area (m2) 1.97±0.22 1.98±0.22 1.94± 0.22 0.041
Body mass index (kg/m2) 26.4±4.3 26.6±4.2 25.6±4.3 0.013
Medical history
Diabetes [n, (%)] 131(20) 90(17) 41(29) 0.001
Ischemic etiology [n, (%)] 398(60) 300(57) 98(70) 0.007
Systolic blood pressure (mmHg) 121±20 123±20 114±19 <0.001
Diastolic blood pressure (mmHg) 72±12 73±12 69±11 <0.001
Medications [n, (%)]
ACE inhibitor/Angiotensin receptor blockers 597(90) 477(91) 120(86) 0.054
Beta-blockers 466(70) 381(73) 85(61) 0.005
Diuretics 551(83) 422(81) 129(92) 0.001
Nitrates 161(24) 120(23) 41(25) 0.12
Statins 386(58) 314(60) 72(51) 0.067
Oral anticoagulants/ Aspirin 619(93) 490(94) 129(92) 0.51
clinical characteristics
NYHA functional class IV [n, (%)] 40(6.0) 26(5.0) 14(10.0) 0.026
Heart rate (bpm) 72±17 72±17 74±16 0.20
QRS duration (ms) 155± 33 155±33 156±31 0.76
Hemoglobin level (mmol/l) 8.3±0.9 8.4±0.9 8.1±1.0 0.017
Renal dysfunction [(n, (%)] 269 (40.6) 176 (33.7) 93 (66.4) <0.001
echocardiographic characteristics
LV end-diastolic volume (ml) 218±80 215±74 231±96 0.22
LV end-systolic volume (ml) 164±69 160±64 180±84 0.029
LV ejection fraction (%) 25±8 26±8 23±8 <0.001
Severe mitral regurgitation [n, (%)] 113(17) 72(14) 41(29) <0.001
ACE: angiotensin converting enzyme; LV: left ventricular; NYHA: New York Heart Association.
Renal dysfunction: glomerular filtration rate ≤60 ml/min/1.73m2
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survivors versus non-survivors
During a mean follow-up of 37±22 months, 140 (21%) patients died. Baseline pa-
rameters of the survivors versus the non-survivors are reported in Table 2. Of note, 
the survivors were younger, had less frequently diabetes, ischemic etiology of heart 
failure, and NYHA functional class IV. Interestingly, the survivors had higher hemoglo-
bin levels and also more preserved renal function. Regarding the echocardiographic 
data at baseline, the survivors had smaller LVESV, higher LV ejection fraction and less 
frequently severe mitral regurgitation. There were 7 (1.3%) hospitalizations for heart 
failure in the survivors and 8 (5.7%) in the non-survivors (p = 0.002) within 6 months 
follow-up.
The survivors were more frequently clinical responders as compared to the non-
survivors (78% versus 70%, p = 0.037). Moreover, the survivors showed higher 
table 2. Cox uni- and multivariable regression analyses for all cause mortality
dependent variable:
All cause mortality
univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Age (yrs) 1.03(1.01-1.05) 0.001 1.03(1.01-1.05) 0.012
Body mass index (Kg/m2) 0.95(0.91-0.99) 0.012 - -
Diabetes 2.06(1.42-2.97) <0.001 2.05(1.40-3.01) <0.001
Ischemic etiology 1.85(1.29-2.67) 0.001 - -
Systolic blood pressure (mmHg) 0.98(0.97-0.99) <0.001 0.99 (0.98-0.99) 0.023
Diuretics 2.24(1.21-4.15) 0.010 - -
Hemoglobin level (mmol/l) 0.75(0.63-0.90) 0.002 - -
Renal dysfunction 3.05(2.15-4.33) <0.001 1.93(1.29-2.89) 0.001
LV ejection fraction (%) 0.97(0.95-0.99) 0.003 0.98 (0.96-1.00) 0.088
Severe mitral regurgitation 1.91(1.32-2.75) 0.001 1.47(1.00-2.14) 0.048
Hospitalizations for heart failure 
within 6 months follow-up
3.93(1.91-8.06) <0.001 4.03(1.91-8.50) <0.001
Clinical response 0.59(0.41-0.85) 0.004 - -
LV reverse remodeling 0.31(0.22-0.43) <0.001 0.35(0.25-0.50) <0.001
CI: confidence intervals; HR: hazards ratio; LV: left ventricular
Renal dysfunction: glomerular filtration rate ≤60 ml/min/1.73m2
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echocardiographic response rate as compared to the non-survivors (69% versus 
37%, p <0.001). The clinical (change in NYHA functional class at 6 months follow-
up) and the echocardiographic (change in LVEDV, LVESV and LV ejection fraction) 
improvements are illustrated in Figure 1.
clinical and echocardiographic response to crt versus long-term mortality
Clinical and echocardiographic responses to CRT were both significantly related to 
all-cause mortality. When the patient population was dichotomized based on clinical 
response to CRT, a cumulative 2%, 7% and 12% of the patients with improvement in 
≥1 NYHA functional class died by 12, 24 and 36 months follow-up, respectively. In con-
trast, a respective 7%, 18% and 23% of the patients without improvement in ≥1 NYHA 
functional class died during the same time period (log-rank p = 0.004: Figure 2A).
When the patient population was dichotomized based on echocardiographic re-
sponse to CRT, a cumulative 1%, 4% and 8% of the patients with LV reverse remod-
eling died by 12, 24 and 36 months follow-up, respectively. In contrast, a respective 
figure 1. Panel a shows the absolute change between 6 months follow-up and baseline in New York Heart 
Association (NYHA) functional class. Panel B and c show the relative changes in left ventricular end-
diastolic (LVEDV) and end-systolic volumes (LVESV). Panel d shows the absolute change in left ventricular 
ejection fraction (LVEF)
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8%, 19% and 27% of the patients without LV reverse remodeling died during the 
same time period (log-rank p <0.001) (Figure 2B).
To identify whether clinical and echocardiographic responses were independent 
predictors of all-cause mortality during follow-up, significant univariable predictors 
with a p value <0.05 were entered into the Cox proportional-hazard model as covari-
ates. On multivariable analysis, echocardiographic response (hazard ratio, 0.35; 
95% CI, 0.25-0.50; p <0.001) but not clinical response was independently associated 
with a superior survival.
As expected, the main cause of death was cardiovascular (91[65%] of 140 patients) 
and specifically related to progression of heart failure (81[89%] of 91 patients). 
Interestingly, echocardiographic non-responder patients died more frequently for 
cardiovascular reasons as compared to responder patients (65 [74%] vs. 26[50%] 
patients, p= 0.004).
Finally, dividing the patient population in 4 subgroups based on combined 
clinical and/or echocardiographic response, patients with both clinical and echo-
cardiographic response to CRT and patients with echocardiographic but not clini-
cal response had significantly lower mortality (12.9% and 10.9%, respectively) as 
compared to patients with clinical but not echocardiographic response or patients 
without any response to CRT (nor clinical or echocardiographic), in whom mortality 
rates were 32.7% and 39.1%, respectively (chi-square = 48.72, p <0.001). Figure 3 
represents the Kaplan-Meier survival curves of these 4 subgroups of patients show-
ing superior survival for patients with both clinical and echocardiographic response 
to CRT and for patients with echocardiographic but not clinical response to CRT.
a B
figure 2. Kaplan Meier curves estimate of all cause mortality. Panel a shows the probability of all-cause 
mortality which differed significantly between the clinical responders and clinical non-responders. Panel 
B shows the probability of all-cause mortality which differed significantly between the echocardiographic 
responders and echocardiographic non-responders. The orange shadowed bar indicates the 6-month follow-
up period after CRT implantation.
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discussion
The present study demonstrated that reduction of ≥15% LVESV, regardless changes in 
clinical status, was a predictor of all-cause mortality in heart failure patients treated 
with CRT. Specifically, LV reverse remodeling was an important and independent pre-
dictor of outcome in CRT recipients over other well established predictors of mortality 
in the general heart failure population.
clinical and echocardiographic response to crt
Along the various single- and multi-center trials on CRT, definition of response to CRT 
has widely varied.16 Different clinical and echocardiographic parameters have been 
used to evaluate the efficacy of CRT. In addition, the response to CRT has been evalu-
ated at different time points, most commonly at 3 or 6 months follow-up. However, it 
has been repeatedly shown that clinical and echocardiographic CRT response may not 
coincide and, indeed, a significant percentage of patients who showed an improvement 
in clinical end points did not show any improvement in echocardiographic parameters 
(≥15% LV reverse remodeling or significant improvement in LV ejection fraction).6, 16, 17 
In the present study, 77% of the patients showed an improvement in NYHA function 
figure 3. Kaplan Meier curves estimate of all cause mortality in 4 subgroups of patients: clinical + 
echocardiographic responders, only echocardiographic responders, only clinical responders and non-
responders (nor clinical or echocardiographic). The orange shadowed bar indicates the 6-month follow-up 
period after CRT implantation.
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class of at least 1-point whereas 62% showed ≥15% reduction in LVESV. This confirms 
previous findings and suggests the presence of a placebo effect that may overesti-
mate the benefits of CRT when the response is defined according to clinical criteria. 
However, it may be more interesting to evaluate whether this improvement in clinical 
status or in echocardiographic parameters at mid-term follow-up conveys or not a 
superior long-term survival. Indeed, the appropriateness of surrogate end points, 
such as NYHA functional class or LV reverse remodeling, to evaluate the efficacy of 
heart failure therapies depends on the strength of the statistical relationship between 
the change in the surrogate end points over time and the clinical outcome.8
response to crt versus long-term survival
The present study demonstrated that the occurrence of significant LV reverse remod-
eling at 6 months follow-up was related with superior long-term survival. In contrast, 
improvement in NYHA functional class was not associated with improved long-term 
survival. This was also confirmed dividing the patient population in 4 subgroups 
based on combined clinical and/or echocardiographic response CRT response. The 
patients with echocardiographic response to CRT (clinical and echocardiographic 
or only echocardiographic CRT response) had better survival as compared to the 
patients without echocardiographic response to CRT (Figure 3). Previously, Yu et al.5 
have shown in 141 heart failure patients that LVESV reduction was independently as-
sociated to mid-term outcome after CRT. The authors found a relationship between 
reduction of LVESV and mid-term clinical outcome. However, the association between 
improvement in clinical status (defined by ≥1 point in NYHA functional class) and 
all-cause and cardiovascular mortality was not evaluated. More recently, the results 
of the REVERSE, MADIT-CRT and RAFT trials have shown that in mildly symptomatic 
heart failure patients (NYHA functional class I-II), CRT reduced the number of heart 
failure re-hospitalizations, induced a significant LV reverse remodeling and improved 
the long-term survival.18-20 This improvement in long-term survival might be related 
to improvement in LV performance and LV reverse remodeling rather than improve-
ments in NYHA functional class since the included patients were asymptomatic or 
mildly symptomatic.
The present study confirms and extends these preliminary results in over 650 
heart failure patients treated with CRT. LV reverse remodeling was independently re-
lated to all cause mortality (hazard ratio, 0.34; 95% CI, 0.25-0.50; p <0.001) together 
with age, presence of diabetes, renal dysfunction, and heart failure hospitalizations. 
These clinical parameters (age, diabetes, systolic blood pressure, renal dysfunc-
tion, and heart failure hospitalizations,) are well known strong prognosticators in 
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patients with advanced heart failure.21-23 However, thus far, the effects of CRT on 
LV dimensions and its implications on long-term survival have not been evaluated 
together with these clinical variables.4, 5 The fact that LV reverse remodeling at 
mid-term follow-up was still an independent predictor of long-term outcome after 
adjusting for these powerful risk factors underlines the relevance of the assessment 
of CRT response at mid-term follow-up based on LV reverse remodeling.
study limitations
The study was retrospective and reported the experience of a single center. Data on 
LV lead position was not included in the present study. The influence of this param-
eter on CRT response and outcome has been well –described in observational and 
randomized trials. However, the impact of LV lead position on CRT response and 
outcome was beyond the scope of the present study which focused on the prognostic 
implications of clinical and/or echocardiographic response. The percentage of beta-
blocker use was relatively low but still higher as compared to previous randomized 
trials (MIRACLE and COMPANION) and similar to the CARE-HF trial but lower than 
the recent REVERSE, MADIT-CRT and RAFT trials.1, 3, 18-20, 24 However all the patients 
received the maximum tolerated dose of beta-blocker.
concLusions
In a large population of heart failure patients treated with CRT, the reduction of LVESV 
at mid-term follow-up demonstrated to be a better predictor of long-term survival than 
improvement in clinical status. In addition, LV reverse remodeling was an important 
and independent predictor of outcome in these patients together with other well 
established predictors of long-term survival.
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aBstract
Background. Quantification of segmental left ventricular (LV) strain by 
speckle-tracking echocardiography can identify transmural in-
farcts in patients with chronic ischemic cardiomyopathy. The 
aim of the study was to explore the relationship between the 
LV longitudinal peak systolic strain (LPSS) of the infarct, peri-
infarct and remote zones and monomorphic ventricular tachy-
cardia (VT) inducibility on electrophysiological (EP) study.
Methods. A total of 134 patients with chronic ischemic cardiomyopathy 
scheduled for EP study were included. The protocol consisted 
of clinical, ECG and echocardiographic evaluation, including LV 
longitudinal strain analysis using speckle-tracking echocardiog-
raphy, immediately before EP study. An infarct segment was de-
fined as a longitudinal strain value of >-5%, and a peri-infarct seg-
ment was defined as immediately adjacent to an infarct segment.
results. The infarct zone had the most impaired longitudinal strain 
(-0.5±3.0%), whereas the peri-infarct and remote zones had 
more preserved longitudinal strain (-10.8±1.9% and -14.5±3.0%, 
respectively; ANOVA p<0.001). Seventy-two (54%) patients had 
inducible monomorphic VT on EP study. There was no significant 
difference in LVEF (31±9% vs. 32±11%, p=0.29) between induc-
ible and non-inducible patients. LPSS of the peri-infarct zone was 
more impaired in inducible patients (-9.8±1.5% vs. -11.0±2.1%, 
p=0.001), but no differences in LPSS of the infarct (-0.5±3.2% 
vs. -0.4±2.7%, p=0.75) and remote (-14.6±2.8% vs. -14.5±3.4%, 
p=0.92) zones were observed. Only LPSS of the peri-infarct zone 
(OR 1.43, 95% CI 1.15-1.78, p=0.001) was independently related 
to monomorphic VT inducibility on multiple logistic regression.
conclusions. Longitudinal strain analysis may be a useful imaging tool to risk-
stratify ischemic patients for malignant ventricular arrhythmia.
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introduction
Coronary artery disease, provoking lethal ventricular arrhythmias, is one of the most 
common causes of sudden cardiac death.1 Usually, the electrical sequence is due to 
the initial development of monomorphic ventricular tachycardia (VT) that subse-
quently degenerate into ventricular fibrillation.2 The classical anatomical substrate 
for monomorphic VT is the peri-infarct zone with re-entry pathways that abounds 
the infarcted myocardial scar tissue.3 These scar areas represented by the infarct 
zone are normally highly fibrosed, whereas the peri-infarct zone constitutes a highly 
heterogeneous area with intermediate degrees of non-transmural fibrosis.4 The tissue 
heterogeneity of the peri-infarct zone may be electrically unstable and constitute the 
substrate for re-entrant VT.4-6
Recently cardiac magnetic resonance imaging (CMR) permits identification of 
myocardial scar tissue and can also characterize the peri-infarct zone.7, 8 Specifi-
cally, the extent of peri-infarct zone can be quantified with contrast-enhanced CMR, 
whereas the mechanical properties of the peri-infarct zone can be assessed by 
tagged CMR.7, 8 These studies demonstrated a strong relationship between the peri-
infarct zone heterogeneity and monomorphic VT inducibility.7, 8
Novel speckle-tracking echocardiography with quantifications of regional 
left ventricular (LV) longitudinal strain has been shown to have good sensitivity 
and specificity in identifying transmural scar tissue by contrast-enhanced CMR.9 
Therefore, regional speckle-tracking analysis of LV longitudinal peak systolic strain 
(LPSS) permits the differentiation of the infarct, peri-infarct and remote zones by 
characterizing the different tissue mechanical properties. Thus, the aim of the pres-
ent study was to explore the relationship between the LPSS of the peri-infarct zone 
detected with speckle-tracking echocardiography and monomorphic VT inducibility 
in patients with chronic ischemic cardiomyopathy.
MetHods
Patient population and protocol
A total of 141 consecutive patients scheduled for cardiac electrophysiological (EP) 
study were included. Inclusion criteria were previous history of myocardial infarction 
(>40 days ago), referral for a clinically indicated EP study because of syncope or non-
sustained ventricular tachycardia at ECG-Holter monitoring, and sinus rhythm during 
the echocardiographic examination.
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The protocol consisted of an extensive clinical, electrocardiographic (ECG), and 
echocardiographic evaluation, including LPSS analysis. Afterwards (maximum 24 
hours later), all patients underwent a clinically indicated EP study to induce mono-
morphic VT. All echocardiographic analyses were performed by an independent 
observer blinded to the EP study results. The echocardiographic analyses included 
assessments of LV volumes, LV ejection fraction (LVEF) and wall motion scoring. 
Speckle-tracking analysis using automated function imaging was applied to deter-
mine global LPSS. In addition, the LPSS of the infarct, peri-infarct and remote zones 
were determined based on segmental strain values.9 Finally, the clinical, ECG, and 
echocardiographic variables were tested by uni- and multivariable logistic regres-
sion analysis to investigate the association with inducibility of monomorphic VT at 
EP study.
standard echocardiography
All patients were imaged in left lateral decubitus position using a commercially 
available system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, 
USA). Standard 2-dimensional images were obtained using a 3.5-MHz transducer and 
digitally stored in cine-loop format; the analysis was performed offline using EchoPAC 
version 108.1.5 (General Electric-Vingmed).
LV end-diastolic volume (LVEDV), end-systolic volume (LVESV) and LVEF were 
calculated using Simpson’s biplane method of discs as recommended by the Ameri-
can Society of Echocardiography guidelines.10
Segmental wall motions were evaluated and scored as 1: normal; 2: hypokinesia; 3: 
akinesia; 4: dyskinesia. Global wall motion score index was calculated using the sum 
of the segmental scores divided by the number of segments analyzed, as previously 
described.10
speckle-tracking analysis
The speckle-tracking software tracks frame-to-frame movements of natural myocar-
dial acoustic markers, or speckles, on standard gray scale images. Each region of the 
myocardium has a characteristic speckle-pattern; therefore it can be followed during 
the cardiac cycle. Furthermore, speckle-tracking analysis is an angle independent 
technique that allows the evaluation of myocardial contraction/relaxation in the cir-
cumferential, longitudinal and radial directions.11, 12
Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with cardiomyopathy ○ 149
9
Longitudinal strain analysis: global, infarct, peri-infarct and remote LPSS
Myocardial strain can be assessed from temporal differences in the mutual distance 
of neighboring speckles. The change in length/initial length of the speckle-pattern 
over the cardiac cycle can be used to calculate longitudinal strain, with myocardial 
shortening represented as negative strain, and myocardial lengthening as positive 
strain. During the systole the myocardium shortens in the longitudinal direction 
and, conventionally, is presented as negative values. Therefore, more negative values 
indicate larger and more preserved longitudinal strain. LV longitudinal strain was 
determined from the apical long-axis, 4- and 2-chamber views with optimal 2D gray 
scale image frame rates ranging from 50 to 100 frame/s. After defining the mitral an-
nulus and the LV apex with 3 index points at the end-systolic frame in each apical view, 
the automated function imaging software automatically traces the endocardial border 
while allowing the user to manually adjust the region of interest width to include 
the entire myocardial wall. Further manual adjustments of the endocardial border 
were performed to ensure adequate tracking throughout the cardiac cycle. The LV 
was automatically divided in 6 segments in each apical view and tracking quality was 
validated for each segment. Finally, the automated algorithm provides the LPSS value 
for each LV segment in a 17-segment model polar plot, with the average value of LPSS 
for each apical view and the averaged global LPSS value for the entire LV.
According to previous evidence, a segmental longitudinal strain value >-5% 
was consistent with transmural scar on delayed enhancement cardiac magnetic 
resonance imaging, and was classified as infarcted segment.9 Thus, all segments 
adjacent to the infarcted segments were classified as peri-infarct segments and all 
remaining segments were classified as remote segments (Figure 1). Finally, LPSS of 
the infarct, peri-infarct and remote zones were calculated as the means of the LPSS 
of the infarct, peri-infarct and remote segments respectively.
The intra- and inter-observer variabilities for longitudinal strain analysis as as-
sessed with Bland-Altman analysis were previously reported and were -0.3 ± 0.6% 
and -0.2 ± 2.6%, respectively.13
cardiac electrophysiological testing
The cardiac EP study was performed within 24 hours after echocardiographic evalua-
tions. Studies were performed in the post absorptive, non-sedated state. Antiarrhyth-
mic drugs were discontinued for 5 half-lives, with the exception of amiodarone which 
was continued in 13 patients.
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The EP study consisted of a programmed extrastimulation protocol using 3 drive 
cycle lengths (600, 500, 400 ms) and 1, 2 and 3 extrastimuli while pacing at 2 right 
ventricular sites (right ventricular apex and right ventricular outflow tract). The 
initial S2 coupling interval in each stimulation sequence was at least 300 ms and 
stimulation was not performed at a coupling interval of <200 ms. Inducibility at 
EP study was defined as the induction of a monomorphic VT lasting for more than 
30 seconds or monomorphic VT requiring termination because of hemodynamic 
compromise.
statistical analysis
All continuous variables are presented as mean ± SD. Categorical data are presented 
as numbers and percentages. Differences in LPSS and number of segments between 
the different zones (infarct, peri-infarct and remote) in the overall population were 
assessed by one-way analysis of variance (ANOVA), and post-hoc analyses were 
performed with Bonferroni correction. Unpaired Student’s t-test and Chi-square test 
were used to compare continuous and categorical variables respectively for inducible 
figure 1. Example of assessment of longitudinal strain from the 3 apical views (upper panel from left to the 
right: 3-chamber, 4-chamber and 2-chamber views). From the polar plot model (lower panel), all segments 
with segmental strain value >-5% were classified as infarct segments. All segments adjacent to infarcted 
segments were classified as peri-infarct segments, and the remaining segments were classified as remote 
segments. Infarct zone strain (the average of the strain of the infarcted segments) was 2.7%. Peri-infarct 
zone strain (the average of the strain of the peri-infarcted segments) was -11.7%. Remote zone strain (the 
average of the strain of the remote segments) was -16.1%.
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vs. non-inducible patients. In order to identify variables related to a positive response 
to EP study, uni- and multivariable logistic regression analyses were performed and 
included clinical (age, gender, etiology, cardiovascular risk factors, time since last 
myocardial infarction, New York Heart Association [NYHA] functional class, heart rate, 
and medications), ECG (PR, QRS duration and corrected QT interval duration), and 
echocardiographic (LV volumes, LVEF, wall motion score index, global LPSS, infarct 
LPSS, peri-infarct LPSS, remote LPSS) variables. Only univariable predictors with a 
p value ≤0.10 were entered as covariates in multivariable logistic regression model 
using an enter method. Odds ratio and 95% confidence intervals were calculated. 
All statistical tests were 2-sided, and a p value <0.05 was considered significant. A 
statistical software program SPSS 16.0 (SPSS Inc, Chicago, IL, USA) was used for 
statistical analysis.
No extramural funding was used to support this work. The authors are solely 
responsible for the design and conduct of this study, all study analyses, the drafting 
and editing of the paper and its final contents.
resuLts
overall population
Reliable speckle-tracking was obtained in 134 (95%) patients and constituted the final 
study population. Tables 1 and 2 show the demographic and clinical characteristics 
of the overall patient population. In particular, the mean age of the overall patient 
population was 67 ± 10 years and 119 (89%) patients were men. Both the QRS dura-
tion and the corrected QT interval were slightly prolonged (122 ± 28 ms and 444 ± 35 
ms respectively). Beta-blockers and angiotensin-converting enzyme inhibitor or an-
giotensin receptor blockers treatments were present in 67% and 92% of the patients, 
respectively; whereas 10% and 16% of the patients were treated with amiodarone or 
sotalol, respectively.
All the patients had dilated LV volumes (LVEDV and LVESV were 171 ± 57 ml and 
120 ± 50 ml respectively) and reduced LVEF (31 ± 10%). The mean global LPSS 
was -9.1 ± 3.8%. A progressive increment in LPSS from the infarct to peri-infarct 
and remote zones (ANOVA p <0.001; Figure 2) was observed. The infarct zone 
showed the most impaired LPSS values (-0.5 ± 3.0%), whereas the peri-infarct and 
remote zones showed more preserved values of LPSS (-10.8 ± 1.9% and -14.5 ± 
3.0%, respectively; Figure 2).
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inducible vs. non-inducible patients
The EP study was conducted in all the patients without major complications. After EP 
study, 72 (54%) patients were classified as inducible and 62 (46%) as non-inducible. 
Table 1 shows the demographic and clinical characteristics of inducible and non-
figure 2. Differences in longitudinal peak systolic strain (LPSS) among infarct, peri-infarct and remote zones.












Age (yrs) 67±10 67±10 67±10 0.84
Male (%) 119 (89) 67 (87) 52 (90) 0.093
Hypertension (%) 58 (43) 31 (43) 27 (44) 0.95
Diabetes (%) 35 (26) 17 (24) 18 (29) 0.47
Family history of cardiac disease (%) 46 (34) 29 (40) 17 (27) 0.12
Current smoker (%) 21 (16) 11 (15) 10 (16) 0.89
Time since last myocardial infarction (months) 88±90 100±94 74±83 0.090
NYHA functional class III-IV (%) 47 (35) 24 (33) 23 (37) 0.65
Heart rate (bpm) 67±10 66±11 68±10 0.13
PR interval (ms) 182±32 185±32 178±33 0.21
QRS duration (ms) 122±28 126±27 117±28 0.044
Corrected QT interval duration (ms) 444±35 446±33 441±36 0.45
MVT: monomorphic ventricular tachycardia; NYHA: New York Heart Association
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inducible patients. There were no significant differences in age, gender, cardiac risk 
factors, NYHA functional class and heart rate. Inducible patients tended to have 
longer time since last myocardial infarction (100 ± 94 months vs. 74 ± 83 months, p 
= 0.090). In addition, QRS duration was significantly longer in inducible patients (126 
± 27 ms vs. 117 ± 28 ms, respectively, p = 0.044). Table 2 showed no significant differ-
ences in the use of cardiac medication between inducible and non-inducible patients.
In regards to the echocardiographic variables, there was a trend towards a more 
dilated LV in inducible patients (178 ± 60 ml vs. 161 ± 53 ml, p = 0.094) but there 
were no significant differences in LVEF (31 ± 9% vs. 32 ± 11%, p = 0.29). However, 
LPSS of the peri-infarct zone was more impaired in inducible patients (-9.8 ± 1.5% 
vs. -11.0 ± 2.1%, respectively, p = 0.001), but there were no significant differences in 
LPSS of the infarct (-0.5 ± 3.2% vs. -0.4 ± 2.7%, p = 0.75) and remote (-14.6 ± 2.8% 
vs. -14.5 ± 3.4%, p = 0.92) zones (Table 3). Figure 3 shows examples of patients with 
and without inducible monomorphic VT. The patient with inducible monomorphic 
VT had a more reduced LPSS of the peri-infarct zone. Furthermore, in this subgroup 
of patients mean VT cycle length was 288 ± 65 ms and this was modestly but sig-
nificantly related to global LPSS (r = 0.52, p <0.001; Figure 4). Conversely, VT cycle 
length was not correlated to LPSS of the peri-infarct zone.











Beta-blockers (%) 90 (67) 46 (64) 44 (71) 0.38
ACE inhibitor/Angiotensin receptor 
blockers (%)
124 (92) 64 (89) 60 (97) 0.083
Ca-antagonists (%) 12 (9) 9 (12) 3 (5) 0.12
Sotalol (%) 21 (16) 12 (17) 9 (15) 0.73
Amiodarone (%) 13 (10) 6 (8) 7 (11) 0.56
Diuretics (%) 90 (67) 49 (68) 41 (66) 0.81
Nitrates (%) 22 (16) 14 (19) 8 (13) 0.31
Statins (%) 106 (79) 56 (78) 50 (81) 0.68
Acetil salicylic acid/anticoagulants 
(%)
126 (94) 68 (94) 58 (94) 0.83
ACE: angiotensin-converting enzyme; MVT: monomorphic ventricular tachycardia
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Predictors of inducibility
After analyzing all clinical, ECG and echocardiographic variables, male gender, time 
since last myocardial infarction, QRS duration, angiotensin-converting enzyme inhibi-
tor or angiotensin receptor blockers usage, LVEDV and LPSS of the peri-infarct zone 
had a p value ≤0.10 on univariable logistic regression analysis and were entered in the 
multivariable model (Table 4). Only LPSS of the peri-infarct zone (odds ratio 1.43, 95% 
confidence intervals 1.15-1.78, p = 0.001) was independently related to monomorphic 
VT inducibility on EP study.
discussion
The current study showed that in patients with chronic ischemic cardiomyopathy, 
LPSS of the peri-infarct zone was strongly associated to monomorphic VT inducibility. 
In particular, after correction for clinical, ECG and echocardiographic variables, LPSS 
of the peri-infarct zone was the only independent factor related to monomorphic VT 
inducibility.











LVEDV (ml) 171±57 178±60 161±53 0.094
LVESV (ml) 120±50 126±52 113±47 0.13
LVEF (%) 31±10 31±9 32±11 0.29
WMSI 1.7±0.4 1.8±0.4 1.7±0.4 0.45
Global LPSS (%) -9.1±3.8 -9.1±3.4 -9.0±4.2 0.81
LPSS of the infarct zone (%) -0.5±3.0 -0.5±3.2 -0.4±2.7 0.75
LPSS of the peri-infarct zone (%) -10.8±1.9 -9.8±1.5 -11.0±2.1 0.001
LPSS of the remote zone (%) -14.5±3.0 -14.6±2.8 -14.5±3.4 0.92
LPSS: longitudinal peak systolic strain; LVEDV: left ventricular end-diastolic volume; LVEF: left ventricular 
ejection fraction; LVESV: left ventricular end-systolic volume; MVT: monomorphic ventricular tachycardia; 
WMSI: wall motion score index.
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figure 3. Example of 2 patients with and without inducible monomorphic ventricular tachycardia (VT). The 
panels show the polar plot model illustrating the values of the longitudinal peak systolic strain for every 
segment (left) and the electrocardiogram at 100 mm/sec obtained during the electrophysiological test for 
inducibility (right). Panel a. Patient with postero-lateral scar with inducible monomorphic VT. LPSS of the 
peri-infarct zone was -9.0%. Panel B. Patient with septal and apical scar without inducible monomorphic VT. 
LPSS of the peri-infarct zone was more preserved (-11.0%) as compared to the inducible patient.
a B
figure 4. Panel a: Correlation between ventricular tachycardia (VT) cycle length and global longitudinal peak 
systolic strain (LPSS). Panel B: Correlation between ventricular tachycardia (VT) cycle length and LPSS of the 
peri-infarct zone.
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Peri-infarct zone and monomorphic Vt
In the chronic phase of myocardial infarction, monomorphic VT is caused by re-entrant 
pathways around the borders of infarcted scar area.3, 5 Therefore, the peri-infarct zone 
is the anatomical substrate for these malignant ventricular arrhythmias.3, 5, 14
Previous animal studies demonstrated that 2 months after induction of myocar-
dial infarction, the myofibers of the peri-infarct zone were highly disorganized with 
replacement by connective tissue.14 In particular, peri-infarct zone was characterized 
by non-uniform anisotropic areas with isles of viable myocardium and fibrosis, 
resulting in slow electrical conduction of the cardiac pulse.14 This tissue hetero-
geneity with altered mechanical properties results in electrical instability and may 
predispose to ventricular arrhythmias.
The tissue heterogeneity of the peri-infarct zone has been investigated with dif-
ferent techniques trying to characterize the electrical, anatomical and mechanical 
properties.
The electrical characterization of the peri-infarct zone has been studied with bipolar 
electrograms derived from electro-anatomic mapping techniques.4, 6, 15, 16 The infarct 
areas had the lowest voltage amplitudes whereas the remote areas had the highest 
voltages amplitudes.15, 16 The peri-infarct zone had intermediate voltage amplitudes 
and subsequently, several clinical studies have demonstrated that these areas were 
the target of successful monomorphic VT ablation.4, 6 Recently, contrast-enhanced 
table 4. Uni- and multivariate logistic regression analysis to identify predictors of monomorphic ventricular 
tachycardia inducibility
dependent variable:
Inducibility of monomorphic VT
univariable analysis Multivariable analysis
or (95% ci) p value or (95% ci) p value
independent variables
Male 2.58 (0.83-8.00) 0.10 1.89 (0.53-6.72) 0.33
Time since last myocardial infarction 
(months)
1.00 (1.00-1.01) 0.093 1.00 (0.99-1.01) 0.16
QRS duration (ms) 1.01 (1.00-1.03) 0.047 1.01 (0.99-1.02) 0.44
ACE inhibitor/Angiotensin receptor 
blockers (%)
0.27 (0.05-1.31) 0.10 0.32 (0.06-1.69) 0.18
LVEDV (ml) 1.01 (1.00-1.01) 0.097 1.00 (0.99-1.01) 0.35
LPSS of the peri-infarct zone (%) 1.44 (1.16-1.80) 0.001 1.43 (1.15-1.78) 0.001
CI: confidence intervals; LPSS: longitudinal peak systolic strain; LVEDV: left ventricular end-diastolic volume; 
LVEF: left ventricular ejection fraction; MVT: monomorphic ventricular tachycardia; OR: odds ratio.
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CMR has been shown to be a useful imaging technique to anatomically characterize 
the peri-infarct zone.8, 17, 18 Whereas the infarct zone shows high-intensity contrast 
signal, the peri-infarct zone shows an intermediate-intensity contrast signal that 
can be quantified with dedicated algorithms.8, 17, 18 The extent of the peri-infarct zone 
has been related to an increased mortality after myocardial infarction, and increased 
inducibility for monomorphic VT on EP testing.8, 18 Indeed, Yan et al.18 demonstrated 
that the extent of peri-infarct zone predicted an increased mortality in patients with 
previous myocardial infarction. Subsequently, Schmidt et al.8 found that that larger 
extent of peri-infarct zone was independently related with an increased inducibility 
for sustained monomorphic VT. More recently, Roes et al.17 corroborated these pre-
vious observations by reporting the association between the peri-infarct zone extent 
and the occurrence of spontaneous ventricular arrhythmia detected as appropriate 
therapies of implantable cardioverter-defibrillator (ICD) in 91 patients with previous 
myocardial infarction and who underwent ICD implantation.
Finally, the mechanical properties of the peri-infarct zone have been recently 
studied by Fernandes et al.7 using tagged CMR. The authors evaluated the circum-
ferential strain and time to peak circumferential strain at the peri-infarct zone. An 
enhanced peak circumferential strain and earlier time to peak circumferential strain 
at the peri-infarct zone were positively related with monomorphic VT inducibility.
In the present study 2-dimensional speckle-tracking analyses of the standard 
grey-scale echocardiographic images was used. This imaging technique provides 
valuable information on the mechanical properties of the peri-infarct zone. Particu-
larly, in the current study the longitudinal mechanics of the peri-infarct zone was 
investigated. Inducible patients had larger impairment of LPSS in the peri-infarct 
zone (-9.8 ± 1.5% vs. -11.0 ± 2.1%, p = 0.001). Furthermore, after correcting for clini-
cal, ECG and echocardiographic variables, LPSS of the peri-infarct zone was the only 
independent determinant of monomorphic VT inducibility (adjusted odds ratio 1.39, 
95% confidence interval 1.11-1.78, p = 0.005). Therefore, this observation confirmed 
the independent relationship between the mechanical properties of the peri-infarct 
zone, particularly the longitudinal mechanics, and monomorphic VT inducibility.
Importantly, in contrast to global LPSS, peri-infarct peak longitudinal strain was 
not related to VT cycle length. This finding underscores that the LPSS values of 
peri-infarct zone did not reflect the extension of the scar but only the longitudinal 
function of the tissue adjacent to the infarcted segments. Conversely, global LPSS 
may reflect the total scar burden,19 and more impaired global LPSS are associated 
to longer VT cycle length.
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clinical implications
The present study underscores the independent relationship between reduced peri-
infarct zone longitudinal strain and VT inducibility in patients with chronic ischemic 
cardiomyopathy. Regional LV longitudinal strain analysis by speckle-tracking echo-
cardiography may be helpful in identifying patients with increased risk of malignant 
ventricular arrhythmias. Furthermore, quantifications of LPSS of the peri-infarct zone 
may be a potentially useful tool for selecting patients who might benefit from ICD 
therapy.
concLusions
In patients with chronic ischemic cardiomyopathy, LPSS of the peri-infarct zone was 
independently associated to monomorphic VT inducibility. Thus, speckle-tracking 
analysis may be a useful imaging tool to risk-stratify patients with chronic ischemic 
cardiomyopathy who might benefit from ICD.
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aBstract
Background. Left ventricular (LV) global longitudinal strain (GLS) is a measure 
of the active shortening of the LV in the longitudinal direction 
which can be assessed with speckle tracking echocardiography. 
The aims of this evaluation were to validate the prognostic value 
of GLS as new index of LV systolic function in a large cohort of 
patients with chronic ischemic cardiomyopathy and determine 
the incremental value of GLS to predict long-term outcome over 
other strong and well established prognostic factors.
Methods and results. A total of 1060 patients underwent baseline clinical 
evaluation and transthoracic echocardiography. Median age 
was 66.9 years [interquartile range (IQR) 58.4, 74.2 years], 
739 (70%) men. The median follow-up duration for the en-
tire patient population was 31 months. During the follow-up, 
270 patients died and 309 patients reached the combined 
end point (all-cause mortality and heart failure hospitaliza-
tion). Compared to survivors, patients who died (270, [25%]) 
had larger LV volumes (p<0.05), lower LV ejection fraction 
(p=0.004), higher wall motion score index (p=0.001) and 
greater impairment of LV GLS (p<0.001). After dichotomiz-
ing the population based on the median value of LV GLS 
(-11.5%), patients with a LV GLS ≤-11.5% had superior outcome 
compared with patients with a LV GLS >-11.5% (log rank chi 
squared 13.86 and 14.16 for all-cause mortality and combined 
end point respectively, p<0.001 for both). On multivariate 
analysis, GLS was independently related to all-cause mortality 
(hazard ratio per 5% increase, 1.69, 95% CI 1.33-2.15; p<0.001) 
and combined end point (1.64, 95% CI 1.32-2.04; p<0.001).
conclusions. The assessment of LV GLS with speckle tracking echocardiog-
raphy is significantly related to long-term outcome in patients 
with chronic ischemic cardiomyopathy.
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introduction
Several studies have shown that various clinical, electrocardiographic (ECG), and 
echocardiographic parameters predict long-term outcome in patients with chronic 
ischemic cardiomyopathy.1, 2 In patients with chronic ischemic cardiomyopathy, left 
ventricular (LV) ejection fraction (EF) and wall motion score index (WMSI) are well 
established predictors of long-term outcome.3-7 However, both LVEF and WMSI have 
some limitations related to reproducibility, geometric assumption and expertise.
Recently new parameters derived from two-dimensional (2D) speckle tracking 
echocardiography permit the assessment of active myocardial deformation in 
multiple directions (radial, circumferential and longitudinal).8-10 Particularly, the 
measurement of LV global longitudinal strain (GLS), which is a measure of the ac-
tive shortening of the LV in the longitudinal direction, is more reproducible than 
LVEF and WMSI and does not rely on geometrical assumptions.11-13
Thus far, preliminary data suggest that LV GLS may be superior to LVEF and 
WMSI for the prediction of long-term outcome in different populations.14 However, 
whether LV GLS is related to long-term outcome in patients with chronic ischemic 
heart disease is not established yet. Accordingly, the aims of this evaluation were 
to validate the prognostic value of LV GLS as new index of LV systolic function in a 
large cohort of patients with chronic ischemic cardiomyopathy, and determine the 
incremental value of LV GLS to predict long-term outcome over other strong and 
well established clinical, ECG and echocardiographic prognostic factors.
MetHods
Patient population and evaluation
The present evaluation consisted of retrospective analysis of clinical and echocar-
diographic data from patients with chronic ischemic heart disease. Patients with 
known coronary artery disease and prior myocardial infarction (>90 days prior to the 
index echocardiography) who underwent echocardiography between 1999 and 2009 
were included in the present evaluation. This patient cohort formed part of ongoing 
institutional registries.15, 16 Clinical and echocardiographic data were prospectively 
entered into the departmental Cardiology Information System (EPD-Vision®, Leiden 
University Medical Center) and the echocardiography database, respectively. All 
patients received optimal medical treatment and coronary revascularization accord-
ing to the current guidelines.17, 18 In the present evaluation, atrial fibrillation, recent 
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myocardial infarction (< 90 days) and poor acoustic window resulting in inadequate 
speckle tracking analysis were exclusion criteria.
All patients underwent an extensive baseline clinical history and physical examina-
tion, 12-lead ECG and transthoracic echocardiography. Baseline clinical variables 
included New York Heart Association (NYHA) functional class, cardiovascular risk 
factors, medical treatment, and glomerular filtration rates (GFR) calculated by the 
Modification of Diet in Renal Disease formula as recommended by the National 
Kidney Foundation, Kidney Disease Outcomes Quality Initiative Guidelines.19 Base-
line echocardiographic variables included LV volumes, LVEF, WMSI, and LV GLS. All 
patients were prospectively followed up for the occurrence of death for any cause. 
From the various clinical, ECG and echocardiographic variables recorded, indepen-
dent determinants of all-cause mortality were identified.
echocardiography
Transthoracic echocardiography was performed with the patients at rest in the left 
lateral decubitus position with commercially available ultrasound equipment (M4S 
probe, Vivid 7, GE-Vingmed, Horten, Norway). All images were digitally stored on hard 
disks for offline analysis (EchoPAC version 108.1.5, GE-Vingmed, Horten, Norway).
LV end-diastolic volume (EDV) and end-systolic volume (ESV) were calculated 
using Simpson’s biplane method of discs. LVEF was calculated and expressed as a 
percentage. To calculate the WMSI, the LV was divided into 16 segments. A semi-
quantitative scoring system (1, normal; 2, hypokinesia; 3, akinesia; 4, dyskinesia) was 
used to analyze each study. Global WMSI was calculated by the standard formula: 
sum of the segment scores divided by the number of segments scored.20
speckle tracking longitudinal strain analysis
In the present evaluation, global systolic LV myocardial function was determined with 
2D speckle tracking strain analysis.12, 21, 22 The speckle tracking software tracks the 
frame-to-frame movement of natural myocardial acoustic markers, or speckles, on 
standard gray scale images. Speckle tracking analysis is angle independent and allows 
accurate evaluation of myocardial deformation in all the LV segments.8, 10 The change 
in length/initial length of the speckle pattern over the cardiac cycle is used to calculate 
longitudinal strain, with myocardial lengthening or stretching represented as positive 
strain, and myocardial shortening as negative strain.
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To quantify LV GLS, 2D speckle tracking analyses were performed on standard 
routine grey scale images of the apical 2-, 4-chamber and long-axis views. During 
analysis, the endocardial border was manually traced at an end-systolic frame and 
the software traced automatically a region of interest that includes the entire myo-
cardium. The width of the region of interest could be manually adjusted to ensure 
proper tracking of the myocardial wall. The software then automatically tracked 
natural myocardial acoustic markers and accepted segments of good tracking qual-
ity and rejected poorly tracked segments, while allowing the observer to manually 
override its decisions based on visual assessments of tracking quality. Results of the 
LV longitudinal strain analysis were automatically displayed as a 17-segment polar 
map model with 17 segmental/regional strain values and a mean global strain value 
for the entire LV (Figure 1).12, 22, 23
figure 1. Example of assessment of global longitudinal myocardial strain (GLS) as provided by the EchoPAC 
software: apical long-axis view where the closure of aortic valve is defined (left upper panel), 4- (right upper 
panel) and 2-chamber (left lower panel) views. In the lower panel, the “bull‘s eye” plot, using a 17-segment 
model, provides the value of longitudinal strain for each segment of the left ventricle and the values of 
longitudinal strain of apical long-axis (GLPSS-LAX), 4-chamber (GLPSS_A4C), 2 chamber (GLPSS_A2C) and 
the value of GLS (GLPSS_Avg)
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Previously reported intra- and inter-observer variabilities for LV GLS analysis 
expressed as mean absolute difference ± 1 standard deviation were 1.2 ± 0.5% and 
0.9 ± 1.0% respectively.22
follow-up and end points
Patients were followed up at 6- 12 monthly intervals according to protocol.15, 16 
Data on the occurrence of adverse events at follow-up were collected by reviewing 
medical records, retrieval of survival status through the municipal civil registries and 
telephone interviews. In the present evaluation, all-cause mortality and heart failure 
hospitalizations were recorded as event. Patients without data on the last 6 months 
were considered as lost to clinical follow-up. Data of these patients were included up 
to the last date of follow-up. From the various clinical, ECG and echocardiographic 
variables recorded, independent determinants of all-cause mortality were identified.
statistical analysis
For uniformity reasons, continuous variables were presented as median and interquar-
tile range (IQR). Categorical variables were presented as frequencies and percentages, 
and were compared using Chi-square test with Yates’ correction. Mann-Whitney U test 
was used to compare unpaired continuous variables. Cumulative event rates from the 
time of inclusion were calculated using the Kaplan-Meier method for each independent 
predictor of all-cause mortality. The log-rank tests for time-to-event data with respect to 
the primary outcome were used for statistical comparison between 2 patient groups.
Multivariate Cox proportional-hazards models were constructed to identify inde-
pendent clinical, ECG and echocardiographic determinants of all-cause mortality 
and combined end point. Univariate variables with a p-value <0.10 were entered 
as covariates using the stepwise backward likelihood ratio selection method. In all 
the analyses, the Cox proportional-hazards models were used to estimate hazard 
ratios and 95% confidence intervals for those independent variables. To avoid 
multicolinearity between the univariate predictors, a correlation coefficient of <0.7 
(corresponding to a tolerance of >0.5) was set. The correlation coefficients between 
LV GLS and LVEF and WMSI were 0.87 and 0.85, respectively (both p<0.001) 
whereas the correlation coefficient between LVEF and WMSI was 0.88 (p<0.001). 
Accordingly, the independent predictive value of echocardiographic variables such 
as WMSI, LVEF and GLS was evaluated in different multivariate models. Finally, the 
incremental value of LV GLS to predict long-term outcome over WMSI and LVEF 
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was assessed by calculating the increment in Harrell’s C concordance statistic.24 
A two-sided p value of < 0.05 was considered significant. All statistical analyses 
were performed using SPSS for Windows (SPSS Inc, Chicago), version 15 and STATA 
software (version 10.1, StataCorp, Texas).
The authors had full access to and take full responsibility for the integrity of the 
data. All authors have read and agree to the manuscript as written.
resuLts
Patient population
Of the 1125 patients included, adequate echocardiographic analyses were feasible in 
1060 (94%) patients (median age 66.9 years [IQR 58.4, 74.2 years], 739 [70%] men) 
and constituted the final patient population. The general characteristics of the overall 
patient population are reported in Table 1.
Hypertension, dyslipidemia and diabetes were present in 459 (43%), 440 (41%) 
and 298 (28%) patients, respectively. Most patients were treated with antiplatelets 
and/or oral anticoagulants (92%), beta-blockers (69%) and angiotensin converting 
enzyme inhibitors or angiotensin-receptor blockers (84%). In addition, 606 (57%) 
patients received an implantable cardioverter-defibrillator device. Furthermore, 32% 
underwent prior coronary-aorto bypass grafting whereas 25% underwent percutane-
ous coronary intervention. The remaining 43% of patients received optimal medical 
treatment. Table 2 summarizes the echocardiographic characteristics of the patient 
population. The median LVEDV, LVESV and LVEF were 140 ml (IQR 91-199 ml), 87 
ml (IQR 39-150 ml), and 34% (IQR 25-58%), respectively. The median WMSI was 1.5 
(IQR 1.0-2.0), and the median LV GLS was -11.5% (IQR -17.0 - -7.6%).
survivors versus non survivors
The median follow-up duration for the entire patient population was 31.0 months 
(IQR 15.5, 52.7 months). A total of 270 (25%) patients died during the study duration 
and the median time to death was 25.9 months (IQR 13.0, 44.5 months). Differences 
in baseline clinical, ECG and echocardiographic variables between patients who died 
and patients who survived are outlined in Tables 1 and 2. Patients who died were more 
likely to be older (p <0.001) and diabetic (p <0.001), and to be in NYHA functional 
class III-IV (p <0.001). Interestingly, patients who died had lower hemoglobin (p = 
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Age – years, median (IQR) 66.9 (58.4-74.2) 65.4 (56.8-72.6) 71.7 (64.0-76.7) <0.001
Male gender – (%) 739 (70) 556 (70) 183 (68) 0.42
Body surface area – m2, median (IQR) 1.97 (1.83-2.10) 1.97 (1.84-2.11) 1.95 (1.83-2.08) 0.24
Medical history
NYHA functional class III-IV– (%) 420 (40) 282 (36) 138 (51) <0.001
Hypertension – (%) 459 (43) 343 (43) 116 (43) 0.89
Dyslipidemia – (%) 440 (41) 338 (43) 102 (38) 0.15
Diabetes – (%) 298 (28) 199 (25) 99 (37) <0.001
Current smoker – (%) 253 (24) 174 (22) 79 (29) 0.016
Family history ischemic heart disease 
– (%)
339 (32) 239 (30) 100 (37) 0.039
Systolic blood pressure - mmHg, 
median (IQR)
130 (112-150) 130 (115-150) 125 (110-148) 0.075
Diastolic blood pressure – mmHg, 
median (IQR)
77 (70-84) 77 (70-85) 75 (65-81) 0.030
device therapy- (%)
Implantable cardioverter-defibrillator 606 (57) 438 (55) 168 (62) 0.052
Cardiac resynchronization therapy 429 (40) 296 (37) 133 (49) 0.001
revascularization- (%) 0.028
Percutaneous coronary intervention 269 (25%) 216 53
Coronary-aorto bypass grafting 336 (32%) 243 93
Medication at baseline – (%)
Antiplatelets 627 (59) 477 (60) 150 (56) 0.16
Anticoagulants 446 (42) 314 (40) 132 (49) 0.009
Beta-blocker 740 (69) 545 (69) 195 (72) 0.32
ACE inhibitor or angiotensin-receptor 
blocker
896 (84) 671 (85) 225 (83) 0.53
Global longitudinal strain predicts long-term survival in patients with chornic ischemic cardiomyopathy ○ 169
10
0.004) and GFR (p <0.001). In addition, they had a higher heart rate (p = 0.005) and 
wider QRS complex (p = 0.001). Regarding echocardiographic parameters, patients 
who died had larger LVEDV (p = 0.012) and LVESV (p = 0.005) and lower LVEF (p = 
0.004). Finally, patients who died had higher WMSI (p = 0.001) and a greater impair-
ment of LV GLS (p <0.001).









Calcium channel blocker 199 (19) 142 (18) 57 (21) 0.25
Diuretic 662 (62) 472 (60) 190 (70) 0.002
Nitrate 208 (20) 136 (17) 72 (27) 0.001
Statin 774 (73) 583 (74) 191 (71) 0.33
Laboratory measure at baseline
Hemoglobin – g/dL, median (IQR) 13.9 (12.6-14.8) 14.0 (12.7-14.8) 13.7 (11.9-14.5) 0.004
Estimated GFR – mL/min/1.73m2, 
median (IQR)
66.8 (51.3-82.8) 71.8 (57.0-85.2) 53.7 (39.7-67.0) <0.001
electrocardiogram at baseline
Heart rate – beats/min, median (IQR) 70 (61-80) 70 (61-80) 73 (63-82) 0.005
QRS duration – ms, median (IQR) 100 (100-146) 100 (100-142) 116 (100-154) 0.001
ACE: angiotensin converting enzyme; IQR: interquartile range; NYHA: New York Heart Association;










Wall motion score index, median 
(IQR)
1.5 (1.0-2.0) 1.5 (1.0-1.9) 1.6 (1.0-2.1) 0.001
LVEF – %, median (IQR) 34 (25-58) 35 (26-59) 33 (22-56) 0.004
LVEDV – ml, median (IQR) 140 (91-199) 136 (90-195) 153 (94-225) 0.012
LVESV – ml, median (IQR) 87 (39-150) 84 (36-142) 100 (42-170) 0.005
GLS – %, median (IQR) -11.5 (-17.0- -7.6) -12.3 (-17.5- -8.5) -9.8 (-15.3- -6.5) <0.001
GLS: global longitudinal left ventricular strain; IQR: interquartile range; LVEDV: left ventricular end-diastolic 
volume; LVEF: left ventricular ejection fraction; LVESV: left ventricular end-systolic volume.
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follow-up
Kaplan-Meier curves for LV GLS of all-cause mortality in ischemic cardiomyopathy 
patients are reported in Figure 2A. Particularly, when the patient population was di-
chotomized based on the median LV GLS (-11.5%), a cumulative 4%, 10% and 17% of 
patients with a LV GLS ≤-11.5% (less impaired LV shortening) died by 1, 2 and 3 years 
follow-up respectively. In contrast, a respective 7%, 17% and 27% of patients with a 
LV GLS >-11.5% (more impaired LV shortening) died during the same time period (log 
rank chi squared = 13.86, p <0.001; Figure 2A).
In addition, the combined end point (heart failure hospitalization and all-cause 
mortality) was reached by 309 patients during the follow-up. Kaplan-Meier estimates 
of the time to the combined end point for patients with an LV GLS ≤-11.5% and 
patients with an LV GLS >-11.5% are indicated in Figure 2B. After 3 years of follow-up, 
the cumulative free survival rates of combined end point in the group of patients 
with an LV GLS ≤-11.5% were 6%, 13% and 20% at 1, 2 and 3 years follow-up, respec-
tively. In contrast, the group of patients with an LV GLS >-11.5% showed cumulative 
free survival rates of combined end point of 10%, 20% and 29% at 1, 2 and 3 years 
follow-up, respectively (log rank chi squared = 14.16, p<0.001; Figure 2B).
figure 2: Kaplan Meier estimates of all-cause mortality (panel A) and combined end point (panel B). The 
cumulative survival rates were compared between patients with left ventricular GLS ≤-11.5% (solid line) and 
patients with GLS >-11.5% (dotted line).
Predictors of all-cause mortality and combined end point
To identify predictors of all-cause mortality, univariate Cox analyses were performed. 
First, among various clinical and ECG variables, the independent determinants were 
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identified (Table 3). Age, diabetes mellitus, hemoglobin and renal function (measured 
with GFR) were independent determinants of all-cause mortality. Next, several 
echocardiographic variables of LV function were introduced in different multivariate 
models to evaluate their prognostic value (Table 4). WMSI (HR 1.43, 95% CI 1.14-1.79; 
p=0.002), LVEF (HR 1.04, 95% CI 1.00-1.08; p=0.026) and LV GLS (HR 1.69, 95% 
CI 1.33-2.15; p<0.001) were significantly associated with all-cause mortality. However, 
the model including LV GLS had the best relative fit and LV GLS provided the highest 
Harrell’s C concordance statistics (Table 5).
In addition, the clinical and ECG variables that were independently associated 
with the combined end point (heart failure hospitalization and all-cause mortal-
ity) were age, diabetes mellitus and renal function. The predictive value of WMSI, 
LVEF and LV GLS was evaluated in different multivariate Cox regression analyses to 
avoid multicolinearity. WMSI (HR 1.44, 95% CI 1.16-1.78; p=0.001), LVEF (HR 1.04, 
95% CI 1.00-1.08; p=0.009) and LV GLS (HR 1.64, 95% CI 1.32-2.04; p<0.001) were 
independent predictors of the combined end point (Table 4). In addition, the model 
including LV GLS had the highest Harrell’s C statistic (Table 5).
table 3. Cox uni- and multivariable regression analysis to identify clinical predictors of all-cause mortality and 
combined end point during follow-up
dependent variable:
Death from any cause
univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Age – years 1.05 (1.03-1.06) <0.001 1.04 (1.03-1.06) <0.001
NYHA functional class III-IV 1.79 (1.41-2.28) <0.001 1.23 (0.92-1.66) 0.164
Diabetes 1.60 (1.25-2.05) <0.001 1.49 (1.15-1.92) 0.002
Diastolic blood pressure, per 10 mmHg 
increase
0.98 (0.97-0.99) <0.001 0.94 (0.84-1.04) 0.227
Cardiac resynchronization therapy 1.73 (1.38-2.16) 0.002 1.32 (0.88-1.98) 0.177
Anticoagulants 1.33 (1.04-1.68) 0.021 1.13 (0.87-1.47) 0.350
Diuretics 1.55 (1.19-2.02) 0.001 0.96 (0.71-1.31) 0.815
Nitrates 1.45 (1.11-1.90) 0.009 1.23 (0.93-1.62) 0.144
Hemoglobin, per 1 g/dl decrease 1.36 (1.06-1.22) <0.001 1.08 (1.01-1.16) 0.043
GFR, per 10 ml/min/1.73m2 decrease 1.02 (1.02-1.03) <0.001 1.15 (1.09-1.22) <0.001
Heart rate, per 5 beats/min increase 1.05 (1.00-1.09) 0.030 … …
QRS duration, per 20 ms increase 1.03 (0.99-1.07) 0.060 … …




univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Age – years 1.04 (1.02-1.05) <0.001 1.03 (1.01-1.04) <0.001
NYHA functional class III-IV 1.63 (1.33-2.03) <0.001 … …
Diabetes 1.37 (1.08-1.74) 0.009 1.30 (1.02-1.66) 0.034
Diastolic blood pressure, per 10 mmHg 
increase
0.88 (0.80-0.96) 0.007 … …
Cardiac resynchronization therapy 1.45 (1.15-1.81) 0.001 … …
Anticoagulants 1.26 (1.01-1.58) 0.043 … …
Diuretics 1.40 (1.10-1.78) 0.006 … …
Nitrates 1.34 (1.04-1.73) 0.025 … …
Hemoglobin, per 1 g/dl decrease 1.12 (1.04-1.20) 0.001 … …
GFR, per 10 ml/min/1.73m2 decrease 1.20 (1.14-1.26) <0.001 1.15 (1.09-1.22) <0.001
Heart rate, per 5 beats/min increase 1.04 (0.99-1.08) 0.072 … …
QRS duration, per 20 ms increase 1.03 (1.00-1.07) 0.041 … …
CI: confidence intervals; GFR: glomerular filtration rate; HR: hazard ratio; NYHA: New York Heart Association




Multivariable analysis -2 log Likelihood
Hr (95% ci) p value
independent variables: clinical + wMsi 3226.8
Age – years 1.04 (1.03-1.06) <0.001
Diabetes 1.55 (1.21-1.99) <0.001
Hemoglobin, per 1 g/dl decrease 1.08 (0.99 -1.16) 0.059
GFR, per 10 ml/min/1.73m2 decrease 1.17 (1.05-1.24) <0.001
WMSI 1.43 (1.14-1.79) 0.002
independent variables: clinical + LVef 3231.6
Age – years 1.04 (1.03-1.06) <0.001
Diabetes 1.59 (1.23-2.04) <0.001





Multivariable analysis -2 log Likelihood
Hr (95% ci) p value
Hemoglobin, per 1 g/dl decrease 1.08 (0.99-1.16) 0.048
GFR, per 10 ml/min/1.73m2 decrease 1.16 (1.10-1.24) <0.001
LVEF, per 5% decrease 1.04 (1.00-1.08) 0.026
independent variables: clinical + GLs 3215.9
Age – years 1.04 (1.03-1.06) <0.001
Diabetes 1.60 (1.24-2.05) <0.001
Hemoglobin, per 1 g/dl decrease 1.08 (1.00-1.16) 0.043
GFR, per 10 ml/min/1.73m2 decrease 1.15 (1.09-1.22) <0.001




Hr (95% ci) p value -2 log Likelihood
independent variables: clinical + wMsi 3733.3
Age – years 1.03 (1.02-1.04) <0.001
Diabetes 1.37 (1.08-1.74) 0.010
GFR, per 10 ml/min/1.73m2 decrease 1.15 (1.09-1.21) <0.001
WMSI 1.44 (1.16-1.78) 0.001
independent variables: clinical + LVef 3737.3
Age – years 1.03 (1.02-1.04) <0.001
Diabetes 1.34 (1.06-1.70) 0.016
GFR, per 10 ml/min/1.73m2 decrease 1.16 (1.10-1.22) <0.001
LVEF, per 5% decrease 1.04 (1.01-1.08) 0.009
independent variables: clinical + GLs 3724.2
Age – years 1.03 (1.02-1.04) <0.001
Diabetes 1.37 (1.08-1.74) 0.010
GFR, per 10 ml/min/1.73m2 decrease 1.14 (1.08-1.21) <0.001
GLS, per 5% increment 1.64 (1.32-2.04) <0.001
CI: confidence intervals; GFR: glomerular filtration rate; GLS: global longitudinal left ventricular strain; HR: 
hazard ratio; LVEF: left ventricular ejection fraction; WMSI: wall motion score index.
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discussion
The main findings of the present study were as follows: 1) LV GLS was significantly 
related to long-term outcome; 2) the predictive model including LV GLS provided the 
best relative fit and, finally, 3) LV GLS was independently related to all-cause mortal-
ity and combined end point and had prognostic incremental value over other well 
established clinical and ECG predictors.
Global longitudinal strain vs. left ventricular ejection fraction and wall motion score 
index
As previously described, LVEF and WMSI are important echocardiographic prognos-
ticators, especially in patients with coronary artery disease.3-7 However, the assess-
ment of LVEF and WMSI has several limitations. The measurement of LVEF with 2D 
echocardiography is based on geometrical assumptions used to calculate LV volumes. 
Although biplane Simpson’s method is the most accurate 2D measurement to calcu-
late LVEF, the presence of wall motion abnormalities or distorted LV geometry, may 
reduce the accuracy of this method to estimate LV systolic function and increase the 
intra- and inter-observer variability. Moreover, the assessment of WMSI is based on 
visual assessment and requires high expertise.
At present, speckle tracking echocardiography is emerging as novel technique 
to allow the assessment of LV mechanics through the quantification of active 
myocardial deformation.8-10 Cumulative data show that, unlike LVEF and WMSI, the 
table 5. Incremental prognostic value of LV GLS: discrimination indices analysis.
Model All-cause mortality Harrell’s C-concordance statistic index
1 Clinical parameters + WMSI 0.689
2 Clinical parameters + LVEF 0.686
3 Clinical parameters + GLS 0.700
Model Combined end point Harrell’s C-concordance statistic index
1 Clinical parameters + WMSI 0.653
2 Clinical parameters + LVEF 0.648
3 Clinical parameters + GLS 0.659
GLS: global longitudinal left ventricular strain; HR: hazard ratio; LVEF: left ventricular ejection fraction; 
WMSI: wall motion score index.
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assessment of LV mechanics with 2D speckle tracking strain imaging is feasible 
and reproducible, does not rely on geometric assumptions and is independent of 
LV geometry.8-10 In particular, the assessment of LV GLS with 2D speckle tracking 
echocardiography has shown to be an accurate marker of LV function.22, 25
Stanton et al.13 reported in a retrospective analysis of 546 unselected patients 
that LV GLS assessed with 2D speckle tracking echocardiography had incremental 
value over LVEF and WMSI for the prediction of outcome. Furthermore, the authors 
showed that LV GLS assessment was more reproducible as compared to LVEF as-
sessment.13 These findings were also confirmed in subsequent series of heart failure 
patients.14, 26
Thus far, the largest series reporting the prognostic value of GLS included 603 
patients with acute myocardial infarction,27 697 patients with ST-segment eleva-
tion acute myocardial infarction treated with primary coronary intervention11 and 
546 unselected patients clinically referred for echocardiography (34% had prior 
myocardial infarction and 17% had prior coronary revascularization.13 The present 
patient population is unique as it includes a homogeneous population with chronic 
ischemic heart disease and far larger (n=1060) compared with previous series. 
Furthermore, the current study provides further insight into the prognostic value of 
LV GLS in patients with chronic ischemic heart disease. In this group of patients, as-
sessment of LV systolic function may be challenged by the presence of wall motion 
abnormalities and highly abnormal LV geometry. Therefore, LV GLS may be a more 
appropriate measure of LV systolic function by direct evaluation of the myocardial 
contractile properties. Particularly, this study investigated the prognostic value of 
LV GLS in 1060 patients extending previous results. LV GLS similarly to LVEF and 
WMSI was more preserved in survivor patients. However, among echocardiographic 
parameters, GLS was independently related to all-cause mortality (hazard ratio per 
5% increase, 1.69, 95% CI 1.33-2.15; p<0.001) and combined end point (all-cause 
mortality and heart failure hospitalization) (1.64, 95% CI 1.32-2.04; p<0.001).
Global longitudinal strain and long-term outcome
Prognosis of patients with coronary artery disease is influenced by several clinical 
parameters.2, 17 Similarly to previous series, the present study showed that age, 
diabetes, hemoglobin levels and renal function (assessed as GFR) were significantly 
and independently related to all-cause mortality in patients with chronic ischemic 
cardiomyopathy.2, 17 More importantly, the present study demonstrated the superior 
prognostic value of LV GLS over these clinical well established predictors of mortality. 
Furthermore, LV GLS provided significant incremental value over the clinical inde-
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pendent predictors of long-term outcome. Particularly, in the present evaluation the 
patient population was dichotomized based on the median value of LV GLS (-11.5%) 
showing a significantly better long-term survival for patients with less impaired LV 
GLS.
This finding underscores that LV GLS assessed with 2D speckle tracking echocar-
diography may be used as novel index of LV longitudinal function and also as strong 
predictor of all-cause mortality in patients with chronic ischemic cardiomyopathy.22, 25
study limitations
Although the present evaluation was retrospective in design, this is the largest popula-
tion cohort in which LV GLS was analyzed. An additional limitation to the present 
study is that radial and circumferential strains were not explored. However, it has 
recently been proven that longitudinal deformation may be a more sensitive marker 
of cardiac function which better exploring the endocardial function as compared 
to radial or circumferential strain.28, 29 This issue is particularly relevant in chronic 
ischemic patients.29
The multivariate models presented are non-nested models and therefore, the 
comparison between the likelihoods may not be appropriate. Therefore, we could 
not demonstrate that GLS provided superior incremental prognostic value over LVEF 
and WMSI. However, the models including GLS had the lowest -2log likelihood and 
the highest Harrell’s C statistic suggesting that GLS may be a valuable method to 
risk stratifiy patients with chronic ischemic heart disease. Other echocardiographic 
parameters related to long-term outcome of patients with chronic ischemic heart 
disease such as left atrial volume, mitral regurgitation and diastolic function were 
not evaluated.
concLusion
The assessment of LV GLS with speckle tracking echocardiography is significantly 
related to long-term outcome in patients with chronic ischemic cardiomyopathy. 
Particularly, LV GLS was independently related to all-cause mortality and provided 
incremental prognostic value over other well established clinical and ECG predictors.
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clinical perspective
In patients with chronic ischemic cardiomyopathy, left ventricular (LV) ejection fraction 
(EF) and wall motion score index (WMSI) are well established predictors of long-term 
outcome. However, both LVEF and WMSI have some limitations related to reproduc-
ibility, geometric assumption and expertise. Recently, two-dimensional (2D) speckle 
tracking echocardiography permit the assessment of active myocardial deformation 
in radial, circumferential and longitudinal directions. The measurement of LV global 
longitudinal strain (GLS), which is a measure of the active shortening of the LV in the 
longitudinal direction, is more reproducible than LVEF and WMSI and does not rely 
on geometrical assumptions. The present study showed that the assessment of LV 
GLS with 2D speckle tracking echocardiography is significantly related to long-term 
outcome in patients with chronic ischemic cardiomyopathy. Moreover, LV GLS was 
independently related to all-cause mortality and provided incremental prognostic 
valve over other well established clinical and ECG predictors. Therefore, these findings 
underscore that LV GLS assessed with 2D speckle tracking echocardiography may 
be used as novel index of LV longitudinal function and also as predictor of all-cause 
mortality in patients with chronic ischemic cardiomyopathy.
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aBstract
aims. Heart failure and atrial fibrillation (AF) frequently coexist and 
AF worsens heart failure prognosis. Device-based diagnostics 
derived from implantable cardioverter-defibrillator (ICD) inter-
rogation provide an accurate method for detecting AF episodes. 
This study sought to determine clinical and echocardiographic 
predictors of AF occurrence, including an index of total atrial 
conduction time derived by tissue Doppler imaging (PA-TDI 
duration), in patients with heart failure. Moreover, the role of 
PA-TDI duration on the prediction of AF occurrence in sub-
groups of patients with and without history of AF was explored.
Methods and results. A cohort of 495 heart failure patients who underwent ICD 
implantation was studied. Baseline echocardiographic param-
eters of systolic and diastolic function were evaluated together 
with clinical parameters. Furthermore, PA-TDI duration was 
measured. All patients were prospectively followed up after ICD 
implantation for AF occurrence detected by ICD interrogation.
 A total of 142 (29%) patients experienced AF over a follow-
up period of 16.4±11.2 months. PA-TDI duration was longer in 
patients with AF occurrence as compared to patients without 
AF occurrence (154±27ms vs. 135±24ms, p<0.001). On Cox-
multivariable analysis, female gender (hazard ratio=1.60; 95% 
confidence intervals=1.09-2.35; p=0.017), history of AF (haz-
ard ratio=2.22; 95% confidence intervals=1.51-3.27; p<0.001), 
and PA-TDI duration (hazard ratio=1.27; 95% confidence in-
tervals=1.13-1.42; p<0.001) were independent predictors of AF 
occurrence. In the subgroups of patients with and without his-
tory of AF, PA-TDI duration remained an independent predic-
tor of AF occurrence.
conclusions. PA-TDI duration may be useful to risk-stratify for AF occur-
rence in heart failure patients with and without a history of AF.
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introduction
Atrial fibrillation (AF) is a frequent arrhythmia associated with increased cardiovascu-
lar morbidity and mortality.1, 2 In particular, AF is well known to result in a substantially 
increased risk for stroke.3 Heart failure is a serious condition frequently associated 
with AF.4 In particular, AF may further worsen the long-term prognosis of heart failure 
by increasing the risk of cardiac thromboembolism.4-6 Thus, the identification of 
predictors of AF occurrence in heart failure patients is crucial for the initiation of pro-
phylactic oral anticoagulant therapy in order to reduce the risk of cardiogenic stroke.
Recently, a novel non-invasive echocardiographic index derived by tissue Doppler 
imaging was demonstrated to predict AF occurrence in a heterogeneous patient 
population.7 Merckx et al. showed that the time-interval from the beginning of the 
electrocardiogram P wave and the peak of A’LATERAL wave on tissue Doppler images 
(PA-TDI duration) provided a good estimation of the total atrial conduction time.8 
In addition, de Vos et al. demonstrated the independent association between PA-
TDI duration and AF occurrence in patients without history of AF.7 However, the 
capability of this index (PA-TDI duration) to predict AF in heart failure patients 
with and without history of AF still remains unknown. Furthermore, it should be 
emphasized that clinical follow-up based on history of AF related symptoms fails 
to identify asymptomatic AF episodes. These asymptomatic episodes have been 
shown to be present in almost 20% of patients with paroxysmal AF and they have 
important prognostic clinical implications.9, 10 Device-based diagnostics derived 
from pacemaker or implantable cardioverter-defibrillator (ICD) interrogation pro-
vide an accurate method for detecting asymptomatic AF episodes.9, 10 Accordingly, 
in order to detect all AF episodes including the asymptomatic AF episodes, a cohort 
of heart failure patients who had undergone ICD implantation was studied, and AF 
episodes were identified by ICD interrogation.
The aims of the present study were two-fold. Firstly, to identify clinical, and/or 
echocardiographic predictors of AF occurrence, including left atrial (LA) volumes, 
LA function and PA-TDI duration, in patients with heart failure. Secondly, the role of 
PA-TDI duration on the prediction of AF occurrence was explored in the subgroups 
of patients with and without history of AF.
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MetHods
Patient population and protocol
A total of 627 consecutive patients with mild to severe heart failure scheduled for ICD 
implantation for primary or secondary prevention according to the current AHA/ACC/
ESC guidelines were included.11 Exclusion criteria were: 1) absence of normal sinus 
rhythm during echocardiographic examination; 2) acoustic window with poor image 
quality.
All patients underwent a complete baseline history taking and physical examina-
tion, 12-lead electrocardiogram and transthoracic echocardiogram prior to ICD im-
plantation. History of AF, defined as documented AF on surface ECG or ECG-Holter 
monitoring was collected. In addition, history of AF was divided into persistent and 
paroxysmal AF. Specifically, history of persistent AF was defined based on the re-
quirement for pharmaceutical or electrical cardioversion. Conversely, paroxysmal AF 
did not require pharmaceutical or electrical cardioversion.5 Patients with permanent 
AF were excluded from the study because of the absence of normal sinus rhythm 
during the echocardiographic examination.
Baseline clinical variables recorded included New York Heart Association (NYHA) 
functional class, cardiac risk factors and consequent CHADS2 score
5, and medica-
tion. Baseline electrocardiographic variables recorded included heart rate, PR 
interval, QRS duration, and corrected QT interval calculated by Bazett’s formula 
(corrected QT=QT/√ RRinterval). Baseline echocardiographic parameters of systolic 
and diastolic function were included. Furthermore, the total atrial conduction time 
was estimated with tissue Doppler imaging (PA-TDI duration), as previously de-
scribed8. All baseline clinical, electrocardiographic and echocardiographic analyses 
were performed by independent blinded observers.
All patients were prospectively followed up after ICD implantation for AF occur-
rence recorded by ICD. AF occurrence after ICD implantation was defined as atrial 
high-rate episodes (>180 bpm) lasting at least 10 minutes in patients with cardiac re-
synchronization therapy and dual-chamber devices. In patients with single-chamber 
devices, AF occurrence was defined based on ICD interrogation with device-based 
diagnostics.12, 13
From the various clinical, electrocardiographic and echocardiographic variables 
recorded, independent predictors of AF occurrence were identified. The patients 
were subsequently divided in 2 subgroups based on the history of AF (present or 
absent) and independent predictors of AF occurrence were identified in each sub-
group.
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echocardiography
All patients were imaged in the left lateral decubitus position using a commercially 
available system (Vingmed Vivid 7, General Electric-Vingmed, Milwakee, Wisconsin, 
USA). Standard 2-dimensional images were obtained using a 3.5-MHz transducer 
and, digitally stored in cine-loop format; the analysis was performed offline using 
EchoPAC version 108.1.5 (General Electric-Vingmed). From the standard apical views 
(4- and 2-chamber) left ventricular volumes and left ventricular ejection fraction were 
calculated according to the American Society of Echocardiography guidelines.14
Severity of mitral regurgitation was graded semi-quantitatively from colour-flow 
Doppler data using the 4-chamber apical views according to the ACC/AHA guide-
lines.15 Mitral regurgitation was classified as mild (jet area/left atrial area <20%), 
moderate (jet area/left atrial area 20-40%) and severe (jet area/left atrial area 
>40%).
Left atrial volumes (LAVs) were calculated from the 4- and 2-chamber apical views 
as recommended by the American Society of Echocardiography guidelines.14 LAVs 
were measured at 3 time points during the cardiac cycle: 1) maximum LAV (LAV-
max) at end-systole, just before mitral valve opening; 2) minimum LAV (LAVmin) at 
end-diastole, just before mitral valve closure; 3) LAV before atrial active contraction 
(LAVpreA) obtained from the last frame before mitral valve reopening or at the time 
of the P wave on the electrocardiogram. Left atrial function was derived from the 
LAV and expressed with the following formulas: 1) Total left atrial (LA) emptying 
fraction = [(LAV max − LAVmin)/LAVmax] × 100; 2) left atrial expansion index: LA 
reservoir function = [(LAVmax − LAVmin)/LAVmin] × 100; 3) passive LA emptying 
fraction: LA conduit function = [(LAVmax − LAVpreA)/LAVmax] × 100; and 4) active 
LA emptying fraction: LA booster function = [(LAVpreA − LAVmin)/LAVpreA] × 100, 
which is considered an index of LA active contraction.16, 17
Spectral Doppler velocities were measured from the apical 4-chamber view using 
a 2 mm sample volume positioned at the mitral leaflet tips. Peak transmitral early 
(E wave) and atrial (A wave) mitral velocities, and the E wave deceleration time were 
obtained. Doppler tracings were obtained in accordance to the recommendations of 
the American Society of Echocardiography.14
Colour-coded tissue Doppler images of the left ventricle obtained in the apical 
4-chamber view were acquired at high frame rates (at least 150 frames/s) during 
end-expiration. Early diastolic myocardial velocities (E’) were determined at the 
septal and lateral sides of the mitral annulus (E’SEPTAL, E’LATERAL). E’MEAN was calculated 
as (E’SEPTAL+E’LATERAL)/2.
18
Total atrial conduction time was estimated with colour-coded tissue Doppler im-
ages by first placing the sample size on the LA lateral wall just above the mitral 
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annulus. Next, the time-interval from the onset of the P-wave on lead II of the elec-
trocardiogram (on echocardiographic images) to the peak of A’LATERAL wave (PA-TDI 
duration) was measured (Figure 1).8
Bland-Altman analysis demonstrated a good intra-observer and inter-observer 
agreements with a non-significant bias for PA-TDI duration measurement. Mean 
differences ± 2 standard deviations for PA-TDI duration were 1.8 ± 10 ms for intra-
observer agreement and 1.7 ± 10 ms for inter-observer agreement.
a
B
figure 1. The time-interval from the beginning of the electrocardiogram P wave and the peak of A’LATERAL wave 
(PA-TDI duration) was obtained with tissue Doppler images by placing the sample size on the LA lateral 
wall just above the mitral annulus; next the PA-TDI duration was measured. Panel a. Patient without atrial 
fibrillation (AF) occurrence. PA-TDI duration was 119 ms. Panel B. Example of patient with AF occurrence 
and longer PA-TDI (171 ms).
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statistical analysis
Continuous data are presented as mean ± SD and categorical data are presented 
as frequencies and percentages. All continuous variables were evaluated for normal 
distribution with Kolmogorov-Smirnov tests. Unpaired T test and Mann-Whitney U-
test were used to compare continuous variables between patients with vs. without 
AF occurrence and between patients with vs. without history of AF, as appropriate. 
Chi-square test was used to compare categorical variables between patients with vs. 
without AF occurrence and between patients with vs. without history of AF. Univariable 
and multivariable Cox proportional hazards regression analyses were performed to 
identify clinical and echocardiographic predictors of AF occurrence. Only significant (p 
<0.05) univariable predictors were entered as covariates in the multivariable analysis, 
which was performed using the enter model. Hazard ratios and 95% confidence inter-
vals (CI) were calculated. Time to first episode of atrial fibrillation in relation to PA-TDI 
duration was analyzed with the Kaplan-Meier method and compared with the log-rank 
test. Therefore, PA-TDI was dichotomized based on the median (139 ms). Similarly to 
the overall patient population, univariable and multivariable Cox proportional hazards 
regression analyses were used to identify predictors of AF occurrence in the subgroups 
of patients with and without history of AF. For all the multivariable Cox proportional 
hazards regression analyses a correlation coefficient of <0.7 (corresponding to a toler-
ance of >0.5) was set to avoid multicollinearity between the univariable predictors. To 
increase clinical utility, the hazard ratios and 95% CI of LAVmin PA-TDI duration were 
reported as per 10 ml/m2 increase and per 20 ms increase, respectively. A 2-tailed 
p value of <0.05 was considered significant. All statistical analyses were performed 
using SPSS for Windows (SPSS Inc, Chicago), version 16.
resuLts
In total 495 patients were included in the analysis: 94 patients were excluded due to 
the absence of normal sinus rhythm during the echocardiographic examination and 
38 patients were excluded because of suboptimal image quality. Primary prevention of 
sudden cardiac death was the reason for implantation in 434 (88%) of the patients, 
whereas 61 (12%) patients were implanted for secondary prevention of sudden cardiac 
death. Overall, 481 (97%) patients were implanted with cardiac resynchronization 
therapy or dual-chamber ICD devices; whereas only 14 (3%) patients got a single-
chamber ICD device.
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The general characteristics of the patient population are reported in Tables 1-3. 
The mean age of the overall population was 62±12 years, and 21% of the patients 
were women. A history of AF was present in 102 (21%) patients and, the majority of 
the patients had high thromboembolic risk according to the CHADS2 score (2.2±1.1). 
The mean QRS duration was 128±32 ms, and 61% of the patients received a cardiac 
resynchronization therapy device. Most of the patients were treated with angio-
tensin converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, 
and diuretics (84%, 69%, and 73%, respectively). All of the patients had dilated 
left ventricles (left ventricular end-diastolic volume = 95±35 ml/m2) with depressed 
left ventricular ejection fraction (29±6%). Similarly, the LA was significantly dilated 
(LAVmax = 31±13 ml/m2) and LA function was reduced (total LA emptying fraction 
= 43±15%). Finally, the total atrial activation time expressed as PA-TDI duration was 
141±26 ms.












Age (yrs) 62.2 ± 11.7 61.9 ± 11.7 62.3 ± 11.8 0.65
Female (%) 105 (21) 42 (30) 63 (18) 0.004
Hypertension (%) 164 (33) 50 (35) 114 (32) 0.53
Diabetes (%) 104 (21) 32 (23) 72 (20) 0.60
History of AF (%) 102 (21) 58 (41) 44 (13%) <0.001
Previous PCI/CABG 259 (52) 69 (49) 190 (54) 0.29
NYHA functional class 2.2±0.8 2.4±0.8 2.2±0.8 0.025
CHADS2 score 2.2±1.1 2.2±1.1 2.2±1.1 0.88
Heart rate (bpm) 70±13 72±14 70±13 0.16
PR interval (ms) 174±34 173±33 174±35 0.73
QRS duration (ms) 128±32 131±31 127±32 0.15
Corrected QT interval duration (ms) 444.8 ± 31.4 444.6 ± 31.3 444.9 ± 31.4 0.95
Cardiac resynchronization therapy (%) 304 (61) 99 (70) 205 (58) 0.016
AF: atrial fibrillation; CABG: coronary artery bypass; NYHA: New York Heart Association; PCI: percutaneous 
coronary intervention.
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Patients with vs. patients without af occurrence
There were no differences in age between patients with and patients without AF oc-
currence. The percentage of women was higher in the group with AF occurrence as 
compared to the group without AF occurrence (30% vs. 18%, p = 0.004) as was the 
history of AF (41% vs. 13%, p <0.001). NYHA functional class was higher in patients 
with AF occurrence as compared to the patients without AF occurrence (2.4±0.8 vs. 
2.2±0.8, p = 0.023). In addition, 70% of the patients with AF occurrence received a 
cardiac resynchronization therapy device, whereas only 58% of the patients without AF 
occurrence received a cardiac resynchronization therapy device (p = 0.016; Table 1).
The use of medications was different for beta-blockers (lower in patients with AF 
occurrence, p = 0.006), diuretics/aldosterone antagonists (higher for the patients 
with AF occurrence, p = 0.046), and for statins (lower for the patients with AF oc-
currence, p = 0.018; Table 2).
Regarding the echocardiographic characteristics, patients with AF occurrence as 
compared to the patients without AF occurrence had larger LAVmax (34±16 ml/m2 
vs. 30±12 ml/m2, p = 0.003), LAVmin (21±13 ml/m2 vs. 17±10 ml/m2, p = 0.001), 
LAVpre-A (24±14 ml/m2 vs. 21±10 ml/m2, p = 0.010). In addition, LA booster func-
tion was more depressed in patients with AF occurrence (18±11% vs. 21±12%, p 
= 0.007). Finally, PA-TDI duration was longer in patients with AF occurrence as 













ACE inhibitors/Angiotensin receptor 
blockers (%)
417 (84) 117 (82) 300 (85) 0.47
Beta-blockers (%) 341 (69) 85 (60) 246 (73) 0.006
Ca-antagonists (%) 30 (6) 7 (5) 23 (7) 0.50
Antiarrhythmics class III (%) 100 (20) 33 (23) 67 (19) 0.29
Diuretics/aldosterone antagonists (%) 363 (73) 113 (80) 257 (73) 0.046
Nitrates (%) 89 (18) 21 (15) 68 (19) 0.24
Statins (%) 345 (70) 88 (62) 257 (73) 0.018
Oral anticoagulants (%) 263 (53) 77 (54) 183 (53) 0.80
Aspirin (%) 210 (42) 54 (38) 156 (44) 0.21
ACE: angiotensin-converting enzyme
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compared to patients without AF occurrence (154±27 ms vs. 135±24 ms, p <0.001; 
Figure 1).
Predictors of af occurrence in the overall patient population
A total ofOverall 142 of the 495 (29%) patients experienced a first AF episode during 
a mean follow-up of 16.4±11.2 months.














LVEDV indexed (ml/m2) 95±35 92±34 97±35 0.22
LVESV indexed (ml/m2) 69±31 67±30 70±32 0.31
LVEF (%) 29±10 29±10 29±10 0.93
Severe mitral regurgitation (%) 28 (6) 9 (6) 19 (5) 0.68
E/A ratio 1.3±0.9 1.4±0.9 1.3±0.9 0.041
Deceleration time (ms) 176±72 181±81 174±68 0.65
E/E’ ratio 22±25 22±20 22±27 0.53
LAVmax indexed (ml/m2) 31±13 34±16 30±12 0.012
LAVmin indexed(ml/m2) 18±11 21±13 17±10 0.004
LAVpre-A indexed (ml/m2) 22±11 25±14 21±10 0.013
LA emptying fraction (%) 43±15 41±16 44±14 0.052
LA reservoir function (%) 92±60 86±61 94±60 0.10
LA conduit function (%) 29±13 29±14 30±13 0.67
LA booster function (%) 20±12 18±11 21±12 0.002
PA-TDI duration (ms) 141±26 154±27 135±24 <0.001
LA: left atrial; LAVmax: maximum left atrial volume; LAVmin: maximum left atrial volume; LAVpre-A: left 
atrial volume before atrial active contraction; LVEDV indexed: left ventricular end-diastolic volume; LVEF: left 
ventricular ejection fraction; LVESV: left ventricular end-systolic volume; PA-TDI duration: time-interval from 
the beginning of the electrocardiogram P wave and the peak of A’
LATERAL wave at tissue Doppler images
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To identify independent predictors of AF during follow-up, univariable predictors 
with a p-value <0.05 were entered into the Cox proportional-hazard model as covari-
ates.
On multivariable analysis, female gender (hazard ratio, 1.60; 95% CI, 1.09-2.35; p 
= 0.017), history of AF (hazard ratio, 2.22; 95% CI, 1.51-3.27; p <0.001), and PA-TDI 
duration (hazard ratio per 20 ms increase, 1.27; 95% CI, 1.13-1.42; p <0.001), were 
independently associated with AF occurrence during follow-up (Table 4).
When the patient population was dichotomized based on the median PA-TDI 
duration (139 ms), the Kaplan-Meier curve demonstrated that patients with longer 
PA-TDI duration experienced significantly higher AF occurrence as compared to 
patients with shorter PA-TDI duration (log rank p <0.001; Figure 2). In particular, 
a cumulative 18%, 30%, and 44% of patients with longer PA-TDI experienced AF 
occurrence at 6, 12 and 18 months follow-up, respectively. In contrast, a respective 
10%, 13%, and 18% of patients with shorter PA-TDI duration experienced AF occur-
rence during the same time period. Figures 3A and 3B show the Kaplan-Meier curves 
for the other 2 variables independently related to AF occurrence during follow-up: 
female gender and history of AF.
table 4. Cox uni- and multivariable regression analysis to identify predictors of AF occurrence during follow-up
dependent variable:
AF occurrence during follow-up
univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Female 1.73 (1.21-2.48) 0.003 1.60 (1.09-2.35) 0.017
History of AF 3.42 (2.44-4.78) <0.001 2.22 (1.51-3.27) <0.001
NYHA functional class 1.32 (1.01-1.63) 0.011 1.09 (0.83-1.43) 0.55
Cardiac resynchronization therapy 1.69 (1.18-2.41) 0.004 1.29 (0.85-1.96) 0.24
Beta-blockers 0.59 (0.42-0.83) 0.002 0.81 (0.56-1.16) 0.24
Diuretics/aldosterone antagonists 1.59 (1.01-2.39) 0.026 1.04 (0.65-1.65) 0.89
Statins 0.66 (0.47-0.93) 0.016 0.95 (0.66-1.36) 0.78
LAVmin indexed (per 10ml/m2) 1.29 (1.13-1.48) <0.001 1.09 (0.92-1.29) 0.31
LA booster function (per 1%) 0.09 (0.02-0.40) 0.002 0.47 (0.08-2.72) 0.40
PA-TDI duration (per 20ms) 1.44 (1.30-1.60) <0.001 1.27 (1.13-1.42) <0.001
AF: atrial fibrillation; CI: confidence intervals; HR: hazard ratio; LA: left atrial; LAVmin: maximum left atrial 
volume; NYHA: New York Heart Association; PA-TDI duration: time-interval from the beginning of the 
electrocardiogram P wave and the peak of A’
LATERAL wave at tissue Doppler images.
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Patients with vs. patients without history of af
From According to the baseline clinical history, a total of 102 (21%) patients had a his-
tory of AF. Of the 102 patients with history of AF, 56 (55%) had history of paroxysmal 
AF and 46 (45%) of persistent AF. Specifically, AF occurrence during follow-up was 
higher in patients with history of persistent AF as compared to paroxysmal AF (70% 
vs. 46%, p = 0.019). There were no differences in the clinical characteristics between 
figure 2. Kaplan-Meier estimates of occurrence of atrial fibrillation (AF). The probability of AF occurrence 
differed significantly between the 2 groups dichotomized based on the median total atrial conduction time 
estimated with tissue Doppler imaging (PA-TDI duration) of 139 ms.
a B
figure 3. Kaplan-Meier estimates of occurrence of atrial fibrillation (AF) in male and female (Panel a), and in 
patients with and without history of AF (Panel B).
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patients with and without history of AF except for age, patients with history of AF 
were older than the patients without history of AF (65±10 vs. 61±12 years, p = 0.005). 
In addition, patients with history of AF were most often treated with antiarrhythmic 
drugs and oral anticoagulants (43% vs. 14%, p <0.001 and 64% vs. 51%, p <0.001, 
respectively), whereas the use of aspirin was larger in patients without history of AF 
(45% vs. 32%, p = 0.021).
Regarding the echocardiographic characteristics, as compared to the patients 
without history of AF, the patients with history of AF had larger LAV (37±18 ml/m2 vs. 
30±12 ml/m2, p <0.001 for LAVmax, 24±14 ml/m2 vs. 17±9 ml/m2, p <0.001 for LAV-
min, 28±15 ml/m2 vs. 21±10 ml/m2, p <0.001 for LAVpre-A) and poorer LA functions 
(38±15% vs. 45±14%, p <0.001 for total LA empting function, 72±50% vs. 97±62%, 
p <0.001, for LA reservoir function, 27±13% vs. 30±13%, p = 0.028, for LA conduit 
function, 15±10% vs. 22±12%, p <0.001, for LA booster function). In addition, PA-
TDI duration was significantly longer in patients with history of AF as compared to 
the patients without history of AF (159±32 ms vs. 136±22 ms, p <0.001).
Predictors of AF occurrence in patients without history of AF
To identify independent predictors of AF during follow-up in patients without history 
of AF, significant univariable predictors were entered into the Cox proportional-hazard 
model as covariates. On multivariable analysis, female gender (hazard ratio, 1.95; 95% 
CI, 1.22-3.10; p = 0.005), and PA-TDI duration (hazard ratio per 20 ms increase, 1.34; 
95% CI, 1.13 to 1.58; p = 0.001), were independently associated with AF occurrence 
during follow-up (Table 5). Figure 4A shows the Kaplan-Meier curves for the PA-TDI 
duration in patients without history of AF.
a B
figure 4. Kaplan-Meier estimates of occurrence of atrial fibrillation (AF) in patients without history of AF 
(Panel a) and with history of AF (Panel B).
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Predictors of AF occurrence during follow-up in patients with history of AF
To identify independent predictors of AF during follow-up in patients with history of 
AF, significant univariable predictors were entered into the Cox proportional-hazard 
model as covariates. On multivariable analysis, cardiac resynchronization device 
therapy (hazard ratio, 2.67; 95% CI, 1.39-5.10; p = 0.003), and PA-TDI duration (hazard 
ratio per 20 ms increase, 1.19; 95% CI, 1.03 to 1.38; p = 0.022), were independently 
associated with AF occurrence during follow-up (Table 6). Figure 4B shows Kaplan-
Meier curves for the PA-TDI duration in patients with history of AF.
discussion
The main findings of the present study are: 1) the independent predictors of AF occur-
rence in advanced heart failure patients were female gender, history of AF and PA-TDI 
table 5. Cox uni- and multivariable regression analysis to identify predictors of AF occurrence during follow-
up in the subgroup of patients without history of AF
dependent variable:
AF occurrence during follow-up
univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Female 1.98 (1.25-3.14) 0.003 1.95 (1.22-3.10) 0.005
NYHA functional class 1.31 (0.99-1.72) 0.051 … …
Cardiac resynchronization therapy 1.24 (0.80-1.94) 0.34 … …
Beta-blockers 0.71 (0.45-1.13) 0.15 … …
Diuretics/aldosterone antagonists 1.33 (0.81-2.18) 0.26 … …
Statins 0.56 (0.36-0.87) 0.010 0.65 (0.42-1.02) 0.060
LAVmin indexed (per 10ml/m2) 1.14 (0.92-1.42) 0.23 … …
LA booster function (per 1%) 0.29 (0.05-1.76) 0.16 … …
PA-TDI duration (per 20ms) 1.34 (1.13-1.58) 0.001 1.34 (1.13-1.58) 0.001
AF: atrial fibrillation; CI: confidence intervals; HR: hazard ratio; LA: left atrial; LAVmin: maximum left atrial 
volume; NYHA: New York Heart Association; PA-TDI duration: time-interval from the beginning of the 
electrocardiogram P wave and the peak of A’
LATERAL wave at tissue Doppler images.
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duration; 2) in the subgroups of patients with and without history of AF, PA-TDI dura-
tion remained an independent predictor of AF occurrence during follow-up.
Heart failure and af
Heart failure and AF are two disorders that frequently coexist. Indeed, many clinical 
conditions such as age, hypertension, diabetes and coronary artery disease are com-
mon risk factors for both AF and heart failure.19 Moreover, in heart failure patients 
conditions such as atrial enlargement or poor atrial function related to the remodel-
ling processes may predispose to AF occurrence.6 In addition, previous studies have 
shown that heart failure patients who develop AF have a worse prognosis than heart 
failure patients free from AF.1, 20-23 Therefore, the identification of heart failure patients 
at higher risk for AF occurrence may be useful in order to initiate early prophylactic 
therapies and improve the long-term outcome of these patients.
process is the ability to identify all of the AF episodes in these patients. In par-
ticular, asymptomatic AF episodes may be misclassified during clinical follow-up 
and it has been shown that these asymptomatic AF episodes may have relevant 
table 6. Cox uni- and multivariable regression analysis to identify predictors of AF occurrence during follow-
up in the subgroup of patients with history of AF
dependent variable:
AF occurrence during follow-up
univariable analysis Multivariable analysis
Hr (95% ci) p value Hr (95% ci) p value
independent variables
Female 1.39 (0.77-2.51) 0.27 … …
NYHA functional class 1.30 (0.91-1.86) 0.14 … …
Cardiac resynchronization therapy 2.99 (1.58-5.65) 0.001 2.67 (1.39-5.10) 0.003
Beta-blockers 0.84 (0.50-1.40) 0.50 … …
Diuretics/aldosterone antagonists 1.72 (0.82-3.64) 0.15 … …
Statins 1.09 (0.64-1.86) 0.76 … …
LAVmin indexed (per 10ml/m2) 1.15 (0.96-1.38) 0.12 … …
LA booster function (per 1%) 0.12 (0.01-2.05) 0.14 … …
PA-TDI duration (per 20ms) 1.25 (1.08-1.45) 0.003 1.19 (1.03-1.38) 0.022
AF: atrial fibrillation; CI: confidence intervals; HR: hazard ratio; LA: left atrial; LAVmin: maximum left atrial 
volume; NYHA: New York Heart Association; PA-TDI duration: time-interval from the beginning of the 
electrocardiogram P wave and the peak of A’
LATERAL wave at tissue Doppler images.
196 ○ Chapter 11 
AF-related complications similar to overt, symptomatic AF episodes.24, 25 Interroga-
tion of newer more sophisticated pacemaker or ICD devices allows the detection 
of asymptomatic AF episodes.9, 26 A study by Glotzer et al.9 demonstrated that in 
patients with a pacemaker for sinus node dysfunction the atrial high rate events 
detected by pacemaker interrogation were significantly related to the risk of death or 
stroke. However, the interrogation of the device to classify AF episodes can be ap-
plied only in patients with a pacemaker or ICD. Therefore, in the current study, heart 
failure patients selected for ICD implantation were recruited in order to detect all the 
AF episodes, including the asymptomatic episodes, through the ICD interrogation.
Predictors of af occurrence in the overall heart failure patient population
In the present study, clinical and echocardiographic predictors of AF occurrence in 
heart failure patients were explored. In particular, among the clinical predictors, fe-
male gender and history of AF were confirmed to be independently associated with AF 
occurrence.5 Among the echocardiographic variables, LA volumes and booster func-
tion together with PA-TDI duration were associated with AF occurrence at univariable 
analysis. However, at multivariable analysis only PA-TDI duration was an independent 
echocardiographic predictor of AF occurrence (adjusted hazard ratio = 1.27, 95% CI 
1.13-1.42, p <0.001). This finding underlines that a surrogate of the total atrial conduc-
tion time like PA-TDI was a stronger predictor of AF occurrence as compared to LA 
volumes and LA function. A possible explanation may be that the LA remodelling pres-
ent in heart failure patients is associated with an increased risk of the development of 
AF. The remodelling process causes an increase in LA volumes, with a deterioration 
in LA function and an increase in LA fibrosis. Both LA enlargement and LA fibrosis 
may promote the occurrence of AF in these patients.27 The total atrial conduction 
time (PA-TDI duration) may be influenced not only by LA enlargement but also by 
LA fibrosis which may further slow down the electrical atrial conduction. Therefore, 
PA-TDI duration may be more strongly related to AF occurrence than measurement of 
LA volumes or function.
Pa-tdi duration as a predictor of af occurrence in the subgroup without history of af
Previous studies have explored the role of total atrial conduction time detected with 
tissue Doppler imaging for the prediction of AF occurrence in patients without history 
of AF.7, 28 In particular, de Vos et al. used the PA-TDI duration to predict AF occurrence 
in 249 patients with preserved ejection fraction (60±10%) referred for a standard 
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echocardiographic examination. The authors demonstrated that PA-TDI duration was 
independently related to AF occurrence during follow-up. In the present study, 393 
of the heart failure patients had no previous history of AF and the mean ejection 
fraction in this subgroup of patients was 29±10%. PA-TDI was still an independent 
predictor of AF occurrence during follow-up. Therefore, the current study highlights 
that PA-TDI is also an important predictor of AF occurrence in heart failure patients 
with depressed left ventricular ejection fraction, extending previous results in different 
patient populations.7, 28
Pa-tdi duration as a predictor of af occurrence in the subgroup with history of af
In the present study a total of 102 heart failure patients had a history of AF. The analy-
sis of this subset of patients underlined that PA-TDI duration was still an independent 
predictor of AF occurrence together with implantation of a cardiac resynchronization 
therapy device. Patients selected for cardiac resynchronization therapy were character-
ized by more advanced heart failure, a condition shown to be an important predictor 
of AF occurrence.4, 5 In addition, the relevance of measuring PA-TDI duration in these 
patients is stressed by previous findings.29 Specifically, Buck et al. reported that an 
estimation of total atrial conduction time with PA-TDI may have great relevance for 
the selection of advanced heart failure patients who will be amenable to cardiac resyn-
chronization therapy.29
The finding that PA-TDI duration was again independently associated with AF 
occurrence during follow-up shows for the first time the relevance of this index even 
in patients with history of AF. Therefore, PA-TDI duration may be useful for the 
risk-stratification of heart failure patients with or without history of AF.
clinical implications
Early risk stratification for AF occurrence is very important, especially in heart failure 
patients who have increased risk of thromboembolic complications during AF. The 
present study has demonstrated that PA-TDI duration can predict AF occurrence in 
heart failure patients. However, future large randomized trials are needed to clarify 
the potential relation between PA-TDI duration and thromboembolic complications 
during AF in heart failure patients.
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concLusions
PA-TDI duration was independently associated with AF occurrence in heart failure 
patients with or without history of AF. This parameter may be useful to risk-stratify 
heart failure patients for AF occurrence.
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The general introduction of the thesis outlines the role of cardiac mechanics assess-
ment in the evaluation and risk stratification of HF patients.
Part i
This part of the thesis summarizes current imaging techniques to assess various 
aspects of LV mechanics in HF patients (chapter 2), differentiating between ischemic 
and non-ischemic HF (chapter 3) and investigating its role in the selection of HF 
patients who are candidates to CRT (chapters 4-6). Furthermore, the role of imaging 
techniques to optimize the results of CRT is summarized in chapter 7.
Part ii
The final part focuses on long-term prognosis of advanced HF patients. Novel echocar-
diographic techniques provide several parameters that have incremental prognostic 
value over well-recognized echocardiographic and clinical parameters (chapters 8-11).
concLusions
The study of cardiac mechanics is crucial in advanced HF patients. Particularly, using 
imagine techniques as speckle-tracking echocardiography, important information on 
the effects of CRT in heart failure patients may be derived. Moreover, studying LV 
mechanics may be helpful for understanding the differences in pathophysiological 
mechanisms of different HF aetiologies. Finally, the role of non-invasive imaging 
techniques for the study of LV mechanics may be paramount for the definition of 
long-term prognosis in advanced HF patients.
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saMenVattinG en concLusies
De algemene introductie van deze scriptie geeft kort weer wat de rol is van de analyse 
van cardiale dynamiek bij de evaluatie en risico inschatting van hartfalen patienten.
deel 1
Dit onderdeel is een samenvatting van de huidige beeldvomings technieken voor het 
beoordelen van de LV dynamiek in hartfalen patienten (Hoofdstuk 2), de differentiatie 
tussen ischemische en non-ischemische hartfalen (Hoofdstuk 3) en de rol hiervan in 
de selectie van CRT kandidaten.
deel 2
Het laatste gedeelte richt zich op de lange termijn prognose van patienten met 
eindstadium hartfalen. Nieuwe echocardiografische technieken en metingen hebben 
steeds meer toenemende waarde naast de bekende, conventionele echocardiografi-
sche en klinische parameters (Hoofdstuk 8-11).
Onderzoek naar cardiale dynamiek is van cruciaal belang bij patienten met eind-
stadium hartfalen. Met beeldvorming zoals speckle-tracking echocardiografie kan 
belangrijke informatie worden verkregen over de effecten van CRT bij deze populatie. 
Bovendien kan analyse van LV dynamiek helpen bij het onderkennen van verschillende 
pathofysiologische processen bij verscheidene vormen van hartfalen. De rol van non-
invasieve beeldvorming zou van essentieel belang kunnen zijn bij het vaststellen van 
lange termijn prognose bij patienten met eindstadium hartfalen.
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